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Abstract 
Idiopathic pulmonary fibrosis (IPF) is a fatal form of fibrotic lung disease. The 
pathogenesis of IPF is unclear. An aberrant alveolar epithelial wound repair is likely to be 
involved in the disease process. Alveolar bronchiolisation, a process where bronchiolar 
Clara cells migrate into the affected alveoli, is a manifestation of abnormal alveolar wound 
repair. The role of Clara cells during alveolar injury repair in IPF is controversial. This 
study was undertaken to investigate the role of Clara cells in alveolar epithelial wound 
repair and pulmonary fibrosis. Currently, there is no curative treatment for IPF; therefore, 
stem-cell mediated regenerative therapy has been suggested. In this study, the paracrine 
role hMSC and hESC on pulmonary epithelial wound repair has also been evaluated. 
 
A direct-contact co-culture in vitro model was utilised to evaluate the role of Clara cells on 
alveolar epithelial cell wound repair. Immunohistochemistry was conducted on IPF lung 
tissue samples to replicate the in vitro findings ex vivo. The paracrine role of hMSC and 
hESC on pulmonary epithelial cells was evaluated by utilising the in vitro wound repair 
system. 
 
This study demonstrates that Clara cells induce apoptosis in AEC through a TRAIL-
dependent mechanism, resulting in significant inhibition of wound repair. Furthermore in 
the IPF lungs, TRAIL-expressing Clara cells were detected within the fibrotic alveoli, 
together with widespread AEC apoptosis. This study also demonstrates that hMSC enhance 
AEC and SAEC wound repair via a paracrine mechanism through stimulation of cell 
migration; whereas, secretory factors of differentiated hESC promote AEC wound repair 
through stimulation of both cell proliferation and migration. 
 
 III 
Through this study I propose a novel hypothesis which implies that the extensive pro-
fibrotic remodelling associated with IPF could be driven by TRAIL-expressing Clara cells 
inducing AEC apoptosis through a TRAIL-dependent mechanism. My study also supports 
the notion of clinical application of hMSC and hESC or their secretory products as 
regenerative therapeutic modality for IPF. 
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1.1. Definition of Idiopathic pulmonary fibrosis 
Idiopathic pulmonary fibrosis (IPF) is defined as a specific form of chronic, progressive 
fibrosing interstitial pneumonia of unknown aetiology, occurring primarily in older adults, 
limited to the lungs, and associated with the histopathological and/or radiological pattern 
of usual interstitial pneumonias (UIP) (Raghu et al., 2011). This disease is also referred as 
cryptogenic fibrosing alveolitis (Selman & Pardo, 2002). The pathophysiology of IPF 
involves micro-injuries to alveolar epithelium, abnormal wound repair, accumulation of 
fibroblasts and myofibroblasts, deposition of excessive extracellular matrix, replacement of 
normal lung tissue with fibrotic scar and alteration of normal lung architecture. IPF is 
clinically manifested by progressive worsening of dyspnoea, deterioration of lung function 
and ultimately respiratory failure (Raghu et al., 2011, Gharaee-Kermani et al., 2007).  
 
IPF, which is synonymously known as UIP, is the most common and possibly the fatal 
form of idiopathic interstitial pneumonias (IIPs). Idiopathic interstitial pneumonias are a 
group of diffuse parenchymal lung diseases of unknown cause associated with varying 
degrees of inflammation and fibrosis (Kim et al., 2006, Maher et al., 2007). Mostly 
affected group are 50 years or older. Unlike the other inflammatory and fibrotic lung 
diseases, IPF does not significantly response to steroids or any other potent anti-
inflammatory drugs. Cytotoxic immunosuppressive agents largely fail to reduce the death 
rate of patients who are suffering from IPF. The only curative treatment option is lung 
transplantation (Selman et al., 1998).  
 
1.2. Epidemiology and vital statistics of IPF  
To date, there is no large-scale statistical study on IPF; thereby, formal estimation of 
incidence and prevalence of IPF is difficult (Raghu et al., 2011). The geographical 
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distribution of IPF is equal across the rural and urban areas, race and ethnicity but 
mortality has been reported slightly higher in whites than blacks. The mostly affected age-
group is over 50 years of age and two-third of them is over 60 years at their presentation of 
disease. Males are more affected than females (ATS/ERS, 2000, Kim et al., 2006). The 
median survival of IPF patient is 2.8 years (Bjoraker et al., 1998). A recent study 
demonstrated that in the United States of America, incidence and prevalence of IPF, on the 
basis of clinical diagnosis, were 16.3 and 42.7 per 100,000 people respectively. But on the 
basis of surgical lung biopsy, BAL (Bronchoalveolar lavage) and CT scan confirmatory 
reports, the incidence and prevalence were 6.8 and 14.0 per 100,000 population 
respectively (Raghu et al., 2006). Higher incidence was found in the age group of 75 years 
or older where it was 76.4 per 100,000 people; as compared to age group 18 to 34 years, 
with 1.2 per 100,000. The prevalence was appeared to be increasing with an approximate 
rate of 150% in the last decade. An estimated 48,000 new IPF cases are currently 
diagnosed annually in the USA alone (ATS/ERS, 2000, Raghu et al., 2006). 
 
A European study demonstrated that in Norway, average incidence of clinically diagnosed 
IPF was 4.3 per 100,000 population with an average prevalence of 21.8 per 100,000 people 
in a 15-year time period (von Plessen et al., 2003). In that study, the incidence of IPF was 
significantly higher in old aged people. A study in the United Kingdom reported an overall 
incidence rate of IPF was 4.6 per 100,000 cases per year with a progressive 11% increment 
of incidence rate per annum between 1991 to 2003 (Gribbin et al., 2006). According to this 
study, more than 4,000 new IPF cases are currently being diagnosed each year in the UK.  
 
The evidence suggests that the mortality rate from IPF has increased over the last two 
decades. In the United States, the mortality rate from IPF has significantly risen from 1992 
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to 2003 time period, where it was 61.2 deaths per 1,000,000 in men and 54.5 deaths per 
1,000,000 for women in the 2003 (Olson et al., 2007). A Japanese study documented 33 
deaths in men and 24 in women per 1,000,000 from IPF (Iwai et al., 1994). The mortality 
rate from IPF has reported to be higher than the deaths from many cancers (Jemal et al., 
2007). 
 
1.3. Risk factors of IPF  
1.3.1. Acquired risk factors 
By definition, IPF is a disease of unknown aetiology, as no specific cause has been 
strongly identified so far. However, numbers of potential risk factors have been reported 
which may have some association with development of this disease (Raghu et al., 2011).  
■ Cigarette smoking: Heavy smoking is believed to be associated with IPF, and this 
association is related to both familial and sporadic IPF (Baumgartner et al., 1997, Steele et 
al., 2005, Antoniou et al., 2008). 
■ Environmental exposures: Exposure to metal dusts, in particular brass, lead and steel as 
well as wood dust has a significant risk for development of IPF (Hubbard et al., 1996, 
Miyake et al., 2005, Gustafson et al., 2007). Some occupational hazards related to farming, 
bird raising, hair dressing, stone cutting/polishing, livestock have also demonstrated 
association with IPF (Baumgartner et al., 1997).  
■ Microorganisms: Chronic viral infection, particularly, Epstein-Barr-Virus (EBV) (Egan 
et al., 1995, Stewart et al., 1999, Tsukamoto et al., 2000, Lok et al., 2001, Kelly et al., 
2002) and hepatitis C virus (Ueda et al., 1992, Meliconi et al., 1996) infections are though 
to have close association with initiation of IPF. A study on 33 IPF patients found evidences 
of herpesvirus infection including cytomegalovirus, EBV, human herpesvirus (HHV)-7 
and human HHV-8 in 97% of IPF cases (Tang et al., 2003). However, in contrast, some 
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other studies reported no correlation between viral infection and IPF (Wangoo et al., 1997, 
Zamò et al., 2005). Despite the large number of studies, no definitive conclusion on the 
role of EBV infection in the development of IPF has been drawn. This is possibly because 
of high prevalence of viral infection in general population (Raghu et al., 2011). 
■ Gastroesophageal reflux: Microaspiration in gastroesophageal reflux is thought to have 
an association with IPF (Tobin et al., 1998, Raghu et al., 2006). 
■ Diabetes mellitus (DM): A recent study demonstrated that DM could have an association 
with IPF as well (Gribbin et al., 2009).   
 
1.3.2. Genetic risk factors 
1.3.2.1. Familial idiopathic pulmonary fibrosis: Mutation in the surfactant protein-C 
(SFTPC) gene has a strong association with familial IPF (Thomas et al., 2002); whereas, 
this mutation is uncommon in sporadic IPF (Selman et al., 2003, Lawson et al., 2004). The 
SFTPC gene mutation is thought to be one the causes of type II alveolar epithelial cell 
(AECII) injury (Thomas et al., 2002). A rare mutation in gene encoded for surfactant 
protein-A2 (SFTPA2) has also been reported in familial IPF (Wang et al., 2009). Recent 
studies identified a mutation in the human telomerase reverse transcriptase (hTERT) gene 
in familial IPF (Armanios et al., 2007, Tsakiri et al., 2007, Alder et al., 2008, Diaz de Leon 
et al., 2010). This mutation causes telomere shortening which may ultimately result in the 
alveolar epithelial cell apoptosis (Raghu et al., 2011). 
  
1.3.2.2. Sporadic idiopathic pulmonary fibrosis: To date, there is no genetic factor 
identified that is consistently associated with sporadic IPF (Raghu et al., 2011). However, 
polymorphisms of genes encoding interleukin (IL)-1α, IL-4, IL-6, IL-8, IL-10, IL-12, 
tumour necrosis factor-α (TNF-α), transforming growth factor-β1 (TGF-β1), angiotensin 
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converting enzyme and matrix metalloproteinase-1 (MMP-1) have been detected, although 
inconsistently, in some cases of sporadic IPF (Riha et al., 2004, Vasakova et al., 2007, 
Hutyrova et al., 2002, Renzoni et al., 2000, Pantelidis et al., 2001, Xaubet et al., 2003, 
Whittington et al., 2003, Morrison et al., 2001, Checa et al., 2008). 
 
1.4. Histopathological features 
The histopathological hallmark and the cardinal diagnostic criteria of IPF/UIP is the 
heterogeneous appearance of lung tissue characterised by areas of fibrosis with scarring 
and honeycomb changes alternating with areas of less affected or healthy-looking lung 
parenchyma (Raghu et al., 2011). This alternate patchy distribution of affected and 
unaffected lung tissue is also termed as „temporal heterogeneity‟ (Dacic & Yousem, 2003). 
These histopathological changes mostly affect the subpleural and paraseptal regions of the 
lung. Inflammation is usually mild and associated with hyperplasia of type II AEC and 
bronchiolar epithelium. Another consistent histopathologic feature is the presence of 
fibroblastic foci which are scattered, convex subepithelial foci composed of dense collagen 
with fibroblasts and myofibroblasts (Figure 1.1). The areas of honeycomb changes are 
often cystic, frequently lined with bronchiolar epithelium and are filled with mucus which 
appears relatively late stages of disease progression (ATS/ERS, 2000, Raghu et al., 2011).  
 
The histological pattern of UIP is not unique to IPF; similar features are also found in 
asbestosis, scleroderma, collagen vascular diseases, drug toxicity, chronic hypersensitivity 
pneumonitis and Hermansky-Pudlak syndrome; but the uniqueness of IPF is the absence of 
any definitive cause (ATS/ARS, 2002, Raghu et al., 2008). On the other hand, some biopsy 
samples of IPF patients may not fulfill the criteria of UIP. In those cases the histological 
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pattern of IPF are termed as “nonclassifiable fibrosis”; hence the diagnosis in made based 
on clinical and radiological findings (ATS/ERS 2000, Raghu et al., 2011). 
 
 
Figure 1.1: Histological slides of normal and IPF lung tissues. 
(A) Alveolar region of normal human lung tissue, immunostained with antibody against Sp-C 
showing Sp-C positive AECII cells (arrow) in high magnification (400X). (B) Fibroblastic foci are 
shown (arrows) in the alveolar region of the affected part of an IPF lung in low magnification 
(100X). (C) Fibroblastic foci (FF) and hyperplasia of AECII (arrows) are shown in the alveolar 
regions of IPF lung. Tissue section stained with antibody against TGF-β; image magnification 
200X. (D) Myofibroblasts within the fibroblastic foci (FF) are stained with antibody against α-
SMA. Image magnification is 400X. (Images are taken from Lomas et al., 2012). 
B A 
C D 
FF 
FF 
Chapter 1:                                                                                                   Introduction 
PhD thesis by K. M. Akram                                                                    Keele University - 8 - 
1.5. Clinical features of IPF 
Most often patients with IPF suffer for more than 6 months before diagnosis. (ATS/ERS, 
2000, Selman et al., 2001). The most common clinical features of IPF are as follows: 
■ Nonproductive cough: Gradual onset. 
■ Exertional breathlessness: Most prominent and disabling symptom. 
■ Paroxysmal dry cough which is not relieved by common antitussives. 
■ Inspiratory crackles: Found in more than 80% of patients which is typically „dry‟ and 
„Velcro‟ type and initially present at lung bases and afterwards appears in the mid and 
upper zones in course of disease progression. 
■ Digital clubbing: Present in 25% to 50% patients.  
■ Cyanosis: Appears in late stage of disease. 
■ Cardiac signs: Cor pulmonale, right ventricular heave, accentuated pulmonic second 
sound and peripheral oedema may be appeared at the late stage of disease. 
■ Generalised illness: Weight loss, fatigue and malaise can be noticed but fever is rare.  
(ATS/ERS, 2000, Selman et al., 2001). 
 
1.5.1. Radiological abnormalities 
Virtually all IPF patients present with some degree of chest radiological changes. 
Typically, bilateral basal reticular opacity is found in the postero-anterior view plain X-ray 
of chest which is widely non-specific (Figure 1.2A) (ATS/ERS 2000, Strollo, 2003, 
Misumi & Lynch, 2006). Computed tomography (CT) and high resolution computed 
tomography (HRCT) have become the mainstay of non-invasive investigation technique 
for diagnosis of IPF and other ILDs (Interstitial lung diseases) (Strollo, 2003). Presence of 
patchy, bilateral, predominantly basal and subpleural reticular opacity (80% cases) 
(ATS/ERS, 2000, Strollo, 2003), peripheral honeycombing (96% cases), minimal degree of 
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ground-glass opacity (75% cases) (Strollo, 2003, Hartman et al., 1993), traction 
bronchiectasis and bronchiolectasis in advanced stages (50% cases) are the classical 
imaging criteria for diagnosis of IPF on HRCT (Strollo, 2003) (Figure. 1.2B). 
 
1.6. Diagnosis of IPF 
During diagnosis, it is essential to exclude IPF from other interstitial lung diseases (ILDs) 
as the prognostic outcome of IPF is worse than other pulmonary fibrosis. Diagnosis of IPF 
is made on the basis of detailed medical history, physical examination, radiological HRCT 
investigation and surgical lung biopsy in some special cases (Figure. 1.3). To make a 
confident diagnosis of IPF, it is essential to take expert opinion of pulmonologists, 
radiologists, pathologists and thoracic surgeons (Raghu et al., 2008). According to the 
recent consensus by ATS/ERS the diagnostic criteria for IPF are as follows (Raghu et al., 
2011): 
 
1.6.1. Diagnostic criteria 
1. Exclusion of other known causes of ILD such as domestic and occupational exposures, 
connective tissue disorders and drug toxicity. 
2. The presence of UIP pattern on HRCT in suspected patients not undergoing surgical 
biopsy. 
3. Presence of specific UIP patterns in HRCT and surgical lung biopsy in patients are 
subject to surgical lung biopsy. 
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Figure 1. 2: Chest radiographs of a patient with IPF. 
(A) The PA-view X-ray chest of a male patient with IPF shows bibasilar and peripheral reticular 
opacity (arrows) with marked reduction of lung volume. (B) HRCT of lung of an IPF patient shows 
subpleural honeycombing (arrows). (The radiographs are kindly provided by Prof. Monica Spiteri, 
Directorate of Respiratory Medicine, University Hospital of North Staffordshire, Stoke-on-Trent, 
UK). 
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Figure 1.3: Algorithmic flowchart for IPF diagnosis. 
Diagnostic algorithm for IPF starts from detailed medical history following radiology to surgical 
lung biopsy. This chart is modified and simplified from (Raghu et al., 2008). 
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Lung function test 
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1.7. Classification of IIP  
According to the International Consensus Statement by the American Thoracic Society 
(ATS) and the European Respiratory Society (ERS) in 2001, IIPs are classified into two 
groups: one is IPF and another is non-IPF IIPs (Figure 1.4). (ATS/ARS, 2002, Raghu et al., 
2008). 
 
 
 
Figure 1.4: Current classification of IIP. 
Interstitial pneumonias (IIP) are broadly classified into IPF and Non-IPF IIP. IPF is again divided 
into two categories, sporadic and familial IPF. Based on clinical features, Non-IPF is divided into 
six categories. 
IIPs 
IPF Non-IPF 
Sporadic IPF 
Familial IPF 
Nonspecific interstitial pneumonia (NSIP)  
 
Cryptogenic organizing pneumonia 
 
Acute interstitial pneumonia 
(Hamman-Rich syndrome)  
Desquamative interstitial pneumonia (DIP) 
Respiratory bronchiolitis interstitial lung 
disease 
Lymphoid interstitial pneumonia (LIP)  
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1.8. Structure of the alveoli 
1.8.1. Alveoli: The functional units of lung 
Alveoli are the functional units of lung. There are approximately 300 million of alveoli 
present in the adult human lung with over 70 m
2
 of gas-exchange surface area. In adult, the 
alveoli are entirely covered with type I and type II pneumocytes (Figure 1.5). These cells 
are also referred to as alveolar epithelial cells (AEC). Type I AEC (AECI) are wide-spread 
squamous-like cells with diameters of up to 100 μm (Selman & Pardo, 2006) covering 
more than 96% of total alveolar surface area (Gharaee-Kermani et al., 2007). These cells 
are very thin with an average thickness of 0.1 μm (Bishop, 2004) which provides a thin 
membrane for gaseous exchange. Type II AEC (AECII) are cuboidal in nature and cover 
only 4% of alveolar surface area; although they accounts for more than 60% of all alveolar 
epithelial cells. AECII cells are usually localised in the corners of the alveoli, lying 
adjacent to the mesenchymal cells. Mesenchymal cells are situated underneath the 
basement membrane of epithelium (Figure 1.5). AECII are multifunctional and believed to 
be the defender and progenitor cells of alveoli (Fehrenbach, 2001).  
 
1.8.1.1. Function of AECII 
■ Putative stem/progenitor cells: Type II AEC are capable of self-renewal and can 
terminally differentiate into AECI and act as progenitor cells for alveolar regeneration 
(Fehrenbach, 2001). 
■ Production of surfactant: AECII cells secret surfactant proteins which primarily regulate 
alveolar surface tension. Alveolar surfactant contains about 90% of lipids and 10% of 
proteins. There are different types of surfactant proteins (SP) present in surfactant fluid, 
named as SP-A, SP-B, SP-C and SP-D. Surfactant also can play role in host defence 
mechanisms, especially with SP-A and SP-D by opsonising pathogens and presenting them 
Chapter 1:                                                                                                   Introduction 
PhD thesis by K. M. Akram                                                                    Keele University - 14 - 
to the macrophages. Surfactant is also believed to contribute in fluid balance in alveoli and 
hence prevent alveolar oedema (Fehrenbach, 2001). 
■ Interaction with other cells: Type II AEC have direct contact with AECI through gap 
junctions. A contact-inhibition interaction between AECI and AECII regulates AECII 
proliferation (Kasper & Haroske, 1996). On the other hand, mechanical stimulation of 
AECI can modulate exocytosis of lamellar bodies and secretion of surfactant by AECII 
(Ashino et al., 2000). In the alveoli, AECII and fibroblasts remain in close proximity and 
show both direct and indirect interactions during lung morphogenesis and 
repair/regeneration process. In vitro co-culture experiment demonstrated that fibroblast 
supernatant increased the alveolar epithelial cell proliferation; whereas, AEC supernatant 
inhibited the proliferation of fibroblasts. In direct cell-cell contact co-culture, AEC 
significantly increased fibroblast proliferation (Adamson et al., 1991). In addition AEC can 
secret interleukin-6 (IL-6) or interleukin-8 (IL-8) which can stimulate neutrophils and thus 
initiate inflammation. AECII may also play a role as an antigen presenting and 
immunoregulatory cell of the lung (Fehrenbach, 2001). They secrete TGF-β which 
indirectly inhibits T-cell activity and proliferation (Zissel et al., 2000). In response to 
stimuli, AEC can release chemokines which recruit macrophages in the alveoli and 
stimulate inflammation (O'Brien et al., 1998). 
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Figure 1.5: Schematic diagram of an alveolus with its adjacent pulmonary blood vessel. 
Alveolus is lined with type I and type II pneumocytes. Type I pneumocytes are very flat and cover 
>95% of surface area while type II pneumocytes are cuboidal and cover <5%. The alveolar duct is 
lined with non-ciliated, cuboidal, Clara cells. Type II pneumocytes and Clara cells are thought to 
have progenitor/stem cell properties. Resident fibroblasts are located within the interstitium. 
Alveolus and pulmonary blood vessel share a common basement membrane which makes the 
„respiratory membrane‟ for gas exchange. 
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1.9. Alveolar repair and regeneration 
1.9.1. Stem cells in alveolar regeneration  
Stem cells are capable of self-renewal, are clonogenic and can be described as an 
unspecialised cell with varying potency which can differentiate into various specialised 
adult phenotypes. Self-renewal is a characteristic property of stem cells that implies the 
production of exact duplicates of stem cells with maintenance of all attributes, including 
the full range of self-renewal of the original. The potency is the capacity of an 
unspecialised stem cell to differentiate into other specialised cell types. Different stem cell 
populations are broadly classified as unipotent, multipotent or pluripotent and totipotent by 
their potency. Unipotent stem cells differentiate into one specialised cell type, multipotent 
and pluripotent stem cells differentiate into many specialised cell types and totipotent stem 
cells can differentiate into all cells types (Martin, 1981, Brecher et al., 1993, Thomson et 
al., 1998).   
 
Undifferentiated multipotent tissue-specific stem/progenitor cells have been identified in 
almost all tissues and are thought to contribute tissue homeostasis and regeneration 
(Sueblinvong & Weiss, 2010). The lung is a complex and vital organ and highly exposed 
to the environment with around 70 m
2
 of alveolar surface area making it susceptible to 
frequent injuries by noxious substances and microorganisms. It is believed that there are 
numbers of anatomical region-specific stem/progenitor cells present within the lung, such 
as basal cells in trachea and distal airways (Rock et al., 2009), Clara cells in bronchioles 
(Stripp & Reynolds, 2008) and type II AEC in alveoli (Evans et al., 1975, Brody & 
Williams, 1992, Rawlins, 2008). These resident stem/progenitor cells contribute lung 
regeneration through their differentiation during physiological turnover and injury repair 
(Selman & Pardo, 2006, Gharaee-Kermani et al., 2007). 
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By lineage tracing study in transgenic mice models, Rock et al. showed that basal cells of 
trachea differentiated into tracheal lining epithelium during postnatal growth and in the 
adult during both steady-state and epithelial injury repair (Rock et al., 2009). In the same 
study, they also demonstrated that mouse and human basal cells isolated from trachea and 
distal airways could self-renew and were capable of differentiating into ciliated airway 
epithelial cells (Rock et al., 2009). On the other hand, Clara cells are non-ciliated cuboidal 
cells, broadly distributed throughout the bronchiolar epithelium which are normally 
quiescent in steady-state condition, but become activated following injury; proliferate and 
differentiate into other bronchiolar cells, hence they are termed as facultative progenitor 
cells (Stripp & Reynolds, 2008, Stripp, 2008). Not all but a subpopulation of Clara cells 
which are resistant to naphthalene-induced injury are thought to be the bronchiolar 
progenitor cells which contribute to bronchiolar repair and regeneration (Chen et al., 
2009). Lineage tracking in animal models has indicated that Clara cells may not participate 
in alveolar injury repair or regeneration (Rawlins et al., 2009). A naphthalene resistant 
population of cells which express both the Clara cell marker CCSP (Clara cell secretory 
protein, also known as CC10) and type II AEC marker proSP-C (ProSurfactant protein-C) 
have been identified at the bronchioloalveolar duct junction in mice. These cells can self-
renew and give rise to progeny which express CCSP, proSP-C or aquaporin-5 (AQP-5, a 
type I AEC marker) in culture, hence they have acquired the title of putative 
bronchioloalveolar stem cells (BASCs) (Kim et al., 2005). However, the role of BASCs in 
bronchiolar or alveolar repair in vivo is unclear and needs to be further elucidated. 
 
For more than 50 years, type II AEC have been described as the stem/progenitor cells in 
the alveoli and are believed to give rise to type I AEC and participate in alveolar 
regeneration and repair (Bishop, 2004). Type II AEC can be sub-divided into two groups; 
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E-cadherin positive and E-cadherin negative. E-cadherin positive cells are quiescent, liable 
to DNA damage with low level of telomerase activity. Whereas, E-cadherin negative cells 
are resistant to DNA damage, proliferative, with a high level of telomerase activity. The E-
cadherin negative type II AEC are likely to be the progenitor cells of alveoli (Reddy et al., 
2004). In late 1960s when Kapanci and colleagues proposed type II AEC as alveolar stem 
cells, this concept was widely accepted. However, there are arguments around whether 
type II AEC fulfill all the criteria to be classified as a stem cell. 
 
Recently, Fujino and colleagues isolated MSC-like cells from human lungs which were 
clonogenic, self-renewing and could differentiate into type II AEC in vitro (Fujino et al., 
2011). They also demonstrated that this MSC-like cell population, which expressed both 
mesenchymal stem cell marker CD90 and type II AEC marker proSP-C, were present in 
the normal human alveolar wall and their number significantly increased in the 
hyperplastic regions of IPF alveoli, possibly, as a reparative response (Fujino et al., 2011). 
The authors suggested these CD90/proSP-C dual positive MSC-like cells could be 
progenitors for type II AEC (Fujino et al., 2011). More recently, an exciting study 
demonstrated that there are undifferentiated stem cells nested in the niche of distal airways 
of human lungs which are clonogenic, self-renewing and multipotent in nature (Kajstura et 
al., 2011). Kajstura and colleagues isolated these stem cells from human lung, particularly 
from the distal airway regions. They expanded those cells in vitro and then transplanted 
into the injured mouse lungs. They demonstrated that those transplanted stem cells 
generated bronchioles, alveoli and pulmonary vasculature (Kajstura et al., 2011). This 
finding has opened a new horizon to manipulate the niche-stem cells to promote lung 
regeneration as a therapeutic intervention for various lung disorders including IPF.  
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Apart from endogenous lung stem cells, bone marrow derived haematopoitic stem cells 
(BM HSC) are thought to be an exogenous stem cell source for maintenance of alveolar 
epithelium during physiological turnover or injury repair (Bishop, 2004, Hunninghake et 
al., 2003). This idea is supported by animal model studies that demonstrated that 
intravenously transplanted bone marrow stem cells were capable of differentiating into 
type I AEC (Kotton et al., 2001) and type II AEC (Theise et al., 2002). In the radiation 
induced pneumonitis mouse model, Theise and colleague demonstrated that after injury 
type II AEC derived from donor bone marrow-transplant and engrafted in the injured 
alveoli. After 2 months of transplantation the entire alveoli were lined with bone marrow-
derived AEC, suggesting that the type I AEC were differentiated from bone marrow 
derived type II AEC (Theise et al., 2002). 
 
1.9.2. Normal healing process following alveolar injury 
The process of alveolar repair is complex and involves interactions along the epithelial-
mesenchymal-inflammatory cellular axis, multiple growth factors, cytokines, chemokines, 
signaling pathways, structural elements and the mechanical environment (Crosby & 
Waters, 2010). Following alveolar injury, the ensuing inflammatory response induces 
release of a wide range of soluble factors by neighbouring AEC, fibroblasts, endothelial 
cells and macrophages which activate the reparative process (Figure 1.6) (Crosby & 
Waters, 2010). However, our understanding of the interaction between soluble factors and 
cellular components in regards to alveolar wound repair is mostly based on in vitro studies; 
thereby, the precise mechanism of in vivo wound repair remains widely elusive.  
 
In general, after injury the denuded area is covered with neighbouring epithelial cells 
through epithelial restitution, which involves migration and proliferation to restore the cell 
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number and differentiation to restore the functions (Puchelle et al., 2006, Zahm et al., 
1991). In the airways, after injury to the epithelium the first 12-24 hours of healing process 
involves epithelial cell spreading and migration as a primary reparative process followed 
by cell proliferation and differentiation which takes days to weeks (Horiba & Fukuda, 
1994). During in vivo alveolar injury repair, the proliferation index of type II AEC is 
considered as a primary indicator of reparative process (Panos et al., 1995, Yee et al., 
2006). Whereas, the wound healing process in vitro is demonstrated through type II AEC 
spreading, migration, proliferation and differentiation into type I AEC in wound repair 
models (Kheradmand et al., 1994, Atabai et al., 2002). The concept of type II AEC 
spreading and migration as primary events during alveolar wound repair is also supported 
by observations in other non-alveolar wound repair mechanisms such as in cornea (Danjo 
& Gipson, 1998), gut (Lotz et al., 2000) and kidney (Fenteany et al., 2000).  
 
Following alveolar injury, AEC, fibroblasts, endothelial cells and inflammatory cells 
secrete a myriad of growth factors, cytokines, chemokines, prostaglandins and matrix 
components (Figure 1.6). A critical balance between the milieu of soluble factors and the 
responses to the cellular components is important for a normal wound healing (Crosby & 
Waters, 2010). Several growth factors such as epidermal growth factor (EGF), keratinocyte 
growth factor (KGF), hepatocyte growth factor (HGF), TGF-α and TGF-β play major role 
during alveolar injury repair. EGF has mitogenic effect on type II AEC and bronchial 
epithelial cells and facilitates their migration (Ryan et al., 1994, Lesur et al., 1996, Leslie 
et al., 1997). KGF has a cytoprotective function and plays a vital role in lung development 
(Panos et al., 1995, Simonet et al., 1995). During wound repair, KGF stimulates type II 
AEC proliferation and promotes cell spreading, migration and adhesion via an EGF-
receptor dependent mechanism (Panos et al., 1995, Atabai et al., 2002, Panos et al., 1993, 
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Ulich et al., 1994, Galiacy et al., 2003). HGF has a mitogenic property and facilitates 
alveolar epithelial wound repair by type II AEC proliferation and migration mechanism 
(Mason et al., 1994, Panos et al., 1996, Furuyama & Mochitate, 2004). 
 
The effects of TGF-β in alveolar wound repair are complex and controversial. The 
biological functions of this growth factor are diverse and plays crucial roles in 
development, inflammation, wound repair, fibrosis and tumourigenesis (Crosby & Waters, 
2010). It has been demonstrated that TGF-α and TGF-β stimulate type II AEC wound 
repair in vitro by increasing cell proliferation and migration (Ryan et al., 1994, Buckley et 
al., 2008, Yu et al., 2008). However, TGF-β has pro-inflammatory and pro-fibrotic 
properties, and its aberrant expression is believed to be responsible for the development of 
pulmonary fibrosis through activation of its downstream target CTGF (connective tissue 
growth factor), collagen and by induction of EMT (epithelial-mesenchymal transition).   
 
Apart from growth factors and cytokines, extracellular matrix (ECM) components also 
play an important role in the resolution of alveolar injury. In the early stages of airway 
epithelial wound repair the provisional matrix, which is composed of serum fibronectin 
and fibrinogen, facilitates cell migration (Perrio et al., 2007). The integrin receptors play a 
major role in type II AEC migration on fibronectin and type I collagen coated matrix 
during alveolar wound repair (Kim et al., 1997). Matrix metalloproteinases (MMPs) are a 
group of enzymes that are believed to play major role during injury repair and ECM 
remodeling. In particular, MMP-1, MMP-7 and MMP-9 have been shown to increase type 
II AEC and other airway epithelial cells migration during wound healing (Planus et al., 
1999, Parks et al., 2001, Chen et al., 2008b, Legrand et al., 2001).  
 
Chapter 1:                                                                                                   Introduction 
PhD thesis by K. M. Akram                                                                    Keele University - 22 - 
Aberrations in the orchestration of soluble bioactive cues and cellular responses results in 
aberrant wound repair and fibrosis. Failure or delayed re-epithelialisation due to impaired 
migration, proliferation, differentiation and increased AEC apoptosis can stimulate 
fibroproliferative activities which likely to underpin the pathogenesis of IPF (Selman et al., 
2001). 
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Figure 1.6: Normal and abnormal healing process after alveolar injury. 
Injured AEC activate inflammatory cells and fibroblasts through secretory cytokines. Activated 
inflammatory cells stimulate fibroblasts. Fibroblasts proliferate and differentiate into myofibroblasts 
which resolve injury by formation of ECM and basement membrane that facilitate alveolar re-
epithelialisation. On the other hand, persistence of the fibroproliferative response causes fibrosis.  
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1.10. Pathogenesis of IPF 
Despite intense research effort, the pathogenesis of IPF is still elusive and controversial. 
Over the last three decades, numbers of hypotheses have been proposed to explain the 
pathophysiological process of this incurable disease. The inflammatory hypothesis has 
been abolished, meanwhile, recent hypothesis describes IPF as a consequence of aberrant 
alveolar wound repair and regeneration due to multiple alveolar epithelial cell injuries, 
disrupted epithelial-mesenchymal cross-talk, imbalanced immune responses and abnormal 
activation of coagulation cascaded (Selman et al., 2001, Gharaee-Kermani et al., 2007). 
 
1.10.1. The evolution of hypotheses of IPF pathogenesis  
1.10.1.1. Inflammatory fibrosis hypothesis  
Previously, it was believed that chronic inflammation played a pivotal role in the 
pathogenesis of IPF. According to this hypothesis, the disease process is characterized by 
inflammation and abnormal injury repair of lung due to hyper proliferation of fibroblasts 
and myofibroblasts and subsequent accumulation of ECM followed by marked alteration 
of tissue architecture and aberration of functionality of lungs. However, clinical, 
histological and experimental findings now do not support this hypothesis (Selman et al., 
2001, Gharaee-Kermani et al., 2007). 
 
Corticosteroids have been used for the treatment of IPF since the 1950s, but these days, it 
is widely accepted that steroids and other anti-inflammatory drugs provide a very little or 
no beneficiary effect in halting the disease progression (Mapel et al., 1996). Even, when 
steroids are used with potent immunosuppressive drugs, they fail to show any significant 
response (Selman et al., 1998, Johnson et al., 1989). The histopathological findings also 
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failed to show significant presence of inflammatory cells at the site of the lesion (Selman et 
al., 2001). 
 
In addition, inflammation is not always essential to initiate a fibrotic response. A mouse-
lung-explant model experiment showed that in a blood-free environment, severe hyperoxic 
alveolar injury could promote fibrosis without the initiation of inflammation. In that case, 
the healing process was completed by fibrosis rather than epithelial regeneration (Adamson 
et al., 1988). This study demonstrated that initiation of the fibrotic response in the absence 
of inflammation was possible, at least, in a mouse model (Selman & Pardo, 2002). Some 
other studies showed that in the absence of IL-10, silica-induced inflammation was unable 
to initiate fibrosis in mice (Huaux et al., 1998) and bleomycin-induced inflammation did 
not induce significant fibrosis in integrin-αvβ6 deficient mice (Munger et al., 1999). These 
findings along with clinical features and poor outcome of anti-inflammatory therapy 
challenge the validity of the „inflammatory fibrosis‟ hypothesis in the pathogenesis of IPF.  
 
1.10.1.2. Epithelial injury and abnormal wound repair hypothesis  
As the „inflammation and fibrosis‟ hypothesis can not clearly explain the 
pathophysiological process of IPF, Selman et al. proposed a new hypothesis. They 
suggested that, idiopathic pulmonary fibrosis occurs due to multiple epithelial injuries 
followed by abnormal wound repair without any preceding chronic inflammation (Selman 
et al., 2001; Kaminski et al., 2003). They did not deny the association of inflammation in 
IPF, but they mentioned that „the inflammatory response neither precedes nor plays a 
relevant role in its pathogenesis‟ (Kaminski et al., 2003). 
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1.10.1.3. Inflammation and immune response followed by fibrosis hypothesis  
More recently, a modified hypothesis of IPF has been proposed which implies that, 
„inflammation is subsequent to injury and that IPF occurs as a result of polarization of the 
immune response of the body to repeated injury (multi-hits) to the lung‟ (Strieter, 2005). 
This hypothesis is based on the well-established theory of wound healing which implies 
that injury to any tissue is always followed by inflammation and subsequent repair. 
Microarray data and HRCT evaluation of IPF patients support this hypothesis. Microarray 
gene analysis of IPF lung samples showed over-expression of pro-inflammatory cytokines 
and chemokine genes which encode immunoglobulins that can stimulate chronic B-cell 
infiltration. However, they did not find any over-expression of acute inflammatory 
cytokines (Zuo et al., 2002). This finding reflects the presence of chronic inflammation in 
IPF. Presence of accentuated adenopathy detected by HRCT scan in 55% IPF patients 
which supports the notion of involvement of abnormal immune responses (Hunninghake et 
al., 2003). However, this study did not show any histopathological confirmation of the 
adenopathy.  
 
According to this hypothesis, IPF occurs due to repeated injury or exposure to antigens 
which leads to an imbalanced response between type-1 and type-2 helper-T cell mediated 
immunity which subsequently influences fibroblast and myofibroblast proliferation and 
excessive ECM deposition resulting in failure of re-epithelialisation and fibrosis. 
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1.10.2. Cellular and humoral events in the development of IPF 
1.10.2.1. Role of alveolar epithelial cells 
The evolving hypothesis is that multiple alveolar epithelial cell injuries and subsequently 
aberrant wound healing leads to the development of IPF (Selman et al., 2001). This 
concept has been accepted by many scientists albeit with lack of sufficient evidence to 
explain the pathogenesis. According to this hypothesis, fibrosis occurs due to disrupted 
epithelial-mesenchymal interaction instead of chronic inflammation. In the following 
sections the contribution of alveolar epithelial cells and fibroblasts in the development of 
IPF will be briefly discussed. 
 
1.10.2.1.1. Repeated alveolar epithelial cell injuries 
Repeated injury to the alveolar epithelial cell is believed to be the initiating trigger for the 
development of fibrosis. However, the exact cause or mechanism of these multiple injuries 
are unknown (Selman & Pardo, 2006). Some believe that the initiating cause may be 
multifactorial and potentially viral. Studies reported the evidence of Epstein-Barr virus 
(EBV) (Egan et al., 1995), cytomegalovirus, human herpesvirus-7 (HHV-7) and human 
herpesvirus-8 (HHV-8) (Tang et al., 2003) in the samples of IPF patients. On the other 
hand, similar study failed to detect any EBV and HHV-8 in IPF lung (Zamò et al., 2005). 
This contradictory data suggests that there might be no universal involvement of virus in 
IPF.  
 
Intrinsic abnormalities in AEC may cause alveolar epithelial injury (Selman & Pardo, 
2006). In some familial IPF cases, mutation in the SP-C gene was observed which resulted 
in the accumulation of misfolded surfactant protein within the alveolar epithelia resulting 
in type II AEC injury (Grutters & du Bois, 2005). This type of intrinsic abnormality is 
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uncommon in patients with sporadic IPF (Lawson et al., 2004). Cigarette smoking is a 
major cause in many lung diseases such as chronic obstructive pulmonary disease (COPD), 
lung carcinomas and some other pulmonary fibrosis. It is speculated that cigarette smoking 
could be related to IPF; however, to date, there is no firm evidence of the involvement of 
tobacco smoking in the development of this disease (Selman & Pardo, 2006).  
 
1.10.2.1.2. Increased AEC apoptosis 
Apoptosis which is also called programmed cell death can be defined as „gene-directed 
cellular self-destruction‟. Apoptosis is a normal physiological process required for the 
development and maintenance of tissue homeostasis. The entire apoptotic process is tightly 
regulated by a number of genes and their products (Uhal, 2008). Exacerbated apoptosis can 
be pathological. The persistent presence of increased AEC apoptosis is frequently detected 
in the lung of IPF patients (Uhal et al., 1998, Kuwano et al., 1999, Barbas-Filho et al., 
2001, Uhal, 2008). A significant up-regulation of pro-apoptotic proteins p53, p21, bax and 
caspase-3 with associated down-regulation of anti-apoptotic protein Bcl-2 was found in 
IPF alveolar epithelial cells (Plataki et al., 2005). TUNEL positive apoptotic AEC were 
also detected in IPF lung samples (Plataki et al., 2005). A Fas-FasL mediated pathway has 
been suggested to be involved in this apoptosis (Maeyama et al., 2001). Electron 
microscopic and biochemical experiments on lung tissue samples taken from patients with 
IPF showed significantly increased apoptosis in type II AEC of healthy-looking alveoli of 
IPF patients comparing non-IPF control lung tissues (Barbas-Filho et al., 2001). These 
cumulative evidences suggest that type II AEC apoptosis could play a key role in the initial 
stage of the disease (Barbas-Filho et al., 2001).  
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Bleomycin-induced pulmonary fibrosis animal model studies demonstrated that pulmonary 
fibrosis occurred due to apoptosis of AEC via activation of pro-apoptotic Bcl-2 family 
member Bid (Budinger et al., 2006), activation of angiotensin receptor A1 (AT1) (Li et al., 
2003) and through Fas-Fas ligands (Hagimoto et al., 1997a, Hagimoto et al., 1997b). How 
apoptosis can initiate or propagate fibrogenesis is not clear. In normal circumstances AEC 
secrete anti-fibrotic factors such as prostaglandin-E2 (PGE2), plasminogen activators and 
metalloproteinase which can inhibit fibroblast proliferation and enhance the degradation of 
ECM. There is a possibility that the loss of AEC by excessive apoptosis or necrosis could 
diminish the anti-fibrotic effects of the alveoli and trigger a fibrotic response. The alveolar 
epithelium acts as a physical barrier between the ECM and the macrophage. Denuded 
basement membrane and ECM can activate the macrophage and stimulate release of pro-
fibrotic factors which can ultimately cause a fibrotic response (Uhal, 2008). Apoptotic loss 
of AECs can cause delay or failure of re-epithelialisation which is another potential key 
mediator for fibrosis (Plataki et al., 2005). More recently, it has been reported that severe 
and chronic endoplasmic reticulum stress in AEC could be an underlying cause of AEC 
apoptosis, which is likely to be involved with sporadic IPF (Korfei et al., 2008, Lawson et 
al., 2011, Tanjore et al., 2012).  
 
1.10.2.1.3. Failure of alveolar re-epithelialisation 
Re-epithelialisation is an essential step in normal tissue repair process (Selman et al., 2001, 
Crosby & Waters, 2010). Following alveolar injury, inflammation starts, healing processes 
proceed and finally repair is accomplished by type II AEC migration, proliferation and 
differentiation into type I AEC, that subsequently cover the denuded area of alveoli. The 
alveolar healing process starts with AEC injury and ends with re-epithelialisation. Failure 
or delay of this re-epithelialisation can cause persistence of reparative responses which can 
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ultimately result in fibrosis. Supporting this concept, increased AEC death or delayed 
repair was shown to promote fibroblast proliferation and subsequent fibrosis (Adamson et 
al., 1990). 
 
In IPF, alveolar re-epithelialisation is likely to be hampered. While the exact mechanism of 
this failure of epithelial restitution is widely unknown, a possible set of aetiology could be: 
1) increased apoptosis, 2) impaired migration and 3) loss of differentiation of AEC 
(Thannickal et al., 2004). In IPF, hyper-proliferation of type II AEC is common; however, 
their differentiation into type I AEC is thought to be seriously impaired (Kasper & 
Haroske, 1996).  
 
1.10.2.1.4. Loss of type II AEC plasticity 
Type II AEC can terminally differentiate into type I AEC, and this differentiation process 
is essential for maintenance of the integrity of alveolar epithelium. Abnormal accumulation 
of ECM proteins and over-expression of pro-fibrotic growth factors and cytokines are key 
mediators that are likely to be involved in the impairment of AEC differentiation (Selman 
& Pardo, 2006). The differentiation of type II AEC depends on the underlying matrix 
proteins. Studies have demonstrated that culture of type II AEC on collagen I or 
fibronectin matrix proteins allowed them to differentiate into type I AEC; whereas, culture 
on laminin-5 supplemented matrix protein interfered this differentiation process (Isakson et 
al., 2001, Isakson et al., 2002). During differentiation, type II AEC first transdifferentiate 
into an intermediate type II/type I cell-like phenotype without underlying matrix protein 
dependence, this intermediate cell can then differentiate into either type I or type II AEC 
depending on the presence of matrix proteins such as collagen, fibronectin or laminin-5 
(Figure 1.7) (Olsen et al., 2005). Like matrix proteins, some growth factors such as KGF 
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(Fehrenbach et al., 1999) and insulin-like growth factor-1 (IGF-1) and IGF-II (Narasaraju 
et al., 2006) have important roles in the differentiation of type II AEC into type I cells 
(Figure 1.7). 
 
Figure 1.7: Differentiation of type II AEC into type I AEC. 
In vitro differentiation of type II AEC into type I AEC occurs through an intermediate phenotypic 
cell transformation.  
 
1.10.2.2. Disruption of epithelial-mesenchymal cross-talk 
A balanced cross-talk between alveolar epithelial cells and fibroblasts is established during 
the alveolar healing process following injury. This cross-talk takes place either by direct 
cell-cell contact or via their secreted soluble factors (Geiser, 2003) (Figure 1.8). The 
epithelial-mesenchymal cross-talk is likely to be interrupted in IPF (Selman et al., 2001). 
In IPF, activated and/or injured AEC secrete increased levels of TGF-β, TNF-α, PDGF 
(platelet-derived growth factor), IGF-1, CTGF and ET-1 (endothelin-1). (Khalil et al., 
1991, Kapanci et al., 1995, Nash et al., 1993, Antoniades et al., 1990, Pan et al., 2001, 
Giaid et al., 1993, Noble, 2008). These factors are capable of inducing fibrosis by 
stimulating growth and proliferation of fibroblasts and myofibroblasts. The sole effect of 
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of EMT (Willis et al., 2005, Willis & Borok, 2007). CTGF and PDGF are potent mitogens 
for fibroblasts. ET-1 promotes fibroblast proliferation, myofibroblast differentiation, 
deposition of ECM and EMT in AEC (Abraham, 2008). IGF-1 can increase proliferation 
and inhibit apoptosis of fibroblasts and myofibroblasts which enhance fibrogenesis (Wynes 
et al., 2004) (Figure. 1.8).  
 
During the normal reparative process activated fibroblasts and myofibroblasts synthesize 
and secrete ECM proteins to create a favorable basement membrane for epithelial 
migration. After completion of the basement membrane, AEC release an array of inhibitory 
molecules which suppress fibroblastic activities. One of the well-documented inhibitory 
factors is PGE2 which inhibits fibroblast proliferation and collagen synthesis. PGE2 is 
decreased in IPF patients (Wilborn et al., 1995, Borok et al., 1991). Another anti-fibrotic 
factor is NO (nitric oxide) which is released by both epithelial cells and fibroblasts and can 
suppress fibroblast and myofibroblast activity (Vernet et al., 2002, Wang et al., 1997). NO 
inhibits proliferation and transdifferentiation of fibroblasts into myofibroblasts resulting in 
reduction of collagen synthesis via neutralization of ROS (reactive oxygen species) 
(Vernet et al., 2002). In IPF, AEC derived NO has found to be reduced as well (Thannickal 
et al., 2004).  
 
However, the precise mechanism of NO reduction in the IPF lung is unknown. TGF-β 
inhibits iNOS (inducible nitric oxide synthase) synthesis causing inhibition of NO 
production (Perrella et al., 1994, Finder et al., 1995). Up-regulation of TGF-β in IPF 
reduces NO by suppression of iNOS. NO has negative feedback effect on myofibroblasts. 
So, inhibition of NO production increases proliferation of myofibroblasts and subsequent 
collagen synthesis (Zhang and Phan, 1999). IL-1β is a potent inducer of iNOS and can thus 
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increase production of NO (Jorens et al., 1992, Lavnikova & Laskin, 1995) and 
subsequently inhibits fibroblasts and myofibroblasts proliferation and induces apoptosis of 
these cells via DNA damage (Zhang et al., 1997). TGF-β can completely block the IL-1β-
induced apoptosis in fibroblast and myofibroblasts (Zhang and Phan, 1999). Interestingly, 
TGF-β induces apoptosis in AEC (Lee et al., 2006) but inhibits apoptosis in fibroblasts and 
myofibroblasts. 
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Figure 1.8: Epithelial- mesenchymal cross-talk during pathogenesis of IPF. 
Injured AEC secrete bioactive cues that activate the Th2 immune response; which then increase 
Th2 type cytokines IL-4, IL-5 and IL-13. These interleukins and other growth factors promote 
fibroblast and type II AEC proliferation. Proliferating type II AEC and fibroblasts then increase 
secretion of pro-fibrotic growth factors. Among them TGF-β plays vital role by promoting 
myofibroblast differentiation, increased apoptosis of AEC and EMT. IGF-1 inhibits apoptosis of 
fibroblasts and myofibroblasts. The cumulative effects of this disrupted cross-talk lead to aberrant 
accumulation of collagen and other ECM proteins with associated derangement of AEC and 
subsequent fibrosis. 
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1.10.2.3. Multi-hits AEC injury: A vicious cycle between alveolar epithelial and 
mesenchymal cells is established. 
While no known exogenous or genetic cause has been identified for the pathogenesis of 
IPF, it is difficult to explain the mechanism of repeated micro-injuries in AEC which 
eventually causes fibrosis. Depending on the cytokine and growth factor profile, the 
speculation is that there might be some active intrinsic factors within the micro-milieu of 
the fibrotic lesion that can cause repeated AEC injuries in a persistent manner. This 
speculation is supported by the demonstration that secretory products of fibroblasts 
isolated from IPF lungs induced apoptosis in cultured AEC (Uhal et al., 1995). 
 
In 2006, Horowitz and Thannickal suggested that dysregulated epithelial-mesenchymal 
interaction in IPF may promote a „vicious cycle‟ in the pathogenesis of this disease (Figure 
1.9) (Horowitz & Thannickal, 2006). Raised levels of pro-fibrotic and pro-apoptotic 
factors, such as TGF-β, TNF-α, and angiotensin are detected in the microenvironment of 
the fibrotic lesion. Following injury, TGF-β, TNF-α, angiotensin (Wang et al., 1999) and 
ROS are released by AEC and mesenchymal cells (fibroblasts and myofibroblasts) 
resulting in further injury to the AEC by apoptosis or necrosis. A vicious cycle is possibly 
established through initial AEC injury by unknown factor followed by secretion of 
cytokines, chemokines and growth factors by AEC and macrophages. These factors then 
promote fibroblast proliferation and differentiation into myofibroblasts causing additional 
release of pro-fibrotic and pro-apoptotic factors and accumulation of collagen and other 
ECM proteins. This combined unfavourable micro-milieu causes further alveolar epithelial 
cell damage, and epithelial injury again starts the fibrotic response through activation of 
mesenchymal cells (Figure 1.9). 
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Figure 1.9: Hypothetical ‘vicious cycle’ in multiple micro-injuries to AEC in IPF.  
The cycle starts following AEC injury by unknown stimuli. After injury, AEC release pro-fibrotic 
cytokines, chemokines and growth factors which activate fibroblast/myofibroblast-driven fibrotic 
responses. This combined AEC and mesenchymal cell activation increase pro-fibrotic and pro-
apoptotic factor levels in the micro-environment of the lesion. Among them, TGF-β, TNF-α, 
angiotensin and ROS can induce apoptosis or necrosis in AEC resulting further epithelial injury 
and thus continues this „vicious cycle‟ of AEC injury. 
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1.10.2.4. Role of fibroblasts and myofibroblasts 
The classical feature of IPF is the presence of „fibroblastic foci‟ within the alveolar wall at 
the leading edge of fibrosis (Katzenstein & Myers, 1998, Thannickal et al., 2004, Lomas, 
et al., 2012). Fibroblasts and myofibroblasts play a pivotal role in the development of IPF. 
During normal healing process, following injury, inflammation takes place and fibroblasts 
become activated in an attempt to repair and secrete ECM proteins to form granulation 
tissue. At later stages, they differentiate into myofibroblasts which help wound contraction 
and facilitate wound healing. At the end-stage of the healing process, myofibroblasts 
disappear by apoptosis which is essential for proper wound repair (Desmouliere et al., 
1995, Selman & Pardo, 2002). Many studies have shown the persistent presence of 
myofibroblasts in the active lesion of IPF (Desmouliere et al., 1995, Selman & Pardo, 
2002, Lomas et al., 2012). Failure of alveolar re-epithelialisation can cause a continuous 
fibrotic response through activation of myofibroblasts that further inhibit re-
epithelialisation. 
 
Fibroblasts isolated from IPF patient‟s lungs are pro-fibrotic where their secretory products 
induce apoptosis in AEC in vitro through an angiotensin-dependent mechanism (Uhal et 
al., 1995, Wang et al., 1999). The in vitro proliferation profile of IPF lung fibroblasts is 
contradictory. One study demonstrated that fibroblasts from IPF lung grew significantly 
faster than those obtained from normal lung (Jordana et al., 1988); whereas, others have 
reported the inverse phenomenon (Ramos et al., 2001). Raghu and colleagues showed that 
fibroblasts isolate from early-fibrotic regions grew faster than those obtained from dense 
fibrotic regions (Raghu et al., 1988). Very recently, our group reported a low proliferative 
status of fibroblast/myofibroblasts within the fibroblastic foci of IPF lung which was 
evaluated based on Ki-67, a cell proliferation marker, expression by an ex-vivo study on 21 
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IPF patients (Lomas et al., 2012). These above findings indicate that the proliferative status 
of fibrotic fibroblasts is heterogeneous and could be related to the disease status. 
 
Myofibroblasts are thought to play a vital role in the development of IPF. Myofibroblasts 
express α-SMA (α-smooth muscle actin) and represent an intermediary phenotype between 
fibroblasts and smooth muscle cells (Darby et al., 1990, Roy et al., 2001). The main 
function of this mesenchymal cell is synthesis and secretion of ECM proteins, wound 
contraction and ECM remodeling. The transient appearance and disappearance of 
myofibroblasts are observed during normal healing and repair process. On the other hand, 
in IPF, the persistent presence of myofibroblasts is a constant feature (Desmouliere et al., 
1995, Selman & Pardo, 2002, Lomas et al., 2012). During activation and proliferation, 
fibroblasts/myofibroblasts release pro-fibrotic factors such as TGF-β, TNF-α, and 
angiotensin which can cause AEC damage. These cells also secret MMP-2 (matrix 
metalloproteinase-2) and MMP-9 which may disrupt the basement membrane, alter the 
tissue architecture and inhibit alveolar re-epithelialisation (Selman et al., 2000). 
 
Although the presence of myofibroblasts within the fibrotic lesion is apparent, their source 
remains elusive. There is ample evidence showing that myofibroblasts can be transformed 
from tissue fibroblasts in presence of TGF-β (Desmoulière et al., 1993) and IL-4 (Mattey et 
al., 1997) in vitro. But in vivo, how myofibroblasts are acquired in the site of fibrotic lesion 
of IPF is largely unknown. Based on their similar cellular kinetics, it is assumed that 
myofibroblasts are transformed cells from pre-existing resident tissue fibroblasts with the 
influence of stimulatory cytokines, such as TGF-β (Phan, 2002) (Figure 1.10). Some 
studies suggested that circulating fibrocytes derived from bone marrow stem cells (MSC) 
could be an extra-pulmonary source of fibroblasts and myofibroblasts in IPF (Lama & 
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Phan, 2006, Hashimoto et al., 2004, Phillips et al., 2004, Epperly et al., 2003, Ishii et al., 
2005). Another possible source of myofibroblasts in fibroblastic foci is AEC by EMT 
(Figure 1.10). 
 
 
Figure 1.10: The origins of myofibroblasts in IPF lesion. 
Schematic diagram demonstrates the acquisition of myofibroblasts from pulmonary and extra-
pulmonary sources at the site of fibrotic lesion in IPF and their effects in the pathogenesis. 
Pulmonary sources are resident fibroblasts and AEC. AEC transformed into 
fibroblasts/myofibroblasts by EMT driven effects of TGF-β and ET-1. Myofibroblasts are 
transdifferentiated from tissue fibroblasts by TGF-β and IL-4. Extra-pulmonary source is 
circulatory bone marrow-derived fibrocytes. 
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1.10.2.5. Role of EMT in IPF 
Epithelial-mesenchymal transition (EMT) is a biological process whereby polarized 
epithelial cells lose many of their epithelial characteristics and undergo morphological 
changes to assume a mesenchymal phenotype (Thiery & Sleeman, 2006). The EMT 
process is frequently observed in IPF lung which suggests that EMT could be involved in 
the disease process. However, the precise mechanism of EMT in pulmonary fibrosis is not 
well understood (Selman & Pardo, 2006, Willis et al., 2005, Willis & Borok, 2007, Willis 
et al., 2006, Kim et al., 2006). In vitro studies demonstrated that TGF-β can transform 
primary human and rat AEC into fibroblast and myofibroblasts (Willis et al., 2005, Kim et 
al., 2006, Kasai et al., 2005). ET-1 is implicated in the pathogenesis of IPF. A study 
demonstrated that ET-1 could induce EMT in AEC through production of TGF-β via an 
ET-A receptor dependent-manner (Jain et al., 2007). Twist, a transcription factor, is not 
normally expressed in AEC; however, high expression levels have been detected in AEC 
of IPF lungs with the accompanying EMT features (Pozharskaya et al., 2009). Murine lung 
fibrosis models and IPF lungs demonstrated that overexpression of Twist in AEC was 
related to viral infection; thereby, it has been suggested that Twist could be involved in 
EMT, particularly in viral infected cases (Pozharskaya et al., 2009). Overexpression of 
Wnt and β-catenin has also been detected in fibroblast/myofibroblast and type II AEC of 
IPF lung (Konigshoff et al., 2008, Chang et al., 2010). The Wnt/β-catenin pathway was 
implicated in the regulation of EMT in other cell types (Dissanayake et al., 2007, Medici et 
al., 2008). It has been suggested that the Wnt/β-catenin signaling pathway could also be 
involved in the EMT process in IPF (Chang et al., 2010). 
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1.10.2.6. Role of alveolar bronchiolisation 
Alveolar bronchiolisation, a process of abnormal proliferation of Clara and other 
bronchiolar epithelial cells and their migration into the alveoli, has been documented in 
both IPF lung tissues and animal models of pulmonary fibrosis (Collins et al., 1982, 
Kawanami et al., 1982, Fukuda et al., 1989, Kawamoto & Fukuda, 1990, Betsuyaku et al., 
2000, Chilosi et al., 2002, Mori et al., 2004, Odajima et al., 2007). A sub-population of 
these Clara cells behaves as functional bronchiolar progenitor cells with participation in 
bronchiolar wound repair and regeneration (Evans et al., 1976, Reynolds & Malkinson, 
2010). However, lineage tracking in animal model studies has indicated that Clara cells 
may not take part in alveolar injury repair (Rawlins et al., 2009). Also, in bleomycin-
induced murine pulmonary fibrosis, abrogation of alveolar bronchiolisation does not 
worsen the disease state (Betsuyaku et al., 2000). Despite these findings, alveolar 
bronchiolisation remains a constant histological feature in IPF lungs albeit that this 
activated event appears to fail to restore alveolar architecture and functionality (Chilosi et 
al., 2002, Mori et al., 2004, Odajima et al., 2007). Thus, the role of the alveolar 
bronchiolisation process in the dynamic between alveolar injury repair on one hand and 
propagation of fibrogenesis on the other remains unclear (see Chapter-3, Section- 3.4). 
 
1.10.2.7. Basement membrane disruption and ECM remodeling 
Basement membrane is a specialized extracellular matrix layer consisting mainly of type 
IV collagen, laminin, fibronectin, entactin and heparin sulfate proteoglycans produced 
mainly by epithelial cells, endothelial cells and mesenchymal cells (Yurchenco & Schittny, 
1990). Basement membrane provides support for epithelial cells and a suitable surface for 
their migration, proliferation and differentiation. This membrane also acts as a physical 
barrier between epithelial and mesenchymal cells. Disruption of this membrane hampers 
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epithelial cell migration and proliferation but facilitates fibroblast and myofibroblast 
migration to the epithelial surface which ultimately causes epithelial cell destruction and 
fibrosis. In IPF, marked disruption of basement membrane is common (Selman et al., 
2001). 
 
Bleomycin-induced pulmonary fibrosis animal model experiments demonstrated that, in 
the early stages of fibrosis, alveolar epithelial basement membrane disruption occurred due 
to the over activity of MMP-9 (Gelatinase B), and in later stages by MMP-2 (Gelatinase 
A). Gelatinase B is predominantly localized in inflammatory cells, whereas, Gelatinase A 
is localized in alveolar epithelial cells (Yaguchi et al., 1998). Gelatinase A and Gelatinase 
B cause degradation of ECM proteins, specially, collagen IV and elastin. The activities of 
MMPs are controlled by TIMPs (tissue inhibitory metalloproteinases). Imbalance between 
MMPs and TIMPs may cause basement membrane disruption and remodeling of ECM and 
thus may contribute in the pathogenesis of IPF. 
 
1.10.2.8. Imbalanced inflammatory response of T cells 
Two types of helper-T cell responses in inflammation take place following an injury. These 
are called Type-1 and Type-2 helper T cell responses (Th1 and Th2 respectively). Specific 
types of cytokines are released in different types of helper-T cell response. In the Th1 
response, the predominant cytokines are IL-2, IL-12, IL-18 and interferon-γ (INF- γ). On 
the other hand, the predominant cytokines of Th2 response are IL-4, IL-5, IL-10 and IL-13. 
In general, the Th1 response regulates cell mediated immunity and injured tissue 
restoration; whereas, the Th2 type response promotes antibody mediated immunity and 
persistence of this type of response initiates fibroblast activation and extracellular matrix 
deposition followed by unresolved fibrosis (reviewed in Keane, 2008). After injury, a 
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balanced response between Th1 and Th2 is essential for proper tissue restoration. 
Uncontrolled over activation of Th2 type response may cause excessive fibrosis (reviewed 
in Keane, 2008). How these two types of immune responses play role in pathogenesis of 
IPF is not clear.  
 
Along with cytokines, some chemokines and their receptors are essential mediators for 
regulation of the Th1 and Th2 inflammatory responses (Sallusto et al., 1998). For example, 
chemokine receptors CXCR3 and CCR5 are predominantly expressed in the Th1 type 
response; whereas, in Th2 type inflammatory response, CCR3, CCR4 and CCR8 
chemokine receptors are predominant (Sallusto et al., 1998) (Keane, 2008). The 
bleomycin-induced pulmonary fibrosis mouse model experiment showed that levels of 
chemokines CCL17 and CCL22 and their common receptor CCR4 were significantly 
raised during the fibrotic process, and that neutralization of CCL17 reduced fibrosis levels 
(Belperio et al., 2004). CCL17 and its receptor CCR4 do not have any effect on fibroblast 
proliferation (Belperio et al., 2004). This indicates that CCL17 may follow an alternative 
pathway in the pathogenesis of pulmonary fibrosis bypassing fibroblast proliferation.  
 
On the other hand, high levels of CCL17 and CCL22 are found in the lung tissue of IPF 
patients, where they are predominantly expressed on epithelial cells, particularly on the 
hyperplastic epithelial cells (Belperio et al., 2004). On the basis of cytokine and chemokine 
profiles of animal model and IPF patient lung tissue, it is postulated that, uncontrolled and 
exacerbated Th2 type immune responses may play crucial role in the pathogenesis of IPF, 
especially in the early stage of disease process (Keane, 2008).  
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1.10.2.9. Oxidative stress 
Increased levels of oxidant and decreased glutathione, a potent anti-oxidant, levels have 
been reported in IPF lung (MacNee & Rahman, 1995, Cantin et al., 1989) which was also 
associated with systemic oxidant/anti-oxidant imbalance (Rahman et al., 1999). 
Glutathione neutralizes H2O2 and other oxidants and thus prevents oxidative damage of 
AEC. A deficiency of glutathione or other anti-oxidant in the alveolar lining fluid can 
make AEC vulnerable to injury. Therefore, an oxidative insult to AEC might cause 
epithelial cell damage and promote fibrosis. Human lung fibroblasts can release H2O2 only 
when stimulated by TGF-β (Thannickal & Fanburg, 1995). In IPF, raised levels of TGF-β 
may stimulate fibroblasts to secret H2O2. This cytokine-fibroblasts-H2O2 interaction is 
implicated in the pathogenesis of IPF. 
 
1.10.2.10. Genetic abnormalities 
The pathogenesis of IPF is complex, so it is unlikely that a single gene abnormality will 
emerge as being responsible for this disease (Loyd, 2008). Selman and colleagues 
produced a microarray-based gene expression profile of IPF, hypersensitivity pneumonia 
and non-specific interstitial pneumonia (NSIP). They demonstrated a distinct gene 
expression patterns between IPF and the other two diseases (Selman et al., 2006). The 
upregulated genes in IPF were associated with extracellular matrix remodeling; and 
adhesion, migration, proliferation and differentiation of AEC and myofibroblasts; whereas, 
in other two diseases, the gene expression profiles were predominantly inflammation 
related (Selman et al., 2006). MMP-7 and (Zuo et al., 2002) osteopontin overexpression 
(Pardo et al., 2005) have also been detected within AEC in most IPF cases. MMP-7 knock-
out mice were resistant to bleomycin induced pulmonary fibrosis (Zuo et al., 2002). 
Osteopontin has been demonstrated to have pro-fibrotic properties by stimulation of 
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fibroblast migration and proliferation (Pardo et al., 2005). These findings suggest that 
aberrant expression of MMP-7 and osteopontin could be involved in IPF pathogenesis.  
 
Most of the genetic abnormalities are found in familial IPF where the common anomalies 
are telomerase shortening and misfolded surfactant protein-C in AEC. In about 8-10% of 
familial IPF, genetic mutation is found in telomerase related genes hTERT and hTR 
(Armanios et al., 2007, Tsakiri et al., 2007). hTERT is a telomerase reverse transcriptase 
which is an important enzyme for maintenance of telomeres (the end region of linear 
chromosomes comprised of TTAGGG repeats which prevents inappropriate recognition by 
DNA damage complexes) and cell proliferation (Loyd, 2008). The hTR gene encodes 
telomerase RNA. Genetic mutation is also found in SFTPC gene which encodes surfactant 
protein-C (SP-C). This mutation results production and accumulation of misfolded protein 
(SP-C) in type II AEC. However, this type of mutation is rare, only found in 1% in study 
group (Nogee et al., 2001). 
 
1.11. Treatment strategies for IPF  
1.11.1. Current Treatments  
1.11.1.1. Anti-inflammatory and immunomodulatory drugs 
Currently, there is no effective treatment for IPF. Anti-inflammatory drugs such as 
corticosteroids are used, but these agents do not show any beneficiary effects to halt the 
disease progression. Moreover, these drugs have tremendous side effects including 
osteoporosis, peptic ulcer disease, weigh gain, avascular necrosis, hyperglycaemia, 
susceptibility to infection and so on. Some immunomodulatory agents like azathioprine, 
cyclophosphamide and colchicine have also shown to be ineffective (Walter et al., 2006). 
IPF is no longer an inflammatory disease; rather it is a special type of fibrotic lung disease 
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that occurs due to multiple alveolar epithelial injuries and abnormal wound healing. 
Possibly, for this reason anti-inflammatory agents appear to be ineffective.  
 
1.11.2. Future potential treatment options 
1.11.2.1. Newer anti-fibrotic agents 
Due to poor response of anti-inflammatory drugs to halt fibrogenesis, some newer anti-
fibrotic agents have recently been proposed for the treatment of IPF; such as pirfenidone 
and etanercept. Pirfenidone is an orally bioavailable synthetic molecule that can inhibit 
activities of TGF-β and TNF-α in vitro and suppress fibroblast proliferation and collagen 
synthesis with subsequent reduction of fibrotic load in animal models of lung fibrosis (Iyer 
et al., 1995, Iyer et al., 1998, Iyer et al., 1999, Nakazato et al., 2002, Oku et al., 2002, 
Hirano et al., 2006). Pirfenidone has already undergone phase II and III clinical trials in 
Japan, USA, Australia, UK and many other countries (Raghu et al., 1999, Nagai et al., 
2002, Azuma et al., 2005, Taniguchi et al., 2010, Noble et al., 2011). Cumulative data 
analysis demonstrated that pirfenidone reduced lung function decline and prolonged 
progression-free survival of patients with IPF (Noble et al., 2011). Another anti-fibrotic 
agent etanercept, a recombinant soluble human TNF-α receptor that can bind and neutralise 
TNF-α (Mohler et al., 1993), has been evaluated in a Phase II clinical trial on IPF patients; 
however, this showed no statistically significant beneficial effects over placebo (Raghu et 
al., 2008). 
 
1.11.2.2. Regenerative cell therapy  
Regenerative medicine is an emerging therapeutic concept that aims to repair, replace or 
regenerate cells, tissues or organs to restore impaired function (Daar & Greenwood, 2007). 
Regenerative medicine-based therapeutic interventions could be effective for the treatment 
Chapter 1:                                                                                                   Introduction 
PhD thesis by K. M. Akram                                                                    Keele University - 47 - 
of specified clinical conditions where currently there is no adequate therapy. Therefore, 
regenerative therapy offers a rational approach for the treatment of IPF. Delivery of 
regenerative therapy could be through a tissue engineered intervention or through stem 
cell-mediated approaches (Daar & Greenwood, 2007). Stem cells are non-specialised self-
renewing cells which can differentiate into various specialised cell lineages under 
appropriate conditions (Martin, 1981, Thomson et al., 1998, Bajada et al., 2008). Broadly, 
stem cells are divided into two types: 1) Embryonic stem cells (ESC), which are 
pluripotent and can differentiate into derivatives of all three embryonic germ layers. 2) 
Non-embryonic stem cells or adult stem cells which are multipotent and can differentiate 
into limited number of phenotypes (Lee & Hui, 2006). Mesenchymal stem cells (MSC) are 
one of the widely studied adult stem cells which have shown enormous potential in 
regenerative medicine. Both MSC and ESC have been suggested for regenerative therapy 
for IPF. 
 
1.11.2.2.1. Mesenchymal stem cells 
Mesenchymal stem cells are a population of adult stem cells which were first discovered 
within the bone marrow through the pioneering work of Friedenstein and colleagues 
(Friedenstein et al., 1970). MSC are multipotent, adherent, spindle in shape and form 
colonies in culture which are known as colony forming unit-fibroblasts (CFU-Fs). The 
cells of the colony can self-renew and are capable of differentiating into, minimally, 
osteoblasts, chondrocytes and adipocytes (Friedenstein et al., 1970) (Figure 1.11). These 
cells are also known as mesenchymal stromal cells. The mesenchyme or stroma as often 
quoted describes the tissue that provides the structural and functional support for the 
growth and development of numerous organ systems. In relation to the bone marrow the 
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mesenchyme forms a layer of cells that delivers the essential support which haematopoietic 
stem cells require for their self-renewal and differentiation (Strobel et al., 1986). 
 
More recently, MSC-like cells have been discovered in almost all tissues and organs (da 
Silva et al., 2006). However, their identification and characterisation are challenging due to 
the lack of any specific biomarkers. To establish a standard of MSC characterisation the 
International Society for Cellular Therapy has provided a guideline which state that MSC 
must express CD73, CD90, CD105 and lack of expression of CD34, CD45, CD14, CD11b, 
CD19 or MHC class II antigen (Figure 1.12) and show capability of tri-lineage 
differentiation into osteoblasts, chondrocytes and adipocytes (Figure 1.11) (Dominici et al., 
2006). MSC also express CD44, CD146 and STRO-1 antigens (Simmons & Torok-Storb, 
1991, Pittenger et al., 1999, Colter et al., 2001, Delorme et al., 2009).  
 
Although MSC were first discovered in bone marrow, recently adipose tissue has offered 
another potential source of MSC for clinical applications (Kuhbier et al., 2010). The 
advantages of adipose tissue as a source of MSC over bone marrow are 1) relatively easy 
collection procedure and 2) and high yield of MSC in comparison to bone marrow. The 
frequency of MSC in the adipose tissue is 1-10 in 100 stromal vascular fraction (Guilak et 
al., 2006, Oedayrajsingh-Varma et al., 2006) whereas, in bone marrow it is 1-10 in 100,000 
of mononuclear cells (Baksh et al., 2007) which provides an advantageous high yield of 
MSC from adipose tissue when comparing equal volumes of bone marrow (Madonna et al., 
2009). Birth-associated tissues such as umbilical cord, umbilical cord blood and Wharton‟s 
jelly have also been proposed to be another source of MSC (Ennis et al., 2008). The 
advantage of birth-associated tissue-derived MSC is their higher proliferative capacity and 
reduced senescence properties; however, their incapability of differentiating into 
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adipocytes has been reported (Conconi et al., 2006, Baksh et al., 2007). Despite multiple 
sources of MSC have been proposed, bone marrow is to date still the gold standard 
location for MSC isolation and further research must be conducted before the use of 
alternative locations becomes common practice within the research community. Since 
discovery of MSC they have amassed significant interest from the medical and scientific 
community due to their differentiation capacity into various tissues and their tissue repair 
and regenerative properties. 
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Figure 1.11: Morphology of human MSC and their classical tri-lineage differentiation.  
Phase image shows the typical spindle shaped morphology of adherent human MSC. Osteogenesis; 
deposited calcium by differentiated osteoblasts was stained with Alizarin Red and osteocalcin was 
labelled by anti-osteocalcin antibody. Adipogenesis; differentiated adipocytes produce triglyceride 
which was stained with Oil Red O and adipocytes were stained with anti-FABP4 antibody. 
Chondrogenesis; chondrogenic nodules were stained with Alcian Blue and anti-aggrecan 
antibody. (Images were taken from Akram et al., 2012). 
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Figure 1.12: Phenotypic antigenic markers of human MSC.  
Human MSC demonstrate positive expression of CD44, STRO-1, CD90, CD146 and negative 
expression to haematopoietic markers CD14 and CD19. Nuclei are stained with DAPI. Phase 
images show typical morphology of MSC. Scale bar, 100µm. (Images were taken from Akram et 
al., 2012).  
 
1.11.2.2.1.1. Reparative mechanism of MSC 
Pre-clinical studies and clinical trials demonstrated that application of MSC stimulated 
wound repair and regeneration resulting in efficient amelioration of clinical conditions 
(Kotton et al., 2001, Berry et al., 2006, Morigi et al., 2004, Rojas et al., 2005) 
(www.clinicaltrials.gov). However, the precise mechanism of MSC-mediated wound repair 
and regeneration is not clearly known. One of the unique properties of MSC is their site-
specific migration and structural engraftment to the injured tissue. Their differentiation into 
specific cell types has also been demonstrated through various experimental animal models 
which suggests their active participation in wound repair and tissue regeneration (Kotton et 
al., 2001, Morigi et al., 2004, Rojas et al., 2005). On the other hand, some studies 
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postulated that MSC-secreted paracrine factors play a vital role for wound repair, most 
likely through their anti-inflammatory, anti-apoptotic, angiogenic and immunomodulatory 
properties (Ortiz et al., 2007, Zhen et al., 2008, Burdon et al., 2011, Baber et al., 2007, 
Nemeth et al., 2010). Additional reports also suggest that MSC secretory products are 
capable of stimulating tissue-specific regional progenitor cells which activate tissue 
regeneration (Gnecchi et al., 2008, Suzuki et al., 2011).   
 
1.11.2.2.1.1.1. Functional contribution of MSC in tissue repair 
MSC classically can differentiate into mesodermal lineages including osteoblasts, 
chondrocytes and adipocytes (Figure 1.11) (Friedenstein et al., 1970, Pittenger et al., 
1999). A rapidly growing number of reports suggest their capacity of differentiation into a 
further wide range of mesodermal and non-mesodermal adult phenotypes including 
cardiomyocytes (Toma et al., 2002, Deb et al., 2003), neurons (Dezawa et al., 2004, Zeng 
et al., 2011), hepatocytes (Sato et al., 2005) and lung epithelial cells (Kotton et al., 2001, 
Ma et al., 2011). The capacity of MSC to differentiate into distinct cell types is a central 
phenotypic feature that has attracted significant interest within the scientific community for 
their application in the field of regenerative medicine.   
 
In 2002, Toma and colleague injected human bone marrow MSC isolated from healthy 
donors into the myocardium of healthy mice and observed that after a week MSC were 
differentiated into cardiomyocyte-like cells (Toma et al., 2002). Berry and colleagues 
injected MSC into the infarct region of cardiac wall of myocardial infarction rat models 
and demonstrated that MSC treatment improved cardiac function, reduced cardiomyocytes 
apoptosis and fibrosis scar comparing non-MSC treated control groups (Berry et al., 2006). 
They also demonstrated that transplanted MSC expressed cardiomyocyte-specific protein 
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„troponin T‟ although their phenotypic morphology was unlike cardiomyocyte suggesting a 
putative paracrine role underpinned the reparative process.  
 
MSC have also been reported to differentiate into type I and type II alveolar epithelial cells 
in vivo (Kotton et al., 2001, Rojas et al., 2005). Studies on bleomycin induced animal lung 
fibrosis models demonstrated that following intratracheal and intravenous administration 
of MSC, a small proportion of transplanted cells engrafted into the affected lung and 
differentiated into AECI and AECII cells with an accompanying amelioration of 
pulmonary fibrosis (Kotton et al., 2001, Rojas et al., 2005). A recent in vitro study also 
demonstrated that human MSC are capable of differentiating into SP-C (a bio-marker of 
AECII) -expressing AECII-like cells when co-cultured with foetal lung mesenchymal cells 
(Ma et al., 2011). In addition, systemic application of murine MSC in a cisplatin-induced 
acute renal failure mouse model resulted in migration and engraftment to the affected 
kidneys and differentiation into renal tubular epithelial cells with amelioration of renal 
dysfunction and augmentation of renal tubular regeneration suggesting MSC as a potential 
candidate for regenerative cell therapy for the cure of acute renal failure (Morigi et al., 
2004). 
 
The differentiation capacity of MSC into hepatocytes was also demonstrated in alcohol-
induced chronic liver injury rat models (Sato et al., 2005). Sato and colleagues injected 
human MSC directly into the alcohol-induced injured part of rat liver and assessed for 
different hepatocyte-specific bio-markers in different time periods. They revealed that on 
and after a 7 post-transplant period MSC started to express a set of hepatocyte-specific 
proteins (hepatocyte bio-markers) namely, human-specific alpha-fetoprotein (AFP), 
albumin (Alb), cytokeratin-19 (CK-19), cytokeratin-18 (CK-18), and asialoglycoprotein 
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receptor (AGPR) (Sato et al., 2005). Apart from these, under specific culture conditions 
MSC have been shown to differentiate into functional neuronal phenotypes (Dezawa et al., 
2004, Zeng et al., 2011), retinal pigment epithelial cells (Arnhold et al., 2007) and skin 
epithelial cells (Nakagawa et al., 2005). 
 
Although increasing reports demonstrated the differentiation potential of MSC into 
different adult phenotypes, in most of the cases the targeted cell-type differentiation was 
confirmed based on their cell-type specific biomarkers. It is true that some markers are 
specific for certain cells; however they do not always have functional relation. In addition 
these markers are not always unique for characterization of a specific cell type. Empirical 
analysis on both human and rodent MSC demonstrated that MSC is, by nature, primed for 
osteogenic, chondrogenic, adipogenic and vascular smooth muscle differentiation and can 
undergo active differentiation under appropriate culture condition via activation of TGF-β, 
hedgehog, peroxisome proliferator-activated receptor interaction and MAPK pathways 
respectively (Delorme et al., 2009). Thereby, precaution must be taken for clinical 
application of MSC to avoid any unwanted ectopic differentiation. 
 
1.11.2.2.1.1.2. Tissue repair by MSC-mediated paracrine mechanism 
A growing body of evidence suggests that the paracrine mechanism of MSC is largely 
involved in the tissue repair and regenerative process. MSC possesses immunomodulatory 
functions which have been demonstrated through their therapeutic efficacy in alleviation of 
graft-versus-host disease (GvHD) and animal model of bronchial asthma through their 
putative role in modulating Type-1 (Th1) and Type-2 (Th2) immune responses (Nemeth et 
al., 2010). MSC-secreted factors are cytoprotective as demonstrated in a cardiac injury 
animal model driven by anti-apoptotic and inotropic effects (Gnecchi et al., 2008). The 
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MSC-mediated anti-apoptotic effects can be driven by up-regulation of the anti-apoptotic 
gene, Bcl-2, which was demonstrated in an animal model of emphysema (Zhen et al., 
2008) (Figure 1.13). Animal model of myocardial infarction and pulmonary hypertension 
have demonstrated that transplanted MSC improved cardiac function and pulmonary 
vasculature by stimulating neovascularisation possibly via their secretory VEGF (vascular 
endothelial growth factor) and eNOS (endothelial nitric oxide synthase) (Burdon et al., 
2011, Baber et al., 2007, Kanki-Horimoto et al., 2006). The anti-inflammatory function of 
MSC has been documented in many animal model studies. The mechanism is paracrine 
and more likely via blocking of anti-inflammatory cytokines such as TNF-α and IL-1 
(Ortiz et al., 2007, Gupta et al., 2007) (Figure 1.13).  
 
1.11.2.2.1.2. Potential MSC-mediated regenerative therapy for IPF 
Due to the lack of available curative treatments for IPF and the repeated failure of anti-
fibrotic drugs, stem cell-mediated regenerative therapeutic approaches have been proposed. 
Several animal models of pulmonary fibrosis have been developed (Moore & Hogaboam, 
2008). Among them the best characterised and most widely used model is the bleomycin-
induced pulmonary fibrosis model (Harrison & Lazo, 1987, Moore & Hogaboam, 2008). 
Other models include radiation-induced fibrosis (Haston & Travis, 1997), silica-induced 
fibrosis (Davis et al., 1998) and asbestos-induced lung fibrosis model (Bozelka et al., 
1983).  
 
The bleomycin-induced pulmonary fibrosis mouse model was applied in the demonstration 
of migration and engraftment of endotracheal or systematically transplanted MSC towards 
the site of injuries of the lung and subsequent attenuation of pulmonary fibrosis (Rojas et 
al., 2005, Ortiz et al., 2003). Ortiz and colleagues demonstrated that the systemic 
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administration of bone marrow derived MSC after 4 hours of bleomycin administration 
attenuated pulmonary inflammation, reduced fibrosis and decreased mortality after 14 days 
of injury and engraftment of transplanted MSC in the injured alveoli with their 
differentiation into type II AEC-like phenotype (Ortiz et al., 2003). However, when MSC 
were administered after 7 days of injury, the MSC-mediated protective function was 
abrogated (Ortiz et al., 2003). Using the same model, Rojas and colleagues also 
demonstrated the injury reparative function of MSC and their engraftment potential to 
injured lung (Rojas et al., 2005). In 2007, Ortiz and colleagues showed that MSC protected 
bleomycin-induced lung injury and reduced fibrosis by blocking pro-inflammatory 
cytokines such as TNF-α and IL-1 by MSC-associated IL-1 receptor antagonist (IL-1RN) 
(Ortiz et al., 2007) (Figure 1.13). 
 
Nemeth and colleagues demonstrated that MSC were stimulated by pro-inflammatory 
cytokines and endotoxin such as TNF-α and LPS respectively. MSC endotoxin-based 
activation occurred via toll-like receptor-4 (TLR-4), resulting in increased production of 
cyclooxygenase-2 and subsequent increased production of potent anti-inflammatory agent 
PGE2 by MSC. MSC-secreted PGE2 drove increased macrophage IL-10 secretion and 
attenuated sepsis and sepsis-associated lung injury (Nemeth et al., 2009). The explanted 
human lung model provided the demonstration that MSC enhanced LPS-induced acute 
lung injury repair had likely occurred in a KGF-dependent manner (Lee et al., 2009a) 
(Figure 1.13). 
 
The administration of KGF-expressing engineered MSC or HSC in the bleomycin-induced 
mouse lung fibrosis model was associated with reduced fibrosis via suppression of 
collagen accumulation (Aguilar et al., 2009). KGF has the established role in the repair of 
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alveolar epithelium through stimulation of type II AEC proliferation, migration and 
spreading (Panos et al., 1993, Guo et al., 1998, Yano et al., 2000). This proof-of-concept 
demonstration that genetically modified MSC or HSC with suitable cytokine/growth factor 
have added benefit in the repair of lung injury with the potential to be a valid stem cell 
therapeutic strategy for pulmonary fibrosis (Aguilar et al., 2009). 
 
Although the above pre-clinical studies suggested MSC as a potential candidate for 
regenerative therapy for IPF, there are some concerns that MSC has fibrotic effects and 
could deteriorate the pathological condition if they are applied in chronic lung fibrosis 
(Yan et al., 2007). Yan and colleagues demonstrated that after systemic application of 
MSC at 4 hours of irradiation-induced lung injury, transplanted cells engrafted in the 
alveolar and bronchiolar epithelium and differentiated into epithelial phenotype; whereas, 
when MSC were administered at 60 and 120 days post-injury they localised in the 
interstitial spaces and differentiated into myofibroblasts, a fibrotic phenotype that plays 
major role in fibrogenesis (Yan et al., 2007). The authors concluded that the fate of MSC 
differentiation is controlled by the microenvironment milieu and warned that MSC therapy 
might be ideal for acute lung injury but may augment fibrosis in chronic lung fibrosis such 
as IPF. 
 
Supporting the putative pro-fibrotic nature of MSC, an in vitro study has demonstrated that 
human and mouse MSC secrete TGF-β1 and Wnt proteins that can stimulate human and 
mouse lung fibroblast proliferation and collagen production, the two major hallmarks of 
lung fibrosis (Salazar et al., 2009). PGE2 treatment significantly inhibited resident MSC 
proliferation and collagen secretion and abrogated fibrotic differentiation into 
myofibroblasts (Walker et al., 2012). If this is true for other MSC from common sources 
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such as bone marrow and cord blood, PGE2 could be administered concomitantly with 
MSC to reduce their putative fibrotic effects. 
 
Conversely, no TGF-β1 expression was detected in MSC isolated from bone marrow of 
either normal healthy individuals or patients with IPF; and the expression of FGF 
(fibroblast growth factor) and VEGF were not significantly different in either cases 
(Antoniou et al., 2010). However, CXCR4, a potent chemokine receptor was significantly 
over-expressed in IPF. The increased CXCR4 expression by IPF MSC suggests that the 
bone marrow is probably implicated in the pathophysiology of IPF by mobilising resident 
MSC in response to preceding lung injury (Antoniou et al., 2010). Further studies are 
required to confirm whether MSC mobilisation is an attempt to repair lung injury or to 
solely aggravate fibrosis in IPF. 
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Figure 1.13: MSC-mediated acute alveolar injury repair.  
This illustration shows an injured alveolus associated with inflammation and AEC apoptosis. MSC 
can be delivered via intratracheal or intravenous (I.V) route. MSC can inhibit alveolar 
inflammation by abrogation of IL-1α-depenednt T-lymphocyte proliferation and suppression of 
TNF-α secretion by the activated macrophages through MSC-secreted IL-1 receptor antagonist (IL-
1RN). Inflammatory environment stimulates MSC to secrete PGE2 which can stimulate activated 
macrophages to secrete anti-inflammatory cytokine IL-10. IL-10 can alleviate alveolar 
inflammatory responses. MSC also can inhibit AEC apoptosis through up-regulation of anti-
apoptotic Bcl-2 gene. MSC-secreted KGF can stimulate AECII proliferation and migration 
propagating alveolar epithelial restitution. Alveolar structural engraftment of MSC is a rare event. 
(Image was taken from Akram et al., 2012). 
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1.11.2.2.2. Embryonic stem cells  
Embryonic stem cells (ESC) are self-renewing, pluripotent stem cells derived from the 
inner cell mass of a 5-6 day-old blastocysts and are capable of unlimited, undifferentiated 
proliferation in vitro. Unlike adult stem cells ESC are capable of differentiating into tissues 
of all three germ layers (Martin, 1981). Murine ESC were first described by Gail Martin in 
1981 (Martin, 1981). Thereafter, it took 17 years before the first human ESC line was 
established in 1998. Since then, at least 225 human ESC (hESC) lines have been created. 
Pluripotent hESC lines express a set of antigens including SSEA-3, SSEA-4, TRA-1-60, 
TRA-1-81, alkaline phosphatase, Oct-4 and Nanog transcription factors and high levels of 
telomerase activity (Thomson et al., 1998, Reubinoff et al., 2000, Henderson et al., 2002, 
Laslett et al., 2003).  
 
1.11.2.2.2.1. ESC in regenerative therapy for IPF 
ESC have been suggested as a suitable source for regenerative cell therapy for lung repair 
and regeneration due to their potential to differentiate into lung epithelial cells (Weiss & 
Finck, 2010). For IPF, ESC could be utilised to replace damaged AEC to facilitate alveolar 
wound repair. Type II AEC have been successfully differentiated from human (Wang et 
al., 2007) and mouse (Ali et al., 2002, Rippon et al., 2006, Roszell et al., 2009) ESC. More 
recently, Wang and colleagues have demonstrated that intratracheal administration of ESC-
derived type II AEC improved survival and ameliorated pulmonary inflammation and 
fibrosis in a bleomycin-induced experimental lung injury model (Wang et al., 2010). In this 
study, structural engraftment of transplanted ESC-derived type II AEC and their 
differentiation into type I AEC were also noted (Wang et al., 2010). However, attenuation 
of bleomycin-induced fibrotic responses occurred as early as 24 to 48 hours of ESC-
derived type II AEC administration indicating a putative paracrine mechanism involved in 
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the amelioration of pulmonary fibrosis. Although ESC have a substantial potential 
differentiation capacity into AEC, the ethical issues of their therapeutic application and 
potential risk of teratoma formation are the main obstacles that need to be overcome before 
their clinical application (see Chapter 5, Section- 5.4). 
 
1.12. Aims and objectives of this study 
IPF is a disease of aberrant alveolar epithelial wound repair of unknown aetiology where 
the pathogenesis is widely unknown. A substantial number of studies have been conducted 
to understand the abnormal epithelial-mesenchymal cross-talk, effects of fibroblasts and 
myofibroblasts in IPF; whereas, the effect of alveolar bronchiolisation in the aberrant AEC 
wound repair in IPF remains unexplored. On the other hand, animal model studies have 
demonstrated that MSC or ESC are capable of attenuating pulmonary fibrosis which 
suggests a stem cell based regenerative therapeutic approach for IPF. However, the 
paracrine influence of MSC or ESC on AEC wound repair has yet to be elucidated.  
 
Aim 1: Through this study, efforts have been taken to understand the role of Clara cells in 
the alveolar epithelial cell wound repair in the context of alveolar bronchiolisation. The 
paracrine role of Clara cells on AEC wound repair has been investigated by using in vitro 
wound repair assay; whereas, a direct-contact in vitro wound repair model has been 
developed to evaluate the Clara cell direct-contact effect on AEC wound repair mimicking 
the scenario of alveolar bronchiolisation.  
 
Aim 2: Whilst the majority of studies have highlighted anti-inflammatory and anti-fibrotic 
effects of MSC, here a set of experiments have been undertaken to explore the paracrine 
role of human MSC on AEC and small airway epithelial cell wound repair in vitro. In 
Chapter 1:                                                                                                   Introduction 
PhD thesis by K. M. Akram                                                                    Keele University - 62 - 
addition, the influence of secretory products obtained from different stages human ESC 
differentiation has been tested on AEC in vitro wound repair model. Understanding the 
paracrine effects of hMSC/hESC and the identification of effective secretory factor(s) are 
definitive advancement towards development of novel acellular stem cell-mediated 
regenerative therapy for IPF and other incurable lung diseases. 
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2.1. Cell lines 
The primary cell and the cell lines that were used in the experiments are tabulated below 
(Table 2.1). All other cell culture materials that used in this study are tabulated in Table 
S1, Appendix-1. 
 
Table 2.1: Primary cells and cell lines 
Cell lines Description Origin 
A549 
Human type II alveolar epithelial cell 
line originated from human lung 
ATCC, Rockville, MD, USA 
H441 
Human Clara cell line originated from 
human lung 
ATCC, Rockville, MD, USA  
SAEC 
Human primary small airway epithelial 
cells isolated from human lung 
Lonza, USA 
hMSC 
Human mesenchymal stem cells isolated 
from bone marrow aspirates 
Human bone marrow aspirates 
from Lonza, USA 
SHEF-2 Human embryonic stem cell line 
Sheffield University, UK; used 
under license from UK Stem 
Cell Bank 
MEFs 
Mouse embryonic fibroblasts isolated 
from 12.5-13.5 days gravid uteri of 
black CB1 hybrid mice 
Keele University small animal 
facilities  
CCD-8Lu Normal human lung fibroblasts ATCC, Rockville, MD, USA 
pAEpiC Human primary alveolar epithelial cells ScienceCell Laboratory, USA 
 
2.2. Cell culture condition 
2.2.1. A549 and H441 cell culture 
Cells were cultured according to the supplier instruction. A549 and H441 cells were stored 
in the liquid nitrogen at -190
0
C in cryovials in freeze-media comprised of 10% DMSO 
(Dimethyl sulfoxide) in FBS (Foetal bovine serum). Cells in cryovials were thawed 
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quickly (within a minute) in water bath at 37
0
C and resuspended in 10 ml of complete 
culture media that composed of DMEM (Gibco, Invitrogen, USA) supplemented with 10% 
FBS (Lonza, Belgium), 1% L-glutamine (Lonza, Belgium) and 1% NEAA (Non-essential 
amino acid) (Lonza, Belgium). Cell suspension was then centrifuged for 3 minutes at 1200 
rpm, a cell pellet formed at the bottom of the centrifuge tube. Supernatant was discarded 
and pellets of A549 and H441 cells were resuspended in 10 ml of complete culture media 
by gentle pipetting. A549 and H441 cell suspensions were then passaged into T75 tissue 
culture flasks separately in total 15-18 ml of complete culture media and incubated in the 
humidified incubator at 37
0
C in presence of 5% CO2 and 95% air. On the next day, media 
was replaced with 15-18 ml of fresh complete culture media. After recovery, the A549 
cells became confluent within 2-3 days and H441 cells took a week for confluency. Both of 
these cell lines were maintained in a continuous subculture throughout the whole 
experimentation period. New vials of A549 and H441 cells were thawed as required.  
 
For subculture, A549 and H441 cells were harvested by trypsinisation and passaged at a 
split ratio of 1:4 to 1:8 in T75 culture flasks in 15-18 ml of complete culture media. The 
trypsinisation process was as follows: a confluent T75 flask of cells was rinsed once with 
10 ml of warm PBS (Phosphate-buffered saline) (pre-equilibrated at 37
0
C) and 5 ml of 
0.05% trypsin/EDTA solution (Lonza, Cat No- BE02-007E) was added to the cells and 
incubated at room temperature for 3-5 minutes. Trypsinised cell were checked under 
microscope, when they appeared rounded and detached from each other the flask was 
rapped against the palm to dislodge the cells completely from their adherent culture surface 
(Figure 2.1). Same volume (5 ml) of complete media was added to the cells to neutralise 
the trypsin. Cell suspension was taken into a 15 ml centrifuge tube and centrifuged at 1200 
rpm for 3 minutes to get cell pellet. Supernatant was discarded and cell pellet was 
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resuspended for passage. Media was replaced twice in a week during the whole period of 
culture. 
 
 
Figure 2.1. Trypsinisation of H441 cells. 
(A) Just after adding trypsin/EDTA solution in confluent monolayer of H441 cells. (B) Cells start 
to detach from each other. (C) Cells appear round-up after 3-5 minutes of adding trypsin. Original 
magnification 400X. Scale bar, 50 µm. 
 
2.2.2. SAEC culture 
Cell recovery: Primary human small airway epithelial cells (SAEC) were purchased from 
Lonza, USA (Cat. No. CC-2547, Lot. No. 0000105938). Cryopreserved SAEC (5 x 10
5
) 
(P-2) in a vial were transported in dry ice; upon receipt cells were stored in liquid nitrogen 
at -190
0C. Cells were recovered and subcultured following the manufacturer‟s instruction 
using recommended culture media (SAGM Bullet Kit, Lonza, USA) and subculture 
reagent pack (Reagent Pack, Lonza, USA). A vial of cryopreserved SAEC (≥5 x 105 cells) 
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were thawed quickly in water bath at 37
0
C and resuspended in 8 ml of complete SAGM 
(Small airway growth media) which was prepared using SABM (Small airway basal 
media) supplemented with 1% of BSA-FAF (Bovine serum albumin-Fatty acid free), 0.4% 
of BPE (Bovine pituitary extract), 0.1% of rhEGF (Recombinant human epidermal growth 
factor), 0.1% of transferrin, 0.1% of triiodothyronine (T3), 0.1% of retinoic acid, 0.1% of 
insulin, 0.1% of epinephrine, 0.1% of hydrocortisone and 0.1% of GA (Gentamicin and 
Amphotericin-B) (All from Lonza, USA). Five ml of pre-equilibrated SAGM at 37
0
C was 
taken in each of total 8 T25 tissue culture flasks (Corning, NY, USA). 1 ml of SAEC 
suspension that contains ≥62,500 cells (Recommended seeding density was 2,500 
cells/cm
2
) was passaged into each T25 flask and incubated in the humidified incubator at 
37
0
C in presence of 5% CO2 and 95% air. On the next day, each flask of SAEC was 
replenished with 6 ml of fresh SAGM. Media was changed on every alternate day and cells 
became 70-80% confluent in 7 days (Figure 2.2). SAEC have a tendency to undergo 
irreversible contact-inhibition once they become confluent. To avoid the loss of 
proliferation capacity, SAEC were never allowed reaching confluency during subculture. 
 
Subculture: For subculture, 70-80% confluent T25 flasks of SAEC were harvested by 
trypsin/EDTA and passaged into T25 flasks at a cell-seeding concentration of 2,500 
cells/cm
2
 in 6 ml of complete SAGM per flask using Reagent Pack (Lonza) that includes 
trypsin/EDTA solution, trypsin neutralisation solution (TNS) and HEPES buffered saline 
solution (HEPES-BSS). For trypsinisation cells were washed once with HEPES-BSS (4 
ml/T25 flask) and then 2.5 ml of trypsin/EDTA solution was added to the cells and 
incubated for 2-5 minutes at room temperature. Trypsinised cells were examined under the 
microscope, when >90% cells became rounded up cells were dislodged from the culture 
surface by gently rapping the flask against the palm. When >95% of cells were dislodged, 
Chapter 2:                                                                                  Materials and Methods 
PhD thesis by K. M. Akram                                                                    Keele University - 68 - 
5 ml of TNS was added to neutralise the action of trypsin. Cell suspension was then taken 
into a 15 ml centrifuge tube and centrifuged for 3 minutes at 1200 rpm to form a cell pellet 
at the bottom of the tube. Supernatant was discarded and the cell pellet was resuspended in 
5 ml of complete SAGM (pre-equilibrated at 37
0
C). Before passaging, cells were counted 
using trypan blue and haemocytometer. Total yield of SAEC from a T25 flask ranged from 
8 x 10
5
 to 1 x 10
6
 cells depending on their passage number and confluency with  >95% 
viability. Approximately 62,500 cells were seeded per T25 flask in 6 ml of complete 
SAGM and cultured in standard condition until they became ready for next passage. Cells 
were growing well up to passage 5; at passage 6 SAEC appeared to be 
quiescent/senescence. During the whole culture period media was changed on alternate 
days. 
 
Cell cryopreservation: SAEC were cryopreserved using recommended freeze-media. The 
freeze-media was composed of 80% SAGM, 10% FBS and 10% DMSO. SAEC (P-3) were 
harvested by trypsinisation as described above. Cell pellet was formed from cell 
suspension by centrifugation. Cell pellets were then resuspended in 1 ml of freeze-media 
and taken into a cryovial. 1 T25 flask of 70-80% confluent cells was stored in each 
cryovial. Cells were frozen using Mr Frosty at -80
0
C in first 24 hours. Frozen cells were 
then transferred into liquid nitrogen cell storage reservoir at -190
0
C for long term 
preservation. 
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Figure 2.2: SAEC recovery. 
SAEC are in 3 days (A) and 7 days (B) of post-recovery phases. Original magnification 200X. 
Scale bar, 100 µm. 
 
2.2.3. hMSC culture 
hMSC isolation: hMSCs were isolated and expanded from human bone marrow aspirates 
(BMA) by plastic adherent culture technique following previously published methodology 
(D‟Ippolito et al. 2004, Wimpenny et al. 2010). A total of 3 human bone marrow aspirates 
(BMA) from 3 different donors which were aspirated from iliac crest were purchased from 
Lonza, USA and processed for experimentation (Table 2.2). Whole bone marrow was 
seeded at a density of 10
5
 mononuclear cells/cm
2
 on 10 ng/ml fibronectin-coated (Cat. No. 
F0895, Sigma) T-75 tissue culture flasks in 20 ml of DMEM supplemented with 5% FBS, 
1% L-glutamine, 1% NEAA and 1% PSA (Penicillin-Streptomycin-Amphotericin B) and 
incubated at 37
0
C in presence of 5% CO2 and 95% of air. For fibronectin coating, 10 ml of 
10 ng/ml fibronectin solution in PBS was added in each T75 flask and incubated 2 hours at 
room temperature. Before use, fibronectin solution was discarded and the culture media 
was added. The whole bone marrow cells containing non-adherent (mononuclear cells) and 
adherent cells (MSC) were maintained in a continuous culture for three weeks in a 
humidified incubator at 37
0
C in the presence of 5% CO2 and 95% air. After 7 days of 
culture half of media was removed and replaced with antibiotic-free fresh DMEM culture 
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medium as above. On the second week, whole media was discarded, cells were rinsed once 
with PBS and complete fresh media was added (20 ml/T75 flask). At the end of third week 
MSC-colony formed (also known as CFU-F, colony forming unit- fibroblast). Cells of 
some T75 flasks were fixed with 95% ethanol for 30 min at room temperature then washed 
twice with PBS. Giemsa stain was added (12 ml/T75 flask) and incubated at room temperature for 
2 hours on a rocker. Then washed with tap water till clear. CFU-F, and cell morphology were 
observed under light microscope (Figure 2.3). The adherent hMSC population was harvested 
with trypsin as described above and subsequently passaged for expansion. Before 
expansion, hMSC were plated on 24-well plates for their functionality characterisation and 
immunophenotyping which is described below in Section- 2.2.3.1, Section- 2.12.3, and 
Section- 2.12.2 respectively. 
 
hMSC expansion: hMSC were expanded up to passage 4 by subculturing. For subculture, 
confluent T75 flasks of hMSC were split at 1:4 to 1:6 ratios and passaged to T75 tissue 
culture flasks. Cells were harvested by trypsin/EDTA as described above. During 
subculture the DMEM was supplemented with 5% FBS, 1% L-glutamine and 1% NEAA 
(complete culture media). Media was changed twice a week. Passage 1-3 hMSC were 
utilised for all of experimentation procedures. 
 
hMSC cryopreservation: After isolation from BMA, substantial number of hMSC at 
Passage-1 were cryopreserved for future use. For cryopreservation, confluent T75 flasks of 
hMSC were harvested by trypsinisation and stored in liquid nitrogen using 10% DMSO in 
FBS freeze media as described above. One confluent T75 flask of hMSC was stored in 
each cryovial in 1 ml of freeze media. 
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Figure 2.3. Recovered hMSC from bone marrow aspirate after 3 weeks. 
(A) CFU-F of hMSC forms after 3 weeks of culture, stained with Giemsa. Light microscopic image 
at 40X. (B) High magnification image at 400X. Purple nuclei stained with Giemsa. (C) Un-fixed 
and un-stained light image of hMSC after 3 weeks at 100X. (D) Image at 200X, stained with 
Giemsa. Scale bar, 100 µm. 
Chapter 2:                                                                                  Materials and Methods 
PhD thesis by K. M. Akram                                                                    Keele University - 72 - 
Table 2.2: Donor details of human bone marrow aspirates. 
No BMA label Donor description Supplier 
1 BMA-8 Human Bone Marrow, Male, Age-35 years Lonza, MD, USA 
2 BMA-11 Human Bone Marrow, Female, Age-26 years Lonza, MD, USA 
3 BMA-12 Human Bone Marrow, Male, Age-32 years Lonza, MD, USA 
 
2.2.3.1. Functional characterisation of hMSC by tri-lineage differentiation 
Differentiation protocol 
To evaluate the multipotency of hMSC, the isolated human bone marrow derived MSC 
were differentiated into osteogenesis, adipogenesis and chondrogenesis lineages using 
StemPro hMSC differentiation kits following the manufacturer instruction (Cat. No- 
A10072-01, A10070-01 and A10071-01; Gibco, Invitrogen, USA). For osteogenesis and 
adipogenesis, 2 x 10
4
 hMSC (P-1) were seeded on each well of 24-well plates and grown 
60-70% confluence in 72 hours using complete culture media. Cells were washed with 
PBS once and SF (Serum-free)-DMEM once to remove serum. hMSC were then cultured 
for three weeks in StemPro
®
 Osteogenic differentiation media (Cat. No- A10072-01) and 
StemPro
®
 Adipogenic differentiation media (Cat. No- A10070-01) (600 µl/well each) with 
media changes every two days. For control, hMSC were cultured in complete growth 
media (600 µl/well) for same duration, with media changes every two days.  
 
For chondrogenesis, the micromass culture system was used according to the 
manufacturer‟s instruction. Briefly, 8 x 104 hMSC were resuspended in 7 µl of complete 
media and dropped in the centre of a 24-well plate as a micromass and cultured for 2 hours 
in the humidified incubator in the standard culture condition allowing them to adhere with 
the culture surface. Micromasses were then replenished with StemPro
®
 Chondrogenic 
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differentiation media (Cat. No- A10071-01) (600 µl/well) and cultured in standard culture 
conditions for three weeks with media change every two days. For control, micromasses 
were cultured with complete growth media for same duration. 
 
Evaluation of tri-lineage differentiation  
After three weeks, the differentiated hMSC lineage was confirmed by histological staining 
and immunocytochemistry. Immunocytochemistry evaluation is described below (Section- 
2.12.3). The mineral deposition by differentiated osteoblasts, lipid accumulation in 
adipocytes and proteoglycan-rich matrix accumulation in chondrocytes was detected by 
classical histological stains; Alizarin Red, Oil Red O and Alcian Blue respectively, 
following standard protocols.  
 
Alizarin Red staining 
Preparation of 1% Alizarin Red solution: 0.5g of Alizarin Red powder (Cat. No- A5533, 
Sigma) was dissolved in 50 ml of dH2O. The pH of this solution was maintained ~4 by 
adding 0.1M HCl acid to allow Alizarin Red to bind with deposited extracellular calcium 
only. Solution was filtered with 0.4 µm porous filter paper before use. 
Staining procedure: Osteogenic differentiated samples and controls were fixed with 10% 
formaldehyde for 30 minutes. After washing once with dH2O, 800 µl of Alizarin Red 
solution was added to each well and incubated for 10 minutes at RT (Room temperature). 
Samples were then washed three times with dH2O to remove excess dye. Images were 
acquired by an inverted light microscope (Nikon Eclipse TS100, Japan) attached with a 
colour CCD camera (Canon, Japan).  
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Oil Red O staining 
Preparation of Oil Red O solution: Stock Oil Red O solution was prepared by dissolving 
0.35g of Oil Red O powder (Cat. No- O-0625, Sigma) in 100 ml of 100% isopropanol (Cat. 
No- I-0398, Sigma). Stock solution was filtered with 0.2 µm filter paper. Oil Red O 
working solution was prepared by adding 6 ml of stock solution with 4 ml of ddH2O. 
Staining procedure: To detect triglyceride produced by differentiated adipocytes, samples 
were stained with Oil Red O. Adipogenic differentiated samples were fixed with 10% 
formalin for 10 minutes at RT. The formalin was removed and again added with fresh 10% 
formalin and incubated for 1 hour at RT. Samples were then washed with ddH2O twice and 
twice with 60% isopropanol for 5 minutes. Samples were then completely air dried. Oil 
Red O working solution was then added in each sample (800 µl/well) and incubated for 10 
minutes at RT. After incubation, Oil Red O was discarded and samples were washed with 
ddH2O four times. Images were acquired by an inverted light microscope attached with a 
colour CCD camera.  
 
Alcian Blue staining 
Preparation of 1% Alcian Blue solution: 1g of Alcian Blue 8GX (Cat. No- A-3157, Sigma) 
was dissolved in 100 ml of 3% acetic acid (Cat. No- A-9967, Sigma) to prepare 1% Alcian 
Blue solution (pH 1.5). Solution was filtered using 0.2 µm porous paper filter.  
Staining procedure: To detect the glycosaminoglycan (GAG) produced by the 
differentiated chondrocytes, cells were stained with 1% Alcian Blue. Samples were fixed 
with 10% formalin for 30 minutes. After fixation samples were washed twice with dH2O 
then 1% Alcian Blue was added (800 µl/well) and incubated overnight at RT. Samples 
were washed with dH2O three times to remove excess stain and images were captured by 
an inverted light microscope attached with a colour CCD camera. 
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2.2.4. hESC culture 
Human embryonic stem cell (hESC) line SHEF-2 cells were obtained from the UKSCB 
after donation by the University of Sheffield, UK and cultured on feeder-free matrigel 
coated tissue culture flasks (T25 flasks) using mouse embryonic fibroblasts (MEFs) 
conditioned media (MEF-CM) following the protocol described by Xu et al. 2001. 
 
MEFs conditioned media (CM) preparation: 12.5 to 13.5-day pregnant black CB1 hybrid 
mice were sacrificed by cervical dislocation and gravid uterine horns were isolated through 
lower abdominal V-shape incision following aseptic protocol at small animal facilities, 
Keele University (Figure 2.4). Segmented uteri were separated and transferred to the flow 
hood at cell culture facilities for further processing. Eight to ten embryos were collected 
from each pair of uteri. Viscera and heads were removed from the embryos using sharp tip 
forceps. Embryos were then washed three times in 1% PSA containing PBS to remove the 
remnants of viscera and blood clots. Embryonic fibroblasts were isolated from mouse 
embryos by trypsin digestion. For this process, 5 embryos were taken into each 7 ml Bijou 
bottle in 5 ml of trypsin/EDTA solution and incubated for 10 minutes in the incubator at 
37
0
C. Trypsinised embryos were vortexed twice at 5 minutes interval during the incubation 
period. After incubation cell supernatants were collected and resuspended in 10 ml of 
DMEM supplemented with 10% FBS, 1% L-glutamine, 1% NEAA and 1% PSA in 15 ml 
sterile centrifuge tube. Cell suspensions were then centrifuged at 1200 rpm for 3 minutes. 
Supernatants were discarded and cell pellets were resuspended in 10 ml of the above 
mentioned DMEM. 2 ml of MEFs cell suspension was seeded into T75 culture flasks in 18 
ml culture media and incubated at 37
0
C in presence of 5% CO2 and 95% air in a 
humidified cell culture incubator. On the next day, media was replaced with antibiotic-free 
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complete culture media and media was changed twice weekly until the MEFs became 
confluent.  
 
A confluent MEF T75 was split into 8 T75 tissue culture flasks at 1:8 split ratio and 
cultured to 50-60% confluency. To prepare MEF-CM, 50-60% confluent MEFs were 
washed once with warm PBS and 30 ml of KO (Knock out)-DMEM (Gibco, Invitrogen) 
supplemented with 20% KO-SR (KO-Serum replacement) (Gibco, Invitrogen), 1% L-
glutamine, 1% NEAA, 0.1 mM β-mercaptoethanol and 4 ng/ml human bFGF (Basic 
fibroblast growth factor) added and cultured for 24 hours. MEF-CM was collected and 
used fresh or stored at -20
0
C before use. MEF-CM was collected on three consecutive days 
from a single T75 flask. Prior to use, MEF-CM was further supplemented with human 
bFGF (4 ng/ml) and sterile filtered with 0.20 µm porous Millipore filtration unit 
(Millipore). This media was labelled as „hESC culture media‟ and used for hESC culture.  
 
Matrigel coating: Culture surfaces of T25 tissue culture flasks were coated with 1:100 
diluted matrigel (BD Matrigel MatrixTM, BD, Bedford, MA, USA; Cat No-354234) in ice 
cold KO-DMEM. 4 ml of ice cold diluted matrigel solution was added into each T25 flask 
(160µl/cm
2
) and incubated at room temperature for 2 hours. Before use, matrigel 
containing flasks were incubated at 37
0
C for 30 minutes in the incubator, after incubation 
the matrigel media was discarded and hESC culture media was added. Prepared matrigel 
coated culture flasks were stored at 4
0
C for later use. 
 
hESC culture: A cryovial of SHEF-2 (P-28) was taken from liquid nitrogen cell storage 
reservoir and thawed in water bath within a minute with a gentle agitation. Cells were 
stored in 10% DMSO in KO-SR solution. Thawed cells were then added into 6 ml of pre-
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equilibrated 37
0
C hESC culture media in a matrigel coated T25 tissue culture flask and 
incubated at 37
0
C in presence of 5% CO2 and 95% air in the humidified incubator. On next 
day, media was replaced by fresh hESC culture media. The cells which attached with the 
culture surface were allowed to grow to 70-80% confluency with a daily media change by 
6 ml of fresh media (Figure 2.5). 70-80%-confluent hESC were harvested by trypsinisation 
and passaged into 2 to 4 T25 flasks at a split ratio of 1:2 to 1:4. For trypsinisation, cells 
were washed once with PBS and 2 ml of trypsin/EDTA solution was added and incubated 
for 1-3 minutes at RT. Cells were dislodged by rapping the flask with palm of the hand 
gently. When 70-90% of cells were dislodged, same volume of hESC culture media was 
added and the solution was taken in 15 ml centrifuge tube and centrifuged for 3 minutes at 
1200 rpm to get cell pellet. Cell pellet was then resuspended in 10 ml of hESC culture 
media and passaged as above split ratio. Cells were passaged every 3 to 7 days and 
maintained in a continuous culture during the whole experimentation period. New vials of 
cells were thawed as required. 
 
hESC cryopreservation: 80-90% confluent T25 flask of hESC were harvested by 
trypsinisation and stored in the liquid nitrogen using 10% DMSO in KO-SR freeze media. 
1 T25 of hESC were stored in each cryovial. 
 
2.2.5. CCD-8Lu cell culture 
Cells were cultured according to the supplier instruction. CCD-8Lu cells (P-7, P-8, P-10) 
were stored in the liquid nitrogen at -190
0
C in cryovials in freeze-media comprised of 10% 
DMSO in FBS. Cells in cryovials were thawed quickly in water bath at 37
0
C and 
resuspended in complete media and washed once by centrifugation as described Section- 
2.2.1. Cells were then passaged into T75 tissue culture flasks in 15-18 ml of complete 
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culture media and incubated in the humidified incubator at 37
0
C in presence of 5% CO2 
and 95% air. Media was changed every two days. Cells were maintained in a continuous 
culture upto passage 14. New cells were thawed as required. 
 
 
Figure 2.4: Embryos isolation from 13-day pregnant black CB1 hybrid mouse. 
(A) Black CB1 hybrid mouse, gravid uteri were isolated from pelvic viscera by opening the lower 
abdomen. (B) Embryos were isolated from segmented gravid uteri (horns). (C) Head and 
abdominal viscera were removed from embryos and ready for trypsin digestion. A and B steps were 
performed at small animal facilities, Keele University; C step was performed in the flow-hood at 
central cell culture facility, Guy Hilton Research Centre, Keele University. 
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Figure 2.5: Recovery of hESC from cryopreservation and in vitro culture. 
(A) hESC attached to the matrigel coated culture surface after 24 hours of seeding. (B) Cells are 
dividing. (C) Start of colony formation was observed from 3
rd 
-4
th
 day post seeding. (D) A small 
colony of hESC on day 5. (E) Typical morphology of hESC with high nucleus: cytoplasm ratio on 
adherent culture. (F) hESC formed embryoid body (EB) in 3D suspension culture. Light 
microscopic images at 400X (A, B, C, D, E) and 200X (F). Scale bar, 50 µm. 
 
2.2.6. pAEpiC culture 
Human primary alveolar epithelial cells (pAEpiC) were purchased from ScienceCell 
Research Laboratories, USA and cultured on poly-L-lysine (Sigma-Aldrich, MO, USA) 
coated culture flasks in alveolar epithelial cell media (AEpiCM) supplemented with 
epithelial cell growth supplements (EpiCGS) (ScienceCell Research Laboratory, USA) 
following the manufacturer protocol. 
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2.3. Optimisation of cell seeding density for wound repair assay 
For in vitro wound repair assay and other experimentation, different size-format well-
plates were used ranging from 24-well plate, 48-well plate and 96-well plate including 
transwells. Other than SAEC, confluent monolayers for experimentation were formed 
within 24 hours of initial cell seeding. The seeding densities of A549 cells and H441 cells 
required to form a confluent monolayer in 24 hrs were determined by seeding cells with 
various densities in different size-format well plates. In 24-well plate, seeding densities 
explored for A549 and H441 cells were 9.4 x 10
3
, 1.87 x 10
4
, 3.75 x 10
4
, 7.5 x 10
4
, 1.5 x 
10
5
 and 3 x 10
5
 cells/well in 1 ml of complete DMEM media for each well (Figure 2.6A). 
Cells were grown for 24 hours in normal culture condition. After 24 hours, wells were 
examined under an inverted light microscope and images captured with a CCD camera 
(Canon, Japan) attached to a microscope (Nikon Eclipse TS100, Japan). Afterwards, cells 
were fixed with 95% ethanol for 30 minutes then stained with Giemsa stain as described 
before (Section 2.2.3). Well-plates were then air dried before capturing images of whole 
well-plates by GeneSnap (Syngene) (Figure 2.6A). Confluent monolayers formed for A549 
cells at 1.5 x 10
5
 cells/well and for H441 cells at 3 x 10
5
 cells/well initial seeding densities 
after 24 hours in 24-well plate format (Figure 2.6B). 
 
Following the same protocol the initial seeding density for A549 cells was determined for 
48-well plate and 96-well plate which were 10
5
 cells/well and 5 x 10
4
 cells/well, 
respectively, that formed confluent monolayers after 24 hours. For 24-well plate-format 
transwells the seeding density for A549 cells was 10
5
 cell/transwell and for H441 2 x 10
5
 
cells/transwell (under surface) that formed confluent monolayers after 24 hours. 
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The initial seeding density for SEAC was determined in 48-well plate and 96-well plate. 
For 48-well plate, 2.5 x 10
4
 and 5 x 10
4
 cells/well were seeded in 500 µl/well of complete 
SAGM. SAEC monolayers were formed after 48 hours when the initial seeding density 
was 5 x 10
4
 cells/well. For 96-well plate, SAEC form confluent monolayers with an initial 
seeding density of 2 x 10
4
 cells/well in 48 hours. 
 
 
Figure 2.6: Optimisation of A549 and H441 cell seeding density for 24-well plate. 
(A) A549 and H441 cells were grown on 24-well plates for 24 hours with a range of different initial 
cell seeding concentration. Cells were fixed and stained with Giemsa and image were captured by 
GeneSnap (Black & white image). Red circled wells indicate formation of confluent monolayers. 
(B) Light microscopic images of A549 cell confluent monolayer at 1.5 x 10
5
 cells/well seeding 
density and H441 cell confluent monolayer at 3 x 10
5
 cells/well seeding density. Original image 
magnification was 100x (B). Scale bar, 200 µm. 
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2.4. Preparation of conditioned media (CM) 
To evaluate the paracrine influence and for proteomics study, CM were prepared from 
A549 cells, H441 cells, hMSC, CCD-8Lu and hESC culture. 
 
2.4.1. Preparation of serum-free CM of wounded and unwounded A549 and H441 
cells 
For preparation of serum-free CM (SF-CM), A549 and H441 cells were grown separately 
to form confluent monolayers on 24-well plates with an initial seeding density of 1.5 x 10
5
 
cells/well and 3 x 10
5
 cell/well, respectively, in complete DMEM media. To prepare SF-
CM from unwounded A549 and H441 cells, unwounded monolayers were washed twice 
with PBS and then SF-DMEM was added (1 ml/well) and cultured for 24 hours in the 
incubator at 37
0
C in presence of 5% CO2 and 95% air. To prepare SF-CM from wounded 
A549 and H441 cells, monolayers were wounded with 200µl plastic pipette tip in a criss-
cross pattern followed by two PBS washes before being replenished with SF-DMEM (1 
ml/well) and cultured for 24 hours as described above. SF-CM were collected and, 
centrifuged to remove any cell debris and stored at -80
0
C. In most instances, fresh SF-CM 
was used. Prior to use, all SF-CM were sterile filtered using 0.2 µm Cellulose Acetate 
syringe filter. 
 
2.4.2. Preparation of SF-CM of hMSC 
hMSC (P-2 to P3) were grown to 80-90% confluency in T75 tissue culture flasks in 
complete hMSC culture media comprised of DMEM supplemented with 5% FBS, 1% L-
glutamine and 1% NEAA. To prepare SF-CM for testing on A549 cells (SF-MSC 
CM
DMEM
), SF-DMEM and for testing on SAEC (SF-MSC CM
SABM
), SF-SABM (Small 
airway basal media, Lonza) was used. Preliminary studies demonstrated that SAEC did not 
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grow properly in SF-DMEM and developed a squamous type morphology but did maintain 
their characteristic morphology in Lonza recommended SABM. hMSC grew properly in 
SAGM with no visible abnormality in cell morphology detectable via microscopy after 24 
hours of culture in this media. For SF-CM (SF-MSC CM
DMEM
 or SF-MSC CM
SABM
) 
preparation, 80-90% confluent hMSC were washed twice with PBS and once with SF-
basal media and 12 ml (0.16 ml/cm
2
 of culture surface) of SF-DMEM or SF-SABM 
(SABM was un-supplemented) added and incubated for 24 hours in normal culture 
condition (37
0
C, 5% CO2 and 95% air). After 24 hours of culture, media was collected in 
15 ml centrifuge tube. To remove cell debris (if any) from SF-CM media was centrifuged 
for 3 minutes at 1200 rpm and supernatant was collected and stored at -80
0
C. Prior use, SF-
CM was sterile filtered with 0.2 µm Cellulose Acetate syringe filter. 
 
2.4.3. Preparation of SF-CM of normal lung fibroblast CCD-8Lu 
Normal human lung fibroblasts CCD-8Lu (P10 to 12) were grown 80-90% confluent in 
T25 tissue culture flasks in complete DMEM supplemented with 10% FBS, 1% L-
glutamine and 1% NEAA. Cells were then washed twice with PBS and once with SF-
DMEM. Following washes, 4 ml of SF-DMEM was added into each T25 flask (0.16 
ml/cm
2
 of culture surface) and incubated for 24 hours in normal culture conditions. After 
incubation, SF-CM was collected, centrifuged as above to remove any cell debris and 
stored at -80
0
C. Prior use SF-CM was sterile filtered with 0.2 µm Cellulose Acetate 
syringe filter. 
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2.4.4. Preparation of CM from hESC 
2.4.4.1. CM from undifferentiated hESC 
hESC (SHEF-2, P-32) were grown 60-70% confluent using hESC culture media in T25 
culture flasks following the hESC culture protocol described above (Section- 2.2.4). Three 
sets of media were conditioned on undifferentiated SHEF-2: KO-DMEM supplemented 
with 20% KO-SR and 4 ng/ml bFGF (+SR +bFGF), 20% KO-SR but no bFGF (+SR –
bFGF) and KO-DMEM without any KO-SR or bFGF (-SR –bFGF). All of these above 
media were supplemented with 1% L-glutamine, 1% NEAA and 0.1 mM β-
mercaptoethanol. 6 ml each of these above media were cultured for 24 hours on 60-70% 
confluent undifferentiated SHEF-2 (P-32) cells in standard culture condition. Before 
conditioning, cells were washed once with PBS and once with basal KO-DMEM. After 
incubation, conditioned media (hESC-CM) was collected, centrifuged to remove any cell 
debris as described above and stored at -80
0
C. Prior use, CM was sterile filtered with 0.20 
µm porous, 33 mm cellulose acetate syringe filter. 
 
2.4.4.2. Preparation of CM from different stages (time points) of differentiated hESC 
through embryoid body (EB) culture 
SHEF-2 cells were differentiated towards endodermal lineages with treatment of 
recombinant human Activin A (Peprotech, USA) through EB culture for 22 days. During 
differentiation, CM was collected from EB culture in different time points as follows 
(Table 2.4). 
 
Formation of EBs (Day 0-1): Three T25 flasks of 80-90% confluent undifferentiated 
hESC, SHEF-2 (P-38) cells were pooled by trypsinisation and seeded on a 90 mm diameter 
non-adherent petri dish (Sterilin, UK) in 20 ml of complete hESC culture media and 
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cultured for 24 hours. Two dishes of EBs were formed, one was for Activin A treatment 
differentiation protocol and another was untreated differentiation protocol. After 24 hours, 
a number of EBs formed. EBs along with media were transferred in 50 ml centrifuge tubes 
and allowed to stand vertically for 10 minutes at RT in the flow-hood allowing EBs to 
settle down at the bottom of the tube. The supernatant (0-1 day CM) was carefully 
collected without disturbing EBs and stored at -20
0
C. 
  
EB suspension culture with 10% FBS (Day 1-3.5): The EBs from Day-1 were then 
transferred into a new 90 mm non-adherent petridish and replenished with 20 ml of KO-
DMEM supplemented with 10% FBS, 1% L-glutamine, 1% NEAA, and 0.1 mM β-
mercaptoethanol and cultured for 2½ days (Day 1 to 3.5) without media change in normal 
culture condition. During this phase of differentiation EBs became more compact. At the 
end of day 3.5, EB culture supernatant (1-3.5 day CM) was collected and stored as 
described above. 
 
EB suspension culture with human Activin A (Day 3.5-8): After Day 3.5, one dish of 
collected EBs were treated with 100 ng/ml human Activin A in 20 ml of KO-DMEM 
supplemented with 10% SR, 1% L-glutamine, 1% NEAA and 0.1 mM β-mercaptoethanol 
and cultured in 90 mm non-adherent petridish for 4½ days (Day 3.5 to 8) without any 
media change. Another dish of EBs was not treated but cultured with above mentioned 
media for same duration. During this phase EBs were increasing in size. At the end of Day 
8 EB culture supernatant (3.5-8 day CM) was collected and stored as described above. 
 
EB suspension culture (Day 8-11): At the end of Day 8, collected EBs were cultured in 
20 ml of KO-DMEM supplemented with 10% SR, 1% L-glutamine, 1% NEAA and 0.1 
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mM β-mercaptoethanol in a 90 mm non-adherent petridish for 3 days (Day 8-11) without 
any media change in standard culture condition. At the end of Day 11, EB supernatant (8-
11 day CM) was collected and stored as described above.  
 
EB suspension culture (Day 11-22): EBs were then cultured in 20 ml of KO-DMEM 
supplemented with 10% SR, 1% L-glutamine, 1% NEAA and 0.1 mM β-mercaptoethanol 
in a non-adherent petridish for 11 days in the standard culture condition. During this phase 
CM was collected on Day 16 (11-16 day CM) and EBs were replenished with fresh media 
and cultured for further 6 days. At the end of Day 22 of EB culture supernatant (16-22 day 
CM) was collected and stored as described above and EB culture was terminated. 
 
Three separate experiments were performed with 3 different passages of SHEF-2 (P-37, P-
38 and P-46) to collect EB conditioned media for wound repair experiments and secretome 
analysis. 
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Table 2.3: SHEF-2 differentiation protocol through EB formation.  
Steps Culture protocol Culture media composition Time line 
Formation 
of EBs 
3 T25 flasks of SHEF-2 
cells were pooled into 
90 mm non-adherent 
petridish in 20 ml of 
complete hESC media.  
Complete hESC culture media: 
KO-DMEM + 20% SR + 8 ng/ml 
bFGF + 0.1 mM β-mercaptoethanol 
+ 1% L-glutamine + 1% NEAA. 
Day 0-1 
FBS 
treatment 
of EBs 
EBs were cultured in 
20 ml of 10%FBS 
supplemented KO-
DMEM. 
KO-DMEM + 10% FBS + 0.1 mM 
β-mercaptoethanol + 1% L-
glutamine + 1% NEAA. 
Day 1-3.5 
Activin A 
treatment 
of EBs  
EBs were treated with 
100 ng/ml human 
Activin A 
KO-DMEM + 10% SR + 100 ng/ml 
human Activin A + 0.1 mM β-
mercaptoethanol + 1% L-glutamine 
+ 1% NEAA. 
Day 3.5-8 
EB 
suspension 
culture 
EBs were cultured in 
KO-DMEM  
KO-DMEM + 10% SR + 0.1 mM β-
mercaptoethanol + 1% L-glutamine 
+ 1% NEAA. 
Day 8-11 
EB 
suspension 
culture 
EBs were cultured in 
KO-DMEM. CM was 
collected on day 16 and 
day 22. 
KO-DMEM + 10% SR + 0.1 mM β-
mercaptoethanol + 1% L-glutamine 
+ 1% NEAA. 
Day 11-22 
 
2.5. Secretome analysis by mass spectrometry 
Secretome (secretory proteome) analysis was performed in CM collected from hMSC and 
hESC by using LC-MS/MS mass spectrometry. The mass spectrometry was performed by 
Dr Heidi Fuller at Keele University Mass Spectrometry Facilities, Oswestry. 
 
Serum-free MSC-CM, 0.2% FBS supplemented MSC-CM and 0.2% FBS supplemented 
DMEM were concentrated (10 times) using Amicon Ultra-15 centrifugal filter device (3 
kDa MW cut off; Millipore) following manufacturer‟s instruction. Briefly, 10 ml of CM 
samples were aliquoted into the upper column of the Amicon Ultra-15 and centrifuged at 
5,000g in the Beckman ultracentrifugation machine (Model J2-21) using a fixed angle 
rotor (JA-20) for 1 hours at 8
0
C. Approximately 1 ml of concentrated sample was collected 
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and stored at -80
0
C before sending to the Mass Spectrometry facility. CM collected from 
hESC EB culture at Day 11 (8-11 day-CM), and Day 22 (16-22 day-CM) of 
differentiation; along with 10% KO-SR supplemented KO-DMEM (un conditioned media 
as control) was concentrated and stored in a similar way as described above. Samples were 
transferred to the Mass Spectrometry facility on dry ice for analysis. 
 
In the Mass Spectrometry centre, samples were reduced and alkylated with 1 µL of 1M 
DTT for 1 hour at 45
0
C and 25 µL of 200 mM iodoacetamide for 30 minutes at room 
temperature in the dark followed by overnight digestion with porcine sequencing grade 
trypsin (2 µg per sample, Promega). The digested samples were then separated by liquid 
chromatography (LC). Peptides were eluted for 40 minutes over a 2%-50% MeCN 
gradient, followed by further elution for 10 minutes at 90% MeCN. Samples were spotted 
onto a MALDI plate and analyzed in both MS and MS/MS modes on a 4800 MALDI 
TOF/TOF (Matrix assisted laser desorption/ionization Time-of-Flight) (Applied 
Biosystems). Data was searched against the non-redundant Human NCBI Protein 
Database. Proteins that were matched with >95% total ion score C.I% and more than 2 
peptides were considered as significant. MSC-CM from three independent donors and 
hESC-CM from two separate experiments were evaluated. 
 
2.6. Calculation of population doubling time for A549 and H441 cells 
Doubling time of A549 and H441 cells in serum-free and 10% FBS supplemented DMEM 
was calculated by cell counting method and using the following formula: 
PD = t x Log2/(LogC2-LogC1) 
[Here, PD = Population doubling time, t = 24 hours (interval of cell count), Log = 10 based 
Log, C1 = 1
st
 cell count, C2 = 2
nd
 cell count]. 
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For calculation of doubling time in 10% FBS supplemented DMEM, 10
5
 A549 cells or 
H441 cells were seeded in T25 tissue culture flask in 10% FBS supplemented DMEM 
(complete media) and cultured for 5 days with media change every alternate days. Cells 
were harvested by trypsinisation and counted by haemocytometer every 24 hours from Day 
1 to Day 5. For calculation of doubling time in serum-free DMEM, 10
5
 A549 or H441 cells 
were seeded in T25 culture flasks in complete DMEM media and grown for 24 hours then 
cells were washed with PBS twice and serum-free DMEM was added into each flask and 
allowed to grow for further 4 days in normal culture condition. Cells were harvested and 
quantified as above every 24 hours from Day 2 to Day 5. None of the above cells 
recovered properly after seeding in serum-free DMEM, this is why for serum-free sample 
cells were initially recovered in complete media. Population doubling (PD) time was 
calculated every 24 hours using the above formula from Day 1 to Day 5 for 10% FBS 
supplemented DMEM sample and from Day 2 to Day 5 for serum-free DMEM sample. 
The mean PD of each time point was determined as the population doubling time for each 
cell-type in each culture condition. A total of three individual experiments were performed.  
 
2.7. In vitro epithelial wound repair experiments 
To explore the effects of various chemical stimuli on epithelial wound repair, I utilised a 
widely used in vitro scratch wound repair system (Figure 2.7A, Figure 2.8) (Kheradmand 
et al., 1994, Atabai et al., 2002, Galiacy et al., 2003, Chen et al., 2008b, Savla & Waters, 
1998, Geiser et al., 2000, Geiser et al., 2004, Sonar et al., 2010, Curley et al., 2012). I also 
developed a novel direct and indirect-contact co-culture wound repair system to investigate 
the direct and paracrine influence of one cell-type to another (Figure 2.7B, 2.7C). 
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Figure 2.7. In vitro epithelial cell wound repair and co-culture system. 
(A) Scratch wound on A549 or H441 cell monolayer on 24-well plate. (B) Indirect-contact co-
culture model: wounded A549 on 0.4 μm porous PET membrane of transwell (upper layer) with 
H441 cells (bottom layer); the gap between two cell layers is 0.8 mm. (C) Direct-contact co-culture 
model: DiI-labelled wounded A549 cells or SAEC (upper layer) with un-wounded DiO-labelled 
H441 cells (bottom layer) grown on 3 μm porous transwell PET membrane. 
 
2.7.1 Principle of scratch wound repair model 
A breach of continuity of an intact epithelial layer is defined as epithelial wound or injury. 
After injury, a reparative process starts in vivo which is complex (Crosby & Waters, 2010). 
The index of epithelial wound repair assessment in vivo is the degree of epithelial cell 
proliferation (Panos et al., 1995, Yee et al., 2006); however, the index of in vitro epithelial 
wound repair includes cell migration, proliferation and differentiation (Kheradmand et al., 
1994, Atabai et al., 2002). Due to the context of our targeted disease, IPF, my primary 
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focus was to investigate the paracrine and direct influence of Clara and stem cells on 
alveolar epithelial cell migration and proliferation during wound repair. In the airways, 
after injury to the epithelium the first 12-24 hours of healing process involves epithelial 
cell spreading and migration as a primary reparative process followed by cell proliferation 
and differentiation which takes days to weeks (Horiba & Fukuda, 1994). Therefore, I 
limited the observation of wound repair upto 24 hours to evaluate the cell migration, which 
is the early effect during epithelial restitution. Lung epithelial cell (A549, H441 and 
SAEC) monolayers were formed on well-plates and transwell membranes and injury was 
made on intact epithelial layers by mechanical scratches introduced by a plastic pipette tip. 
The wound was then treated with various conditioned media and recombinant proteins to 
investigate their effects on epithelial wound repair. The degree of wound gap closure 
which represents the wound repair was monitored after 24 hours. Images were captured 
just after wounding (0 hour) and after 24 hours of treatment with a CCD camera at the 
same target point of the wound (Figure 2.8, 2.9) and the area measured manually using 
Image J software (NIH, USA). The percentage of wound repair was calculated after 24 
hours using the following formula: 
---------------------------------------------------------------------------------------------------- 
Wound repair (%) = 100
1
21
X
Y
YY 
 
 
Here, 
 
0 hour wound size = Y1  
 
24-hour wound size = Y2 
 
Wound size change = Y1 - Y2 (where Y1 > Y2). 
 
---------------------------------------------------------------------------------------------------- 
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2.7.2. Direct and indirect-contact co-culture wound repair system 
To evaluate the direct-contact effect of Clara cells on alveolar epithelial cell wound repair 
a novel direct-contact wound repair model was developed. A transwell system was utilised. 
Transwell provides an infrastructure of two compartments which are separated by a porous 
PET membrane. Alveolar A549 cells were grown monolayer on the upper surface of the 
PET membrane to make an alveolar compartment. H441 Clara cells were grown 
monolayer on the opposite surface of the PET membrane to provide a bronchiolar 
compartment where the porous PET membrane (3 µm pore size) allowed cell migration 
from one compartment to another (Figure 2.7C). Mechanical injury was made on Alveolar 
A549 cells and responses of Clara and A549 cells were monitored. This direct-contact 
model was also replicated in similar SAEC-H441 direct-contact wound repair model. To 
evaluate the influence of hMSC on alveolar epithelial wound repair, this direct-contact 
wound repair model was utilised. 
 
An indirect-contact wound repair model was developed using 0.4 µm porous transwell 
system to evaluate the paracrine role of Clara cells on alveolar epithelial wound repair 
within a close proximity (Figure 2.7B). In this setting, alveolar A549 cells monolayer was 
formed on the upper surface of transwell PET membrane and H441 Clara cells were grown 
on the bottom surface of companion well-plate maintaining a distance of 0.8 mm between 
these two cell layers. The 0.4 µm porous transwell PET membrane allows free movement 
of secretory proteins from one chamber to another; therefore, provides a suitable interface 
for study of paracrine cross-talk between Clara and alveolar epithelial cells. 
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Figure 2.8: Schematic diagram of in vitro wound repair system. 
This diagram shows cell seeding and formation of confluent monolayers (A); making scratch 
wound (B) and capturing images (C). 
All images 
were taken in 
this area 
Wound 
Line drawn on the 
under surface of 
each well 
Well of 24-well plate 
A549/H441 
Cell seeding 
200 µl pipette tip 
24-well plate 
Confluent monolayer of cells 
Scratch wound 
A 
B 
C 
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Figure 2.9: Epithelial cell wound area measurement by Image-J software. 
The areas of scratch wounds (yellow borders) at 0 hour (A) and after 24 hours (B) of wounding. 
The wound was made on A549 cell monolayer by 200 µl pipette tip. Images were captured by CCD 
camera attached with an inverted light microscope. Image magnification 100X. Scale bar, 200µm.  
 
2.7.3. Alveolar A549 cell and H441 (Clara) cell wound repair assay with SF-DMEM, 
10% FBS supplemented DMEM and SF-CM 
1.5 x 10
5
 A549 cells and 3 x 10
5
 H441 cells were seeded on each well of 24-well plates 
(Nunclon) and cultured for 24 hours in DMEM supplemented with 10% FBS, 1% L-
glutamine and 1% NEAA (complete growth media) to confluence as monolayers under 
standard culture conditions. Linear scratch wounds were made on cell monolayers with a 
200 µl plastic pipette tip (Figure 2.7, 2.8, 2.9) followed by a wash with pre-heated PBS and 
once with pre-heated SF-DMEM to remove cell debris and serum. Then samples were 
replenished with 1 ml of either SF-DMEM or 10% FBS supplemented DMEM or SF-CM 
obtained from wounded or unwounded A549 or H441 cells (Section- 2.4.1) and cultured 
for 24 hours. Wound images were recorded with a CCD digital camera (Canon, Japan) 
attached to an inverted light microscope (Nikon Eclipse, TS100, Japan) at 0 and after 24 
hours of wounding. Circumferential wound gaps were measured by Image J software 
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(NIH, USA) (Figure 2.9) and percentage of wound repair after 24 hours was calculated as 
described in the Section- 2.7.1. 
 
2.7.4. Alveolar A549 cell wound repair assay with hMSC CM and CCD-8Lu CM 
10
5
 A549 cells were seeded on each well of a 48-well plate and cultured to confluence as 
monolayers as described above. Linear scratch wounds were made on A549 cell 
monolayers as above and treated with SF-MSC CM
DMEM
 (500 µl/well) or with serum-
supplemented MSC CM for 24 hours in standard culture condition. SF-MSC CM was 
supplemented with different concentration (0.1%, 0.2%, 0.3%, 0.4%, 0.5%, 1%, 2%, 5% 
and 10%) of serum (FBS). For negative and positive control, samples were treated with 
SF-DMEM or 10% FBS supplemented DMEM respectively. To compare the wound repair 
effect of MSC-CM with that of fibroblast CM, the similar wound repair assay was 
replicated on A549 cells with CM obtained from CCD-8Lu. Wound images were recorded 
at 0 and 24 hours. Image analysis and wound repair calculation were performed as 
described in the Section- 2.7.1, 2.7.3. 
 
2.7.5. SAEC wound repair assay with hMSC CM 
5 x 10
4
 SAEC (P-3) were seeded into each well of a 48-well plate in 500 µl of SAGM 
(complete growth media) and cultured in standard culture condition for 48 hours to achieve 
confluent monolayers. Linear wounds were made on SAEC monolayers and washed with 
preheated PBS and SABM (basal media) to remove cell debris. Wounds were then treated 
with SF-MSC CM
SABM
 (500µl/well) for 24 hours. For negative and positive control, 
samples were treated with serum-free SABM and complete SAGM respectively. Images 
were captured at 0 and 24 hours of wounding. Wound repair was calculated as described in 
the Section- 2.7.1, 2.7.3. 
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2.7.6. Alveolar A549 cell wound repair assay with hESC CM 
1.5 x 10
5
 A549 cells were seeded into each well of a 24-well plate and cultured to 
confluence as monolayers as described above. Linear scratch wounds were made on A549 
cell monolayers and treated for 24 hours with three sets of CM (1 ml/well) obtained from 
undifferentiated hESC. CM was named according to composition: 
+SR+bFGF
CM (contains 
20% KO-SR and 4ng/ml bFGF), 
+SR-bFGF
CM (contains 20% KO-SR but no bFGF) and 
–SR-
bFGF
CM (contains no KO-SR or bFGF). Corresponding paired controls were similar culture 
media but un-conditioned (Un-CM).  
 
To evaluate the effects of CM obtained from different stages of Activin-directed or 
Activin-free hESC differentiation (Section- 2.4.4.2), A549 wounds were treated with 3.5-8 
day-CM (collected on 3.5
th
 day), 8-11 day-CM (collected on 11
th
 day), 11-16 day-CM 
(collected on 16
th
 day) and 16-22 day-CM (collected on 22
nd
 day) for 24 hours (media 
volume 1 ml/well). For positive and negative controls, wounds were treated with 10% KO-
SR supplemented KO-DMEM and SR-free KO-DMEM respectively. Images were 
captured at 0 and 24 hours of wounding and wound repair calculation was done as 
described in the Section- 2.7.1, Section- 2.7.3. 
 
2.7.7. A549 cell and SAEC wound repair assay with recombinant human proteins 
Plasma Fibronectin, Lumican, Periostin, and IGFBP-7 recombinant human proteins (Table 
2.4) were assessed on the A549 and SAEC (P-3 to P-4) in vitro wound repair system. A549 
and SAEC monolayers were formed on 48-well plate as described in the Section-2.3. 
Linear wounds were made on A549 cell confluent monolayers and treated with proteins in 
soluble form in either SF-DMEM or 0.2% FBS supplemented DMEM at different 
concentrations (1 pg/ml to 100 µg/ml) (Table 2.4). SAEC wounds were treated with the 
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above mentioned proteins in SF-SABM for 24 hours. Recombinant human Gelatinase-A 
was assessed on A549 cell wound repair only. For negative control (NC), wounded A549 
cells were treated with SF-DMEM or 0.2% FBS supplemented DMEM and SAEC were 
treated with supplement-free basal SABM for 24 hours. For positive control (PC), 
wounded A549 cells were treated with 10% FBS supplemented DMEM and SAEC were 
treated with complete SAGM. Individual positive controls were run for SF and 0.2% FBS 
supplemented A549 wound samples. PC and NC were included in each experiment to 
confirm specificity of response. The percentage of wound repair after 24 hours was 
calculated as described in the Section- 2.7.1, Section- 2.7.3. 
 
Table 2.4: Proteins tested with the in vitro wound repair system. 
Protein name Description Company 
Fibronectin 
Human plasma Fibronectin 
Source: Human plasma.  
Molecular weight 220 kDa 
Cat. No. F0895 
Sigma-Aldrich, USA 
Lumican 
Recombinant human protein 
Source: Murine myeloma cell line. 
NSO-derived Asn22-Gln836 
C-terminal 6-His tag 
Molecular weight 37.5 kDa  
Cat. No- 2846-LU 
R & D System, USA 
Periostin 
Recombinant human protein 
Source: Murine myeloma cell line. 
NSO-derived Gln19-Asn338 
C-terminal 6-His tag 
Molecular weight 91.7 kDa 
Cat. No- 3548-F2 
R & D System, USA 
IGFBP-7 
Recombinant human protein 
Source: Murine myeloma cell line. 
NSO-derived Asp30-Leu282 
N-terminal 10-His tag 
Molecular weight 27.5 kDa 
Cat. No- 1334-B7 
R & D System, USA 
Gelatinase A 
Recombinant human protein 
Source: E. coli 
Entire catalytic N-terminal and C-terminal 
Molecular weight 62.0 kDa 
Cat. No-66-96-206 
First Link UK Ltd, 
UK 
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2.7.8. Direct and indirect-contact co-culture wound repair assays 
2.7.8.1. A549-H441 and SAEC-H441 and A549-CCD 8Lu cell direct and indirect-contact 
co-culture wound repair and cell migration assay 
For direct-contact co-culture wound repair experiments (Figure 2.7C), 2 x 10
5
 DiO-labeled 
(Vybrant
TM
 Multicolor Cell Labeling Kit, Cat. No- V22889, Invitrogen, USA) H441 cells 
were grown on inverted 24-well plate-format 3 μm porous transwell PET (polyethylene 
terephthalate) membranes (up side down) (BD Bioscience, NJ, USA) in 100µL complete 
growth media for 4 hours in a humidified incubator at 37
0
C allowing them to adhere with 
the PET transwell membrane (Figure 2.10B, 2.10C, 2.10E). After 4 hours of incubation the 
transwells were reverted and placed back into the companion well plate (BD Bioscience, 
NJ, USA) and then 10
5
 A549 or 1.5 x 10
5
 SAEC (P-3 to P-4)  DiI-labeled (Vybrant
TM
 
Multicolor Cell Labeling Kit, Invitrogen, USA) cells were seeded onto the upper surface of 
the transwell PET membrane and sufficient complete growth media (10% FBS 
supplemented DMEM for A549-H441 direct contact and complete SAGM media for 
SAEC-H441 direct contact) added (300µl media on upper chamber and 700µl in the lower 
chamber of the transwell) (Figure 2.10D). For A549-CCD8 Lu direct-contact co-culture, 
10
5
 DiO-labelled CCD8-Lu (P-14) cells were grown on inverted 24-well plate-format 3 μm 
porous transwell PET transwell membranes instead of H441 cells as described above. 
 
Cells were labelled with DiO or DiI live-cell label following the manufacturer‟s 
instructions. Briefly, adherent cells were harvested by trypsinisation and washed with PBS 
once by centrifugation technique to remove serum. 10
6
 cells were resuspended in 1 ml of 
pre-heated (pre-equilibrated at 37
0
C) SF-DMEM for A549 or H441 or CCD-8Lu and 
SABM for SAEC. 5 µl of DiO or DiI solution was added in the cell suspension and mixed 
with gentle pipetting. This cell suspension was then incubated in the incubator at 37
0
C for 
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15 minutes in the dark. During incubation cells were gently agitated every 5 minutes to 
avoid cell clump formation. After incubation cells were washed once with PBS and once 
with SF-DMEM or SABM by centrifugation and resuspended in the required volume of 
complete culture media (complete DMEM for A549 or H441 or CCD-8Lu and complete 
SABM for SAEC) to seed on transwell. 
 
For indirect-contact co-culture, 10
5
 A549 cells were grown on the upper surface of 0.4 μm 
porous PET membrane of 24-well plate format transwells (BD Bioscience, NJ, USA) and 3 
x 10
5
 H441 cells or 2 x 10
5
 CCD-8Lu cells (un-labelled) on the bottom surface of the 
companion well plate in complete growth media (Figure 2.7B). Cells of both direct and 
indirect-contact co-culture were grown in standard culture condition for 24 hours to 
achieve confluent layers. Linear wounds were made on A549 cell or SAEC monolayers 
using 10 µl plastic pipette tip followed by washing (once with PBS and once with SF-
media) to remove cell debris and serum. H441 or CCD-8Lu cells were also washed to 
remove all serum. Wounded A549 cells or SAEC along with their accompanying H441 or 
CCD-8Lu cells were then cultured in SF-DMEM for A549-H441 and A549-CCD 8Lu co-
culture or SABM basal media for SAEC-H441 co-culture for a further 24 hours.  
 
Prior to imaging the direct-contact co-culture H441 or CCD-8Lu cells were removed 
carefully from the undersurface of the PET membrane with a wet cotton swab and washed 
with warm PBS. The cells of the upper surface of PET membrane were then fixed with 4% 
paraformaldehyde (4% PFA) (Fisher Scientific, UK) for 30 minutes. The PET membranes 
were cut from transwell housing and mounted on glass slides and fixed with cover slips for 
microscopy. Images of direct-contact co-culture were acquired with a laser scanning 
confocal microscope (Olympus Fluoview, Japan) at both 0 and 24 hours of wounding. 
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Images of indirect-contact co-culture wounds were taken by an inverted light microscope 
as described above. Wound gap measurement and wound repair analysis were performed 
as previously. For negative and positive controls A549 or SAEC monolayers were 
wounded and cultured in SF-DMEM or SF-SABM and complete 10% FBS supplemented 
DMEM or complete SAGM, respectively. Control cells were grown on the respective PET 
membranes specific to the direct or indirect contact co-culture model used.  
 
For assessment of H441 cell migration in A549-H441 or SAEC-H441 cell direct-contact 
co-culture, DiO-labelled H441 cells and DiI-labelled A549 cells or SAEC were counted at 
the respective wound sites at 0 and 24 hours after wounding. Confocal Z-scanning was 
performed to confirm the migration. 
 
2.7.8.2. A549-MSC direct contact co-culture wound repair and migration assay 
10
5 
DiI-labeled A549 cells and 10
5
 DiO-labeled hMSC were grown to confluency in 
complete culture media on the contra-lateral surfaces of 3 μm porous PET membranes of 
the 24-well plate format transwell over 24 hours as described in Section- 2.7.8.1. Linear 
wounds were made on A549 cell monolayers as described in Section- 2.7.8.1. Wounded 
cells were then cultured in SF-DMEM for 24 hours. Prior to imaging hMSC were removed 
carefully with a wet cotton swab from the undersurface of the PET membrane. Cells on the 
upper surface of the PET membrane were then fixed with 4% PFA. Images were acquired 
with a laser scanning confocal microscope at both 0 and 24 hours. Wound gap 
measurement and wound repair analysis were performed as described in Section- 2.7.8.1. 
 
For assessment of hMSC migration to A549 wound sites in A549-MSC direct-contact co-
culture DiO-labelled hMSCs were counted at the A549 wound gaps and their juxta-wound 
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monolayers at 0 and after 24 hours of wounding. Confocal Z-scanning was performed to 
confirm the migration. A minimum of three fields were counted per sample. 
 
 
Figure 2.10: Direct-contact co-culture wound repair technique using transwell system. 
(A) A 24-well plate-format transwell. (B) DiO-labelled H441 cells were seeded on 3 µm porous 
PET membrane on inverted transwells in 100µl complete DMEM. (C) Inverted transwells were 
covered with their accompanying well plate in up side down position. (D) After H441 cells had 
adhered to the under surface of transwell membrane, the transwells were reverted and placed in 
their accompanying well plate the in original position and A549/SAEC were seeded on the upper 
surface of PET membrane with adequate media. (E) Cells were grown in the incubator. 
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2.8. Measurement of internuclear distances 
To measure the relative migration of A549 cells during wound repair, internuclear 
distances between migrated A549 at wound margins were measured after 24 hours of 
wounding using Image J software. Three measurements were taken per migrated cell 
which was adjacent to the wound margins (Figure 2.11). The distance was measured 
between nuclei of the cells. A total 18 measures were recorded per wound.  
 
 
 
Figure 2.11: Measurement technique of internuclear distances.  
Inverted light microscopic images of A549 cell wound repair after 24 hours with SF-MSC CM. 
Image magnification 100X. 
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2.9. MTT cell proliferation assay 
To evaluate the effects of MSC-CM, CCD-8Lu CM, hESC-CM and recombinant proteins 
on alveolar A549 cell proliferation during wound repair, the MTT (3-(4,5-dimethylthiazol-
2-yl)-2,5-diphenyltetrazolium bromide) cell proliferation assay was performed using the 
MTT reagent Thiazolyl Blue Tetrazolium Bromide (Sigma, Cat No- M5655) following 
manufacturer‟s instructions (Plumb et al., 1989). Briefly, 105 A549 cells were grown to 
confluence on each well of a 48-well plate in 24 hours and wounds were made as described 
is Section-2.3, Section- 2.7.6. For a 0 hour reading, MTT was performed immediately after 
wounding. Wounded monolayers were washed and 300 µl of 0.5 mg/ml MTT reagent 
containing SF-DMEM solution was added to each well and incubated at 37
0
C for 2 hours. 
After incubation, MTT solution was discarded and washed twice with pre-heated PBS. The 
formazan was extracted by 100% DMSO (250 µl/well) incubation for 10 minutes in the 
incubator at 37
0
C. 200 µl of extracted formazan-DMSO solution was then loaded in each 
well of 96-well plate and absorption measured with a micro-plate reader (BioTek, Synergy 
2) at a 630 nm wavelength. For 24 hours readings, wounded A549 cell monolayers were 
treated with either SF-MSC CM, 2% FBS supplemented MSC-CM, SF-CCD 8Lu CM, 
0.2% FBS supplemented CCD 8Lu CM, or hESC-CM (3.5-8 day-CM, 8-11 day-CM, 16-
22 day-CM) for 24 hours in the incubator at 37
0
C with standard culture condition. For 
negative control (NC), wound samples were treated with SF-DMEM or SF-KODMEM or 
0.2% FBS supplemented DMEM and for positive controls (PC), wounded samples were 
treated with 10% FBS supplemented DMEM, or 10% KO-SR supplemented KO-DMEM 
for 24 hours. After 24 hours of incubation, media was discarded and the MTT assay 
performed as above. Triplicate experiments were performed for each sample. Data 
presented as percentage increase of optical density (OD) reflecting degree of cell 
proliferation after 24 hours. 
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2.10. TUNEL assay for evaluation of apoptosis 
2.10.1. Ligand induced apoptosis 
To assess ligand-induced apoptosis in wounded A549 cell monolayers, 5 x 10
4
 DiI-labelled 
A549 cells were seeded into each well of a 96-well plate and grown to confluence over 24 
hours using complete culture media. Linear wounds were made as described in Section-
2.7.3 and wounded monolayers were treated with recombinant human soluble TRAIL (200 
ng/ml, 400 ng/ml, 800 ng/ml) or FasL (200 ng/ml, 400 ng/ml, 800 ng/ml, 1.6 µg/ml, 3.2 
µg/ml) (Peprotech, NJ, USA) for 24 hours in SF-DMEM. Ligand-induced apoptosis was 
blocked through pre-incubation of A549 cells with TRAIL-R1 (HS101, 1µg/ml, 5 µg/ml, 
10 μg/ml) and/or TRAIL-R2 (HS201, 1µg/ml, 5 µg/ml, 10 μg/ml); and Fas (SM1/23, 10 
μg/ml) receptor blocking antagonistic monoclonal antibodies (mAbs) (Enzo Life Science, 
Switzerland). For induction of apoptosis in SAEC with soluble TRAIL, 5 x 10
4
 SAEC cells 
were seeded into each well of 96-well plate and grown to confluency over 24 hours in 
complete SAGM growth media. After 24 hours cells were treated with different 
concentration of soluble TRAIL (200 ng/ml, 400 ng/ml, 800 ng/ml, 1.6 µg/ml) in SF-
SABM for 24 hours. For positive control, wounded monolayers were treated with 200 µM 
H2O2 (Cat. No- H-1009; Sigma, MO, USA) in SF-DMEM for A549 cells and SF-SABM 
for SAEC for 24 hours. For negative control, samples were treated with SF-DMEM or SF-
SABM.  
 
Apoptosis induction was evaluated with the TUNEL (terminal deoxynucleotidyl 
transferase mediated deoxyuridine triphosphate nick end-labelling) method using an In Situ 
Cell Death Detection Kit, Fluorescein (Roche Applied Science, USA) according to the 
manufacturer‟s protocol. Briefly, cells were fixed with 4% PFA for 30 minutes. Cells were 
then permeabilised with 0.1% Triton X-100 (Sigma, MO, USA) for 2 minutes and washed 
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twice with PBS. TUNEL reagent (a mixture of Enzyme solution and Label solution) was 
then added in each well (50 µl/well) and incubated at 37
0
C in the incubator for 1 hour in 
the dark. After incubation, samples were washed three times with PBS and images were 
captured on a laser scanning confocal microscope. 
 
2.10.2. Direct contact induced apoptosis  
To assess H441 or CCD-8Lu cell direct-contact induced apoptosis in alveolar A549 cells 
or SAEC, DiI-labelled A549 cells or SAEC were cultured in direct-contact with un-
labelled H441 or CCD-8Lu cells using 3 µm porous transwell for 24 hours in complete 
growth media as described above in Section- 2.7.8.1. Linear wounds were made on A549 
cell and SAEC confluent monolayers and cultured for an additional 24 hours in serum-free 
basal media (SF-DMEM for A549-H441 or A549-CCD-8Lu and SF-SABM for SAEC-
H441 co-culture) as described above in Section- 2.7.8.1. To block apoptosis, samples were 
treated with either Fas (SM1/23, 10μg/ml) or TRAIL-R1/R2 (HS101, HS201; 10 μg/ml) 
receptor blocking antagonistic mAbs throughout the entire co-culture wound repair period. 
After 24 hours of incubation, H441 or CCD-8Lu cells were removed from the under-
surface of the PET membrane and the remaining cells on the upper surface were fixed with 
4% PFA for 30 min and permeabilised with 0.1% Triton X-100 for 2 minutes as described 
above. PET membranes were cut from the transwell housing and placed on the pockets of 
Glastic
®
 Slide-10 cell counting chamber (Cat. No-87144, Kova, USA) (Figure 2.12). 50 µl 
of TUNEL reagent was added in each pocket covering the entire PET membrane properly 
and incubated for 1 hour as described above in Section- 2.10.1. For positive control, 
apoptosis was induced in A549 or SAEC monoculture by 200 µM H2O2 treatment in SF-
DMEM/SABM respectively for 24 hours. For negative control, cells were cultured 
(monoculture) in serum-free basal media (SF-DMEM/SABM). All control cells were 
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cultured on identical cultures surfaces that were used for respective experimentation. 
Images were acquired with a laser scanning confocal microscope. TUNEL positive cells 
were quantified along the wound margins and data were standardised against positive 
control and presented as percentage of apoptosis. 
 
2.10.3. Apoptosis evaluation in patient tissue samples 
The TUNEL assay was performed alongside Ms. Nicola Lomas at the Histopathology lab 
of University Hospital of North Staffordshire and at Central Cell Culture Lab of Guy 
Hilton Research Centre. For combined TUNEL assay and immunohistochemistry with 
proSP-C antibody on lung tissue, formalin-fixed, paraffin-embedded lung tissue samples 
were cut to 3 µm thick sections. Sections were deparaffinised and pre-treated for heat 
mediated antigen retrieval in citrate buffer (pH 6). Samples were stained on a Dako 
autostainer using Dako REAL detection kit (Dako, Denmark) according to the 
manufacturer protocol. Samples were first treated with proSP-C primary antibody over 
night at 4
0
C (polyclonal, ab40879, dilution 1:1500; Abcam). For visualisation, samples 
were treated with anti-rabbit IgG-NL557 secondary antibody (R & D systems). 
Afterwards, TUNEL was performed as described before (Section- 2.10.1). Samples were 
examined under the fluorescence microscope and TUNEL positive nuclei were counted. 
Briefly, 100 proSP-C labelled cells were counted in the above mentioned areas of IPF lung 
tissue samples and dual proSP-C/TUNEL labelled cells were recorded. Same was 
performed in control sample. Data was presented as percentage of dual proSP-C/TUNEL 
positive cells with ± SEM per case. 
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Figure 2.12: TUNEL assay on direct contact co-culture. 
(A) PET membranes were cut from transwell and placed on the pockets of Glastic
®
 Slide-10 (on 
reversed surface) and TUNEL reagent was added (red arrow). (B) Sample incubation in the 
incubator in a plastic box. 
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2.11. Reverse transcription-PCR (RT-PCR) 
Semi-quantitative RT-PCR was performed to determine the mRNA expression of TRAIL, 
TRAIL-R1 and TRAIL-R2 in A549 and H441 cells; and Oct-4, Nanog, hTERT, AFP, 
ACTC1, SOX1 in hESC. The primers were designed using human gene sequences from 
NCBI Map Viewer or Ensemble Genome Browser and Primer 3. Designed primers were 
evaluated in NCBI Primer-BLAST to check specificity. Customised primer sets were 
purchased from Invitrogen, USA. Primers are tabulated below (Table 2.5). RT-PCR was 
performed with a one-step protocol. 
 
RNA extraction 
Total RNA was extracted using the QIA RNeasy Mini Spin Column (Qiagen, Germany) 
according to the manufacturer protocol. Briefly, adherent A549, H441 and hESC were 
harvested by trypsinisation and hESC-EBs collected from suspension culture. Cells were 
washed with PBS once and pellets were formed by centrifugation. Cell pellets were then 
lysed with RLT lysis buffer (350 µl RLT buffer + 3.5 µl β-mercaptoethanol per sample). 
Cell lysates were transferred into the upper column of the QIA Shredder and centrifuged 
for 3 minutes at 13,000 rpm. Cell lysates were collected in the collection tube and stored at 
-80
0
C. For RNA extraction, cell lysates were thawed on ice and 350 µl of 70% ethanol 
added. Cell lysate-ethanol solution (700 µl total) was then transferred into the upper 
column of QIA RNeasy Mini Spin Column and centrifuged for 25 seconds at 6000 rpm 
(13.2 g). Flowthrough was discarded and 700 µl of RW1 buffer was added and centrifuged 
for 25 seconds at same speed. Flowthrough was again discarded and 500 µl of RPE buffer 
added into the upper column and centrifuged for 25 seconds. This step was repeated with 2 
minutes of centrifugation. The collection along with the collecting tube was discarded and 
the upper column was transferred into a fresh collection tube and centrifuged for 1 minute 
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without adding anything. Finally, the upper column was transferred into a fresh eppendorf 
and 20 µl of RNAse/DNAse-free dH2O was added onto the membrane of the upper column 
and allowed to stand vertically for 1 minute before centrifugation for 1 minutes at 13.2 g, 
this step was repeated once for maximum yield of RNA. The extracted RNA was collected 
into the eppendorf. The quality and quantity of RNA yield were determined by 
measurement of absorption at 260 and 280 nm using NanoDrop ND-1000 
spectrophotometer (NanoDrop, USA). The ratio of optical density at 260 and 280nm was 
>1.8 in all cases.  
 
One-step RT-PCR 
One-step RT-PCR was performed using SuperScript
®
 III One-Step RT-PCR System with 
Platinum
®
 Taq High Fidelity kit (Invitrogen, CA, USA) and amplified in DNA Engine
®
 
Thermal Cycler (MJ Research, MA, USA) in a single tube according to the manufacturer 
protocol. In short, 10 ng RNA of each sample was mixed with 6.25 μL 2X Reaction Mix, 3 
μL RNAse-free water, 1 μL of each primer (10 μM) and 0.25 μL of Platinum® Taq 
polymerase enzyme. The thermal cycling protocol comprised an initial reverse 
transcription at 50
0
C for 30 minutes, pre-denaturation at 94
0
C for 2 minutes followed by 30 
cycles of denaturation at 94
0
C for 15 seconds, annealing at 53-56
0
C (depending on 
primers) for 30 seconds and extension at 68
0
C for 1 minute followed by a final extension at 
64
0
C for 5 minutes. The PCR fragments were separated by electrophoresis on 2% agarose 
gel (Fisher Scientific, NJ, USA) and visualized by staining with ethidium bromide (Sigma, 
MO, USA) under UV light. Primers for β-actin were used as a loading control. All primers 
were obtained from Invitrogen, USA (Table 2.5). 
 
 
Chapter 2:                                                                                  Materials and Methods 
PhD thesis by K. M. Akram                                                                    Keele University - 110 - 
Agarose gel preparation 
The PCR products were separated by electrophoresis on 2% agarose gel. 2 g of agarose 
powder (Fisher Scientific, NJ, USA) was dissolved in 100 ml of 1X TAE (Tris Acetate-
EDTA) buffer in the microwave oven. When agarose had completely dissolved 5 µl of 
ethidium bromide (10 mg/ml) was added and mixed properly. The hot agarose solution was 
then immediately poured onto an agarose gel case and a comb was placed to make pockets. 
After 45 minutes at room temperature, the gel formed and became ready to use.  
 
Gel electrophoresis protocol 
The agarose gel was placed on the electrophoresis machine (Bio-Rad DNA Sub Cell) and 
immersed in 1X TAE buffer. Each PCR product (sample) was mixed with 2 µl of loading 
buffer. 6 µl of PCR product was then loaded per well. 6 µl of DirectLoad
TM
 wide range 
DNA marker (Cat. No- D7058-1VL; Sigma) was loaded into two wells to determine 
product size after electrophoresis. Electrophoresis was performed for 45 minutes with 100 
volts constant current. 
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Table 2.5: Primer sequences. 
Official name is listed in gene column with alternative name in parentheses. Forward and 
reverse primers are listed in 5' to 3' orientation.  
Gene Primers (5’-3’) 
Annealing 
temp (
0
C) 
Amplicon 
size (bp) 
TNFSF10 
(TRAIL) 
F CTGCAGTCTCTCTGTGTGG 
55 196 
R TCTTTCTAACGAGCTGACG 
TNFRSF10A 
(TRAIL-R1) 
F CAAAGAATCAGGCAATGG 
55 196 
R GTGAGCATTGTCCTCAGC 
TNFRSF10B 
(TRAIL-R2) 
F CACCAGGTGTGATTCAGG 
53 220 
R CCCACTGTGCTTTGTACC 
POU5F1 
(Oct-4) 
F GCAATTTGCCAAGCTCCTGAAGCAG 
55 536 
R CATAGCCTGGGGTACCAAAATGGGG 
NANOG 
(Nanog) 
F GGTGGCAGAAAAACAACTGGC 
55 300 
R TGCAGGACTGCAGAGATTCC 
TERT 
(hTERT) 
F GCAGCTCCCATTTCATCAGC 
53 343 
R CAGGATGGTCTTGAAGTCTG 
AFP 
F CAGAAAAATGGCAGCCACAGC 
54 399 
R TGGCAGCATTTCTCCAACAGG 
ACTC1 
F CATCCTGACCCTGAAGTATCCCATC 
56 315 
R CCCTCATAGATGGGGACATTGTGAG 
SOX1 
F CCAGGAGAACCCCAAGAGGC 
56 206 
R CGGCCAGCGAGTACTTGTCC 
ACTB 
(β-actin) 
F GCCACGGCTGCTTCCAGC 
55 477 
R AGGGTGTAACGCAACTAAGTC 
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2.12. Fluorescent immunocytochemistry  
Basic protocol: Samples were fixed with 4% PFA (Fisher Scientific, UK) for 30 minutes. 
Samples were washed with PBS once and permeabilised with 0.5% Triton-X 100 (Sigma) 
for 5 minutes at RT. Samples were then washed with PBS twice and blocked with 3% BSA 
(unless otherwise mentioned) for 1 hour at RT. After blocking, samples were washed once 
with PBS and treated with primary antibodies (Table S2, Appendix-1) in 0.1% BSA in 
PBS buffer for 24 hours at 4
0
C. After primary antibody incubation, samples were washed 
twice with PBS and secondary antibodies were added and incubated for 2 hours in the dark 
at RT. For secondary antibody control, samples were treated with secondary antibody 
(IgG) only. Samples were washed once with PBS and before being immersed in DAPI 
(Sigma) solution at (1:500 in PBS), for nuclear counter staining, for 10 minutes in the dark 
at RT. Samples were then washed three times with PBS and examined under a fluorescent 
microscope. 
 
2.12.1. Fluorescent immunocytochemistry profiling of proSP-C, TRAIL, TRAIL-R1 
and TRAIL-R2 in A549 cells H441 cells and SAEC 
For immunocytochemistry, either 2.5 x 10
4
 A549 cells, 5 x 10
4
 H441 cells, or 2.5 x 10
4
 
SAEC were seeded into each well of 48-well plate and grown to sub-confluence over 24 
hours in complete culture media. Cells were fixed, permeabilised and blocked as described 
above (Section 2.12). Expression of proSP-C in A549 and SAEC cells was determined by 
immunostaining with anti-proSP-C primary antibody (polyclonal, ab40879, dilution 1:250; 
Abcam, Cambridge, UK) and visualised by secondary antibody anti-rabbit IgG-NL493 
(dilution 1:200, NorthernLights, R & D System, MN, USA) according to manufacturer‟s 
instructions protocol as described above in Section- 2.12. TRAIL, TRAIL-R1 and TRAIL-
R2 expression were detected in unwounded A549 and H441 cells using anti-TRAIL 
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primary antibody (polyclonal, ab2435, dilution 1:100; Abcam) and TRAIL-R1 
(monoclonal, HS101, 10μg/ml) and TRAIL-R2 (monoclonal, HS201, 10μg/ml) (both Enzo 
Life Science, Switzerland) according to the manufacturer‟s protocol. Anti-rabbit IgG-
NL493 secondary antibody (1:200) against TRAIL antibody (ab2435) and anti-mouse IgG-
NL557 (1:200) against TRAIL-R1 and –R2 antibodies were used (NorthernLights, R & D 
System). TRAIL evaluation was also conducted on unwounded SAEC. All primary 
antibody (Table S2, Appendix-1) treatment incubation was for 24 hours at 4
0
C and 
secondary treatment was for 2 hours at room temperature. DAPI was used for nuclear 
counterstaining (Sigma or Invitrogen, USA). Images were acquired by a fluorescent 
microscope (Olympus Fluoview, Japan or Nikon Eclipse Ti-ST, Japan).  
 
2.12.2. Characterisation of hMSC 
5 x 10
4
 hMSC (P-1, P-4) were plated on each well of a 24-well plate and grown to 80-90% 
confluency for immunophenotyping. Cells were fixed with 4% PFA, permeabilised with 
0.5% Triton-X 100 and blocked with 3% BSA as described above (Section 2.12). Fixed 
hMSC cells were characterised using the human MSC characterisation kit containing anti-
human mouse anti-CD44, anti-CD90, anti-CD146, anti-CD14, anti-CD19 and anti-STRO-1 
primary antibodies at 1:500 dilution (Cat. No. SCR067, Millipore). Cells were incubated 
with primary antibodies at 4
0
C overnight. Secondary antibodies were anti-mouse IgG-
NL557 for all except STRO-1 and anti-mouse IgM-NL493 for STRO-1 (both at 1:200 
dilutions) (NorthernLights, R & D System). DAPI was used for nuclear staining. Images 
were acquired by a fluorescent microscope (Nikon Eclipse Ti-ST, Japan). 
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2.12.3. Functional characterization of differentiated hMSC 
hMSC (P-1) were differentiated into osteoblasts, adipocytes and chondrocytes using 
StemPro differentiation media in 24-well plates (Section- 2.2.3.1). The tri-lineage 
differentiation of hMSC was characterised with the Human Mesenchymal Stem Cell 
Functional Identification Kit containing anti-human mouse anti-Osteocalcin for 
osteoblasts, goat anti-FABP-4 for adipocytes and goat anti-Aggrecan for chondrocytes at 1 
µg/100µl concentration (250 µl/well) (Cat. No. SC006, R & D System). Cells were 
incubated with primary antibodies at 4
0
C overnight. Secondary antibodies were anti-mouse 
IgG-NL557 for Osteocalcin and anti-goat IgG-NL493 for FABP-4 and Aggrecan (both at 
1:200 dilutions) (NorthernLights, R & D System). DAPI was used for nuclear staining. 
Images were acquired by a fluorescent microscope (Nikon Eclipse Ti-ST, Japan).  
 
2.12.4. Characterisation of hESC 
2.5 x 10
4
 SHEF-2 (P-44) cells were plated on each well of a 48-well plate and grown to 70-
80% confluency for evaluation of embryonic stem cell pluripotent markers by 
immunocytochemistry. Cells were fixed with 4% PFA, permeabilised with 0.5% Triton-X 
100 and blocked with 3% BSA as described above (Section 2.12). Fixed SHEF-2 cells 
were characterised using the “Human Embryonic Stem Cell Marker Antibody Panel” kit 
containing anti-human mouse anti-alkaline phosphatase (ALP), goat anti-Oct-4, goat anti-
Nanog, mouse anti-SSEA-1 and mouse anti-SSEA-4 primary antibodies at 1µg/100µl 
concentration (150 µl/well) (Cat. No. SC008, R & D System). Cells were incubated with 
primary antibodies at 4
0
C for 24 hours. Secondary antibodies were anti-goat IgG-NL493 
(1:200, NorthernLights, R & D System) for Oct-4 and Nanog; and TRITC-conjugated anti-
mouse IgG (1:200, ab6787, Abcam) for ALP, SSEA-1 and SSEA-4. DAPI was used for 
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nuclear staining. Images were acquired by a fluorescent microscope (Nikon Eclipse Ti-ST, 
Japan).  
 
2.12.5. Evaluation of pluripotent markers in differentiated EBs 
SHEF-2 cells were differentiated with Activin A through EB suspension culture as 
described above. EBs were fixed with 4% PFA for 1 hours on day 1 and day 11 of 
differentiation. More than 100 EBs were fixed per well. EBs were permeabilised with 0.5% 
Triton X-100 for 20 minutes and then washed twice with PBS. EBs which were subject for 
visualisation with donkey secondary antibody were blocked with 3% BSA and 1% donkey 
serum; and those EBs which were subject for visualisation with goat secondary antibody 
were blocked with 3% BSA and 1% goat serum for 2 hours at RT. EBs were treated with 
Human Embryonic Stem Cell Marker Antibody Panel kit containing anti-human mouse 
anti-alkaline phosphatase (ALP), goat anti-Oct-4, goat anti-Nanog, mouse anti-SSEA-1 
and mouse anti-SSEA-4 primary antibodies at 1µg/100µl concentration (150 µl/well) (Cat. 
No. SC008, R & D System) for 24 hours at 4
0
C as described above. EBs were washed 
three times with PBS and treated with secondary antibodies and incubated for 2 hours at 
RT as described above. DAPI was used for nuclear staining. Images were acquired by a 
fluorescent microscope (Nikon Eclipse Ti-ST, Japan). 
 
2.12.6. Immunohistochemistry on lung tissue samples 
This section of study was conducted alongside Ms. Nicola Lomas at Histopathology lab of 
the University Hospital of North Staffordshire. Experiments were performed by Ms Nicola 
Lomas and analysis performed jointly.  
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Formalin-fixed, paraffin embedded lung tissue samples were cut to 3 µm thick sections. 
Sections were deparaffinised and pre-treated for heat mediated antigen retrieval in citrate 
buffer (pH 6). Samples were stained on a Dako autostainer using Dako REAL detection kit 
(Dako, Denmark) according to the manufacturer protocol. Type II AEC and Clara cells 
were differentiated by dual immunostaining of samples with proSP-C antibody 
(polyclonal, ab40879, dilution 1:1500; Abcam) and CC10 antibody (polyclonal, ab40873, 
dilution 1:200; Abcam). For dual immunostaining with TRAIL and CC10 antibodies 
samples were first treated with TRAIL primary antibody (polyclonal, ab2435, dilution 
1:80; Abcam) and visualised by DAB followed by second antibody treatment by CC10 
antibody and visualised by VIP (Very Intense Purple, Lab Vision, UK) in dual 
immunostaing and by DAB in mono-staining. For dual-immunohistochemistry staining an 
avidin biotin block was performed after completion of the first antibody labelling to 
prevent cross reaction with the detection kit. The Negative controls included omission of 
the primary antibody. Sections were counterstained using haematoxylin Z (CellPath, UK).  
 
Sections were reviewed by two independent pathologists for expression of the above 
mentioned markers at the sites of interest in IPF and control lung tissues. For quantification 
of CC10, TRAIL and CC10/TRAIL stained cells within the vicinity of fibrotic regions of 
IPF lung samples, 100 epithelial cells were counted and the number of cells expressing 
each marker (or dual marker) was recorded. The same was performed at the alveolar 
regions of the control samples. Data was presented as percentage of specified marker 
expressing cells with ± SEM per case. 
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2.13. Collagen drop cell migration assay 
To evaluate the effect of identified hMSC secretory proteins on alveolar A549 cell 
migration as substrate components, I developed a cell migration assay tool where 5 x 10
4
 
A549 cells were resuspended in 10 µl of 1 mg/ml concentration of rat tail collagen I (BD 
Bioscience) in 0.2% FBS supplemented DMEM. The cell/collagen solution was dropped 
(10 µl/drop) on different concentration of Fibronectin or Lumican or Periostin coated 24-
well plates. Well-plates were coated with proteins by adding 500 µl of different 
concentrations of proteins (in PBS) and incubating them at 4
0
C over night. After 
incubation, solution was discarded and wells were air dried before plating the collagen 
drop. Acidity of collagen was neutralised using 1M NaOH buffer. A single drop (10 µl) 
was placed at the centre of each well and incubated for 30 minutes in the humidified 
incubator at 37
0
C allowing the drops to form into gel. Following gel formation, 20% FBS 
supplemented DMEM was added to each well to provide a chemoattractant-bias for the 
promotion of cell migration out of the gel barrier (Figure 2.13). After 24 hours migratory 
cells were quantified microscopically using inverted light microscope. The radius of each 
drop was measured by Image J software and the circumference of each drop was 
calculated. Results were expressed as mean migration through per millimeter of 
circumference of collagen-drop barrier. 
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Figure 2.13: Collagen drop cell migration assay. 
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2.14. Statistical Analysis 
The significance of difference between two groups was determined by paired, two-tailed 
Student t-test. Differences between three or more groups were analysed by one-way 
ANOVA with Post-hoc Tukey‟s Multiple Comparison analysis (unless otherwise 
mentioned). Patient data were analysed by Wilcoxon matched-pairs signed rank test or 
Mann Whitney U test. Correlation analysis between different doses of proteins and wound 
repair responses was conducted by Spearman rank correlation coefficient test (Moine et al., 
1997, Park et al., 2011). Correlation data were presented in logarithmic scale for better 
presentation (Moine et al., 1997). A „p‟ value less than 0.05 was considered to indicate 
statistical significant. In vitro data are presented as mean ± standard deviation (SD) and 
patient data presented as mean ± standard error of mean (SEM). For in vitro studies, at 
least three separate assays were performed for each experimental setting which is 
represented as „n‟ number and replicate number per assay is mentioned as „replicates per 
n‟. „n‟ numbers are mentioned throughout the manuscript at the figure legends. All data 
were processed and analysed using Microsoft Excel of Microsoft Office XP
®
 software 
(Microsoft Corporation, USA). Statistical analysis was conducted using GraphPad Prism
®
 
version 5.00 software for Windows (GraphPad Software, San Diego California USA).  
 
2.15. Study approval 
Human tissue research was approved by the South Staffordshire Local Research Ethics 
Committee (08/H1203/6). 
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Chapter 3 
 
Clara cells inhibit alveolar epithelial wound repair via 
TRAIL-dependent apoptosis: a potential novel 
mechanism for pulmonary fibrogenesis 
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3.1. Background 
Idiopathic pulmonary fibrosis (IPF) is a chronic, progressive fibrosing interstitial 
pneumonia of unknown aetiology occurring primarily in older adults, and limited to the 
lungs (Raghu et al., 2011). The pathophysiological process of this disease is not well 
understood. However, recently it has been hypothesised that multiple micro-injuries to 
alveolar epithelial cells (AEC), imbalanced immune response and abnormal wound repair 
are the key mediators of IPF pathogenesis where inflammation may not be an initiating 
trigger (Selman et al., 2001, Kaminski et al., 2003, Strieter, 2005). After injury, the 
restoration of alveolar integrity and functionality through rapid re-epithelialisation of the 
denuded alveolar basement membrane through AEC migration, proliferation and 
differentiation is essential. In IPF this healing process seems to be impaired (Selman et al., 
2001); whilst the precise mechanism for this remains uncertain, it is likely to involve 
multifactorial interactive processes of repeated injury and substantial type I AEC loss 
(Corrin et al., 1985, Selman et al., 2001), increased AEC apoptosis (Uhal et al., 1998, 
Kuwano et al., 1999, Barbas-Filho et al., 2001), dysregulated epithelial-mesenchymal 
cross-talk (Selman & Pardo, 2002), polarised immune response (Strieter, 2005) and 
alveolar bronchiolisation (Chilosi et al., 2002, Odajima et al., 2007).  
 
Alveolar bronchiolisation, a process of abnormal proliferation and alveolar migration of 
Clara and other bronchiolar epithelial cells, has been documented in both IPF lung tissues 
and animal models of pulmonary fibrosis (Odajima et al., 2007, Chilosi et al., 2002, 
Kawanami et al., 1982, Mori et al., 2004, Betsuyaku et al., 2000, Kawamoto & Fukuda, 
1990, Fukuda et al., 1989, Collins et al., 1982). A sub-population of these Clara cells 
behaves as functional bronchiolar progenitor cells with participation in bronchiolar wound 
repair and regeneration (Evans et al., 1976, Reynolds & Malkinson, 2010). However, 
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lineage tracking in animal model studies has indicated that Clara cells may not take part in 
alveolar injury repair (Rawlins et al., 2009). Also, in bleomycin-induced murine 
pulmonary fibrosis, abrogation of alveolar bronchiolisation does not worsen the disease 
state (Betsuyaku et al., 2000). Despite these findings, alveolar bronchiolisation remains a 
constant histological feature in IPF lungs accompanied by failed alveolar architecture and 
functionality restoration (Odajima et al., 2007, Chilosi et al., 2002, Mori et al., 2004). I 
hypothesise that with the onset of IPF, the activated migration of Clara cells towards the 
alveolar regions and their interaction with in situ AEC is pivotal to the consequent aberrant 
repair response and ensuing fibrotic tissue remodelling. Elucidation of this key Clara cell-
AEC interaction could unravel exploitable targets for pharmacological manipulation 
beneficial to IPF, a disease for which there is still no efficacious treatment. 
 
3.1.1. Aim of this study 
The aim of this study was to evaluate the role of Clara cells in the aberrant alveolar 
epithelial wound repair in the pathogenesis of IPF, particularly, during alveolar 
bronchiolisation process. 
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3.2. Study design 
Before approaching to the major experimentation, the growth and wound repair rates of 
human type II AEC cell line A549 cells and human Clara cell line H441 cells were 
evaluated (Section- 2.6, Section- 2.7.3) (See Chart 3.1). Next, the paracrine role of Clara 
cells on alveolar A549 cell wound repair was evaluated by testing conditioned media (CM) 
obtained from wounded and unwounded H441 cells and tested on alveolar A549 cell 
wound repair system (Section- 2.7.1, Section- 2.7.3). An indirect-contact co-culture wound 
repair system was developed to investigate the cross-talk between Clara cells and alveolar 
A549 cells during A549 cell wound repair (Section- 2.7.2, Section- 2.7.8.1). To explore the 
direct-contact effects of Clara cells on AEC wound repair, a novel A549-H441 direct-
contact co-culture wound repair system was developed (Section- 2.7.2). Using this direct-
contact model the migratory aspect of Clara cells towards alveolar A549 cell wounds was 
investigated (Section- 2.7.8.1). The direct-contact effect of Clara cells on alveolar A549 
cell wound repair was assessed by measurement of wound repair rate and TUNEL 
apoptosis assay (Section- 2.7.8.1, Section- 2.10.2). The Clara cell direct-contact effect on 
human primary small airway epithelial cells (SAEC) was also evaluated using the similar 
SAEC-H441 direct-contact wound repair model (Section- 2.7.8.1). Apoptosis pathway was 
determined by using Fas and TRAIL-receptor blocking antagonistic monoclonal antibodies 
(Section- 2.10.1, Section- 2.10.2). The in vitro finding was translated on human IPF lung 
tissue through determination of Clara cell localisation by immunohistochemistry with 
CC10 antibody and AEC apoptosis by TUNEL assay (Section- 2.12.6, Section- 2.10.3). 
The experimental data was analysed using the Excel programme of Microsoft Office XP. 
The statistical analysis was performed using the software GraphPad Prism version 5.00 
(Section- 2.14). A conclusion was drawn according to the outcome of the experimental 
results (See Chart 3.1). 
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Chart 3.1: Major study plan steps. A detailed description is provided in the methodology 
section. 
H441 paracrine role H441 direct-contact role 
A549 wound repair with 
CM obtained from H441 
Section- 2.7.3 
A549 wound repair 
stimulation? 
No Yes Yes 
Yes 
Presence of TRAIL-
expressing Clara cells in 
the IPF alveoli? 
Section- 2.12.6 
Result analysis and conclusion generation 
In vitro evaluation 
A549-H441 direct 
contact wound repair 
Section- 2.7.8.1 
A549 wound repair 
inhibition? 
H441 migration to A549 
wound 
A549 cell destruction 
A549 cell apoptosis? 
Section- 2.10.2 
TRAIL-mediated? 
TRAIL-Receptor blockers 
Inhibit A549 
apoptosis? 
Reverse H441-induced A549 
wound repair inhibition? 
Presence of AEC 
apoptosis in the 
bronchiolised IPF alveoli? 
Section- 2.10.3 
Study on normal and IPF 
lung tissue 
Ex vivo evaluation 
Evaluation of Clara (H441) cell role in AEC (A549 cell) 
wound repair in the context of idiopathic pulmonary fibrosis 
Fas-mediated? 
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3.3. Results 
3.3.1. Determination of initial cell seeding density to form monolayer 
For the in vitro wound repair assay, the formation of a uniform epithelial cell monolayer is 
a key prerequisite. Prior to approaching the major experiments designed to test my 
hypothesis, I performed a set of feasibility tests on my selected cohort of human lung 
epithelial cells (Table 2.1) to establish whether they were capable of forming monolayer in 
my in vitro wound repair and culture system (Section 2.3). I also determined the cell 
seeding density of those cells for various well-plates (Section 2.3). The human type II AEC 
line, A549 cells and human Clara cell line, H441 cells formed confluent monolayers on 
well-plates (Figure 3.1A, 3.1B). In addition, human primary small airway epithelial cells 
(SAEC) also formed uniform monolayers on well-plates (Passage 3-4) (Figure 3.1C). 
However, despite multiple approaches and attempts the human primary AEC (pAEpiC) 
obtained from ScienceCell Research Laboratory, USA failed to form monolayers and did 
not provide evidence of an epithelial morphology in the recommended culture condition 
(Figure 3.1D). Therefore, pAEpiC were considered as „unsuitable‟ for my in vitro wound 
repair experiments and discontinued from further experimentation. Alveolar A549 cells 
formed uniform monolayers in 24 hours on 24-well plate, 48-well plate and 96-well plate 
with initial cell seeding densities at 1.5 x 10
5
, 10
5
 and 5 x 10
4
 cells/well respectively 
(Section- 2.3). 3 x 10
5
 H441 cells formed monolayers on 24-well plate in 24 hours. SAEC 
(P-3 to P-4) formed monolayers on 48-well plate and 96-well plate in 48 hours when initial 
cell seeding densities were 5 x 10
4
 and 2 x 10
4
 cell/well respectively (Section-2.3). 
 
3.3.2. Alveolar A549 cells express proSP-C 
SP-C is the definitive antigenic marker for type II AEC (Zhou et al., 1996). In my culture 
conditions, alveolar A549 cells expressed proSP-C protein as detected through 
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immunocytochemistry (Section-2.12.1). The SAEC, which are by origin small airway 
epithelial cells, did not express proSP-C (Figure 3.2).  
 
 
Figure 3.1: Formation of monolayers in vitro with human lung epithelial cells. 
Inverted light microscopic images show A549 cells (A), H441 cells (B) and SAEC (C) formed 
uniform monolayers on well-plates. (D) pAEpiC did not form perfect monolayers. Image 
magnification 100X for all cell types. Scale bar, 100 µm. 
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Figure 3.2: proSP-C expression profile in A549 and SAEC. 
Immunocytochemistry with anti-proSP-C antibody on A549 cells and SAEC. Nuclear staining was 
done with DAPI. Image magnification 200X. Scale bar, 100 µm. 
 
3.3.3. H441 (Clara) cells do not stimulate alveolar A549 cell wound repair through 
paracrine factors 
To establish evidence of cross-talk between secretory products of alveolar and bronchiolar 
cells, I first investigated the wound repair patterns of A549 and H441 cells using an in 
vitro wound repair model (Kheradmand et al., 1994, Atabai et al., 2002, Galiacy et al., 
2003, Chen et al., 2008b, Savla & Waters, 1998, Geiser et al., 2000, Geiser et al., 2004, 
Sonar et al., 2010, Curley et al., 2012) (Section-2.7, Section- 2.7.1, Section- 2.7.3). The 
H441 cells are slow-growing in comparison to A549 cells in both serum-free (SF) and 10% 
serum supplemented DMEM (Figure 3.3A, 3.3B) (Section- 2.6). The calculated doubling 
times of alveolar A549 and H441 cells in SF media were 22 ± 4.97 hours and 100 ± 9.83 
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hours, respectively, and in 10% FBS supplemented media 18 ± 1.71 hours and 50 ± 8.66 
hours, respectively (Figure 3.3C) (Section- 2.6).  
 
In spite of this difference, in the presence of 10% serum, no significant differences in the 
wound repair patterns of A549 and H441 cells were observed (Figure 3.4A, 3.4B). 
However, in SF media, the rate of H441 cell wound repair was 2.5-fold higher than that 
seen for A549 cells (65 ± 11.32% H441 vs. 26 ± 2.65% A549; p<0.001) (Figure 3.4A, 
3.4B) (Section- 2.7.3). 
 
Next, I tested SF-CM (serum-free conditioned media) obtained from wounded and un-
wounded H441 and A549 cell monolayers on A549 cell wound repair (Section- 2.4.1, 
Section- 2.7.3). SF-CM from both wounded and unwounded H441 cells did not affect 
A549 cell wound repair (32 ± 2.52% wounded SF-CM vs. 38 ± 9.02% SF-Negative 
control, 44 ± 3.06% un-wounded SF-CM vs. 38 ± 9.02% SF-Negative control respectively) 
(Figure 3.5A, 3.5C). Likewise, SF-CM from alveolar A549 cells, irrespective of wounding, 
did not stimulate any effects on A549 cell wound repair after 24 hours of wounding 
(Figure 3.5B). 
 
On the other hand, SF-CM of unwounded A549 cells inhibited H441 cell wound repair 
after 24 hours; whereas, SF-CM of wounded A549 cells did not (47 ± 2.65% unwounded 
SF-CM vs. 65 ± 7.37% Negative control, p<0.05) (Figure 3.6). Taken together, this 
indicates that Clara cells (H441 cells) can auto-stimulate wound repair in serum-free 
conditions but not stimulate repair of AEC wounds. In addition, uninjured A549 cells have 
a negative effect on Clara cell (H441 cells) wound repair in vitro. 
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Figure 3.3: A549 and H441 cell growth and population doubling time.  
(A) A549 and H441 cell growth in 10% FBS serum supplemented complete DMEM culture media. 
(B) A549 and H441 cell growth in serum-free DMEM. (C) Population doubling time (PD) of A549 
and H441 cell lines in serum-free and 10% FBS supplemented DMEM. n = 3 independent 
experiments. Data presented as mean ± SD. ***p<0.001. 
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Figure 3.4: A549 and H441 cell in vitro wound repair. 
(A) Inverted light microscopic images of A549 and H441 cell wound repair with SF-DMEM and 
10% FBS supplemented DMEM at 0 and after 24 hours. (100X magnification). (B) Wound repair 
of alveolar A549 cells and H441 cells in serum-free and 10% FBS supplemented media after 24 
hours. (n = 4 independent experiments, ≥5 replicates per n). Data presented as mean ± SD. 
***p<0.001, ns = not significant. Scale bar, 200 µm. 
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Figure 3.5: A549 cell in vitro wound repair with H441 and A549 CM. 
(A) A549 cell wound repair after 24 hours with serum-free CM of wounded and un-wounded H441 
cells. (n = 3 independent experiments, 4 replicates per n). (B) A549 cell wound repair after 24 
hours with serum-free CM of wounded and un-wounded A549 cell (n = 3 independent experiments, 
3 replicates per n). (C) Inverted light microscopic images of A549 cell wound repair. Positive and 
negative controls represent wound repair with 10% FBS supplemented and serum-free media 
respectively. Data presented as mean ± SD. ***p<0.001, ns = not significant. Scale bar, 200 µm. 
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Figure 3.6: H441 cell wound repair. 
(A) H441 cell wound repair after 24 hours with SF-CM obtained from wounded and un-wounded 
A549 cell monolayers (n = 3 independent experiments, 3 replicates per n). Positive and negative 
controls represent wound repair with 10% FBS supplemented and serum-free media respectively. 
(B) Inverted light microscopic images of H441 cell wound repair. Data presented as mean ± SD. 
**p<0.01. Scale bar, 200 µm. 
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3.3.4. H441 cells inhibit alveolar A549 cell wound repair in A549-H441 cell co-culture 
wound repair system 
To further explore the role of H441 cells in alveolar A549 cell wound repair, I developed a 
direct and indirect-contact co-culture wound repair system (Figure 3.7) (Section- 2.7.2, 
Section- 2.7.8.1). Direct and indirect-contact co-culture of H441 cells with wounded A549 
monolayers significantly reduced A549 cell wound repair rates after 24 hours (11 ± 5.89% 
Direct-contact vs. 36 ± 8.96% Negative control, p<0.01, and 20 ± 5.38% Indirect-contact 
vs. 36 ± 8.96% Negative control, p<0.05) (Figure 3.8A, 3.8D, 3.8E). 
 
Coupled to the reduction of repair rate in A549 cell wounds, I also observed substantial 
H441 cell migration into the wounded A549 cell monolayers, where a 4.25-fold greater 
number of migrated H441 cells were located at the juxta-wound monolayer sites in 
comparison to the wound gap itself (234 ± 39.13 cells/field juxta-wound monolayers vs. 55 
± 27.34 cells/field wound-gaps, p<0.001) (Figure 3.8B, 3.8E). Coupled to this migration, a 
55% reduction of A549 cells at the juxta-wound monolayers was also noted after 24 hours 
of wounding (700 ± 61.10 A549 cells at 0 hr. vs. 318 ± 40.54 A549 cells at 24 hrs., 
p<9x10
-4
) (Figure 3.8C, 3.8E). H441 cells did not migrate into the uninjured AEC 
monolayer in a similar direct-contact co-culture experiment (Figure 3.9A, 3.9B, 3.9C); and 
in the absence of A549 cells, H441 cell migration after 24 hours was negligible (Figure 
3.9D, 3.9E).  
 
In contrast, normal human lung fibroblasts CCD-8Lu cells did not inhibit A549 cell wound 
repair in A549-CCD 8Lu direct and indirect-contact co-culture (30 ± 3.49% Direct-contact, 
29 ± 3.23% In-direct-contact and 37 ± 15.97% Negative control) (Figure 3.10A, 3.10B) 
(Section- 2.7.8.1). Moreover, CCD-8Lu cell migration to the A549 cell wound site in 
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direct-contact model was negligible (Figure 3.10B). No apparent reduction A549 cell 
numbers from the wound margins and 24 hours of direct-contact co-culture with CCD-8Lu 
was noted (Figure 3.10B). Taken together, these results suggest that H441 (Clara) cells but 
not normal lung fibroblasts inhibit alveolar A549 cell wound repair in a proximity 
dependent manner, where at least for the direct-contact model, wound repair inhibition was 
due to direct interruption and destruction of AEC population. 
 
 
 
Figure 3.7: In vitro direct and indirect-contact co-culture wound repair system. 
(A) Indirect-contact co-culture wound repair model: wounded A549 cells on 0.4 μm porous PET 
membrane of transwell (upper layer) with H441 or CCD-8Lu cells (bottom layer); the gap between 
these two cell layers was 0.8 mm. (B) Direct-contact co-culture wound repair model: DiI-labelled 
wounded A549 cells or SAEC (upper layer) with un-wounded DiO-labelled H441 or CCD-8Lu 
cells (bottom layer) grown on 3 μm porous transwell PET membrane. After wounding the direct 
and indirect-contact samples were cultured in serum-free basal media for 24 hours. 
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Figure 3.8: A549-H441 direct and indirect-contact co-culture wound repair. 
(A) A549 cell wound repair after 24 hours in direct and indirect-contact co-culture with H441 cells. 
Positive and negative control represent the wound repair with 10% FBS supplemented and serum-
free media respectively (n = 4 independent experiments, 3 replicates per n). (B) Migration of H441 
cells into the A549 juxta-wound monolayers and wound gaps (n = 5 independent experiments). (C) 
Number of A549 cells per field at the juxta-wound monolayers in direct-contact co-culture with 
H441 cells after 24 hours (n = 5 independent experiments). (D, E) Laser scanning confocal 
microscopic images (100X) of A549-H441 direct-contact co-culture at 0 and 24 hours respectively. 
DiI-labelled red cells are A549 and DiO-labelled green cells are H441 cell. Vertical side bars 
represent Z-slicing through the corresponding juxta-wound monolayers whereas horizontal bars 
represent Z-slicing through wound gaps. A significant proportion of migrated H441 cells were 
noted at the juxta-wound monolayers of A549 cells after 24 hours of wounding (E). *p<0.05, 
**p<0.01, ***p<0.001. Data presented as mean ± SD. Scale bar, 150 µm. 
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Figure 3.9: H441 cell migration in absence of wound in A549 cells in the A549-H441 direct 
contact model. 
(A) Number of migrated H441 cells at unwounded A549 cell layer at 24 hours (equivalent duration 
of 0 hour wound) and 48 hours (equivalent duration of 24 hours wound) of A549-H441 direct-
contact co-culture (n = 3 independent experiments). (B, C) Laser scanning confocal microscopic 
images show migrated DiO-labelled H441 cells (Green) at DiI-labelled A549 cell layer (Red) at 24 
(B) and 48 (C) hours of A549-H441 direct-contact co-culture. (D, E) Migration of H441 cells to the 
contra-lateral surface of transwell PET membrane in absence of A549 cells. Laser scanning 
confocal microscopic images show DiI-labelled H441 cells (Red) on the under-surface of PET 
membrane at 0 hours (D) and on the contra-lateral surface of PET membrane after 24 hours of 
culture (E). Data presented as mean ± SD. Scale bar, 200 µm.  
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Figure 3.10: A549-CCD 8Lu cell direct and indirect-contact co-culture wound repair.  
(A) A549 cell wound repair after 24 hours in direct and indirect-contact co-culture with CCD-8Lu 
cells. Positive and negative control represent the A549 cell wound repair with 10% FBS 
supplemented and serum-free media respectively in monoculture (n = 3 independent experiments). 
(B) Laser scanning confocal microscopic images (100X) of A549-CCD 8Lu direct-contact co-
culture at 0 and 24 hours. DiI-labelled red cells are A549 cells and DiO-labelled green cells are 
migrated CCD-8Lu cells. Vertical side bars represent Z-slicing through the juxta-wound 
monolayers and horizontal bars represent Z-slicing through wound gaps. A negligible number of 
CCD-8Lu cells migrated to the A549 wound sites after 24 hours of wounding (B). *p<0.05, 
**p<0.01, ns = not significant. Data presented as mean ± SD. Scale bar, 150 µm.  
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3.3.5. Soluble TRAIL and FasL induce apoptosis in A549 cells 
I hypothesized that the reduction in A549 cell numbers at juxta-wound sites in A549-H441 
direct-contact co-culture could be due to H441-induced apoptosis. To test this hypothesis, I 
first examined the sensitivity of A549 cells to established apoptosis-inducing ligands; 
TRAIL and FasL (Pan et al., 1997, Walczak et al., 1997, Sheridan et al., 1997, Griffith et 
al., 1995) (Section- 2.10.1). Significant apoptosis was induced in A549 cell monolayers 
with either soluble TRAIL or FasL at 800 ng/ml or 3.2 μg/ml, respectively (57 ± 2.17% 
apoptosis with TRAIL 800ng/ml, 21 ± 6.19% apoptosis with FasL 3.2 µg/ml, 2 ± 0.83% 
apoptosis with SF-DMEM (0 ng/ml); p<0.001 vs SF-DMEM) (Figure 3.11A, 3.11B). 
100% of apoptosis was observed in A549 cells (Positive control) following 24 hours of 
H2O2 treatment (Figure 3.11B). 
 
The specificity of TRAIL and FasL-induced apoptosis was established by blocking the 
apoptotic response using their corresponding receptor blockers anti-TRAIL-R1, -R2 and 
anti-Fas antagonistic mAbs (Section- 2.10.1). A549 cell pretreatment with 10µg/ml anti-
TRAIL-R1 and/or anti-TRAIL-R2 antagonistic mAbs significantly blocked TRAIL (800 
ng/ml)- induced apoptosis (6 ± 1.03% anti-TRAIL-R1 mAb, 2 ± 0.89% anti-TRAIL-R2 
mAb, 3 ± 1.10% TRAIL-R1+R2 mAbs; p<0.001 vs TRAIL-induced apoptosis) (Figure 
3.12A, 3.12C). FasL-induced apoptosis specificity was demonstrated via the use of 10 
µg/ml anti-Fas antagonistic mAb (2 ± 0.49% anti-Fas mAb, p<0.001 vs FasL-induced 
apoptosis) (Figure 3.12B, 3.12D). This indicated the presence of functional Fas and TRAIL 
receptors on alveolar A549 cells.  
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Figure 3.11: Assessment of apoptosis in alveolar A549 cell monolayers. 
(A) Dose response of apoptosis induction in A549 cells with soluble FasL and TRAIL (n = 3 
independent experiments). Results were standardised against positive control where apoptosis was 
induced in A549 cells with treatment of 200 µM H2O2 for 24 hours. (B) Laser scanning confocal 
microscopic images of FasL and TRAIL induced apoptosis in DiI-labelled A549 cells (red) after 24 
hours. Green nuclei are TUNEL positive nuclei. *p<0.05, **p<0.01, ***p<0.001 vs 0 ng/ml 
(negative control, NC). Data plots represent mean experiment values ± SD. Scale bar, 200 µm. 
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Figure 3.12: Blocking of ligand-induced apoptosis in A549 cell monolayers. 
(A) Blocking of TRAIL-induced apoptosis in A549 cells by anti-TRAIL-R1 or anti-TRAIL-R2 or 
combined mAbs (10 µg/ml each) (n = 3 independent experiments). (B) Blocking of soluble FasL 
induced apoptosis in A549 cells with anti-Fas mAb (10 µg/ml) (n = 3 independent experiments). 
Positive controls represent apoptosis in A549 cells induced by 200 µM H2O2. (C, D) Laser 
scanning confocal microscopic images show TRAIL (C) and FasL (D) induced apoptosis in DiI-
labelled A549 cells in presence or absence of their corresponding receptor blockers. Green nuclei 
are TUNEL positive nuclei. ***p<0.001. Data presented as mean ± SD. Scale bar, 200 µm. 
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3.3.6. Direct-contact of H441 cells induces apoptosis in A549 cells through TRAIL-
dependent mechanism 
To confirm my earlier hypothesis, I performed the TUNEL assay to evaluate apoptosis on 
alveolar A549 cell wounds in the direct-contact model with H441 cells (Section- 2.10.2). I 
observed a significant rate of apoptosis in A549 cells in the juxta-wound margins (52 ± 
13.86% normalized to positive control vs. 1 ± 0.31% A549 monoculture, p<0.001) (Figure 
3.13A). Migratory H441 cells did not stain positively for TUNEL and were therefore 
considered not to be apoptotic (Figure S3.1, Appendix-2). In a similar A549-CCD8 Lu 
direct-contact wound repair setting, CCD-8Lu cells did not induce apoptosis in A549 cells 
(Figure S3.2, Appendix-2). 
 
Next, I investigated whether blocking of either TRAIL-receptors or Fas could block the 
H441 cell direct-contact induced apoptosis in A549 cells (Section-2.10.2). Pre-incubation 
of A549 cells with a blocking antibody specific to Fas (anti-Fas mAb, 10 µg/ml), prior to 
seeding into the direct-contact model with H441 cells, failed to block the apoptotic 
response in A549 cells (39 ± 3.14% Direct-contact vs. 31 ± 6.80% Direct-contact with 
anti-Fas mAb) (Figure 3.13B, 3.13D, 3.13F). However, pre-incubation of A549 cells with 
anti-TRAIL R1/R2 mAbs (10 µg/ml) completely blocked H441-induced apoptosis in the 
direct-contact model (39 ± 3.14% Direct-contact vs. 1 ± 0.54% Direct-contact with anti-
TRAIL-R1/R2 mAbs, p<0.001) (Figure 3.13B, 3.13D, 3.13E). 
 
I next sought to investigate whether the TRAIL receptor blocker could reverse the H441 
cell direct-contact induced A549 cell wound repair inhibition. I observed that following 
addition of anti-TRAIL-R1/R2 mAbs (10 µg/ml) to the A549-H441 direct-contact wound 
repair system, the A549 cell wound repair was significantly improved after 24 hours over 
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untreated counterpart (32 ± 7.45% anti-TRAIL-R1/R2 mAbs treated vs. 8 ± 1.57% 
untreated sample; p<0.05) (Figure 3.14A, 3.14B). These results demonstrate that H441 
cells induce apoptosis in wounded alveolar A549 cells and inhibit wound repair through a 
TRAIL-dependent mechanism in a direct-contact co-culture wound repair system. 
 
3.3.7. TRAIL, TRAIL-R1 and –R2 expression profile in H441 and A549 cells 
I evaluated the expression profile of TRAIL and its receptors TRAIL-R1 and TRAIL-R2 in 
A549 and H441 cells at transcriptional level by RT-PCR (Section- 2.11) and translation by 
immunocytochemistry (Section- 2.12.1). Transcriptional analysis confirmed TRAIL, 
TRAIL-R1 and TRAIL-R2 mRNA expression in both unwounded H441 and A549 cells 
where the band density for TRAIL was faint in the A549 sample in comparison to H441 
(Figure 3.15A). Immunocytochemistry detected a higher level of TRAIL-R1 and –R2 
expression in unwounded alveolar A549 cells than H441 cells. The TRAIL protein 
expression was high in unwounded H441 cells; whereas, TRAIL expression was barely 
detected in unwounded A549 cells (Figure 3.15B). 
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Figure 3.13: Assessment of apoptosis in A549-H441 direct-contact co-culture. 
(A) Apoptosis in A549 cells at juxta-wound monolayers after 24 hours in A549-H441 direct-
contact co-culture wound repair (grey bar) (n = 3 independent experiments). (B) A549-H441 direct-
contact co-culture induced apoptosis blocking with anti-TRAIL-R1+R2 and anti-Fas mAbs (10 
µg/ml each). For positive control, apoptosis was induced in A549 cell monolayers by 200 µM H2O2 
and for negative control (A549 alone), A549 monolayers were treated with SF-DMEM only. (n = 3 
independent experiments). (C-G) Laser scanning confocal microscopic images of TUNEL assay on 
A549-H441 direct-contact co-culture (300X). Red cells are DiI labelled A549 cells and green 
nuclei are TUNEL positive A549 cell nuclei. (C) A549 cell monoculture (as negative control). (D) 
A549-H441 cell direct-contact co-culture without any blockers. (E) A549-H441 direct-contact co-
culture with anti-TRAIL-R1 and –R2 mAbs. (F) A549-H441 direct-contact co-culture with anti-Fas 
mAb. (G) Positive control: apoptosis induced in A549 monoculture with 200 µM H2O2. 
***p<0.001. ns = not significant. Data presented as mean ± SD. Scale bar, 100 µm. 
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Figure 3.14: Assessment of A549 cell wound repair in A549-H441 direct-contact co-culture 
with TRAIL blockers. 
(A) Alveolar A549 cell wound repair in presence and absence of anti-TRAIL-R1+R2 mAbs 
(10µg/ml) in A549-H441 direct-contact co-culture after 24 hours. Negative and positive controls 
represent A549 cell wound repair on transwell membrane in monoculture with serum-free and 10% 
FBS containing DMEM respectively (n = 3 independent experiments). (B) Representative laser 
scanning confocal microscopic images (100X) of A549-H441 direct-contact co-culture wound 
repair. DiI-labelled red cells are A549 and DiO-labelled green cells are migrated H441 cells 
*p<0.05, **p<0.01. ns = not significant. Data presented as mean ± SD. Scale bar, 150 µm. 
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Figure 3.15: TRAIL and TRAIL receptor expression profile in A549 and H441 cells. 
(A) RT-PCR of TRAIL, TRAIL-R1, and TRAIL-R2 of A549 and H441 cells. (B) Fluorescent 
immunocytochemistry for TRAIL, TRAIL-R1 and TRAIL-R2 in A549 and H441 cells. DAPI was 
used for counter staining of nuclei. Scale bar, 50 µm. 
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3.3.8. H441 cells migrate to SAEC wound sites and induce apoptosis in SAEC in 
SAEC-H441 direct contact co-culture wound repair system 
Although SAECs are proSP-C negative (Figure 3.2) and do not represent type II AEC, due 
to their suitability for wound repair model (O'Toole et al., 2009) and biological relevance 
to my experiments I replicated a set of major experiments that were conducted using A549 
cells to exclude the potential of cancer cell line related bias in our results (Section- 
2.7.8.1). First, I assessed the migratory properties of H441 cells towards wounded SAEC 
monolayers. Interestingly, my experiments recapitulated the observations noted in the 
A549-H441 direct-contact co-culture model. A significant proportion of H441 cells 
migrated to the SAEC wound sites after 24 hours of wounding, where a 7.25-fold greater 
number of migrated H441 cells were located at the juxta-wound monolayers in comparison 
to the wound gap (58 ± 7.51 cells/field vs 8 ± 5.03 cells/field, p<0.001) (Figure 3.16A, 
3.16B, 3.16C). 
 
The TRAIL-ligand induced an apoptotic response in SAEC in a dose-dependent manner 
(Section- 2.10.1) which though reduced in comparison to A549 cells was demonstrably 
significant when compared to the relevant control (Figure 3.17A, 3.17B, 3.17C). Similarly, 
TRAIL-expressing H441 cells induced significant apoptosis in wounded SAEC in SAEC-
H441 direct-contact co-culture when compared to SAEC monoculture (9.54 ± 1.90% vs 
0.38 ± 0.11%, p<0.001) (Figure 3.18A, 3.18B, 3.18C). Confocal microscopy confirmed 
that TUNEL positive nuclei were SAEC and not migrated H441 cells (Figure S3.3, 
Appendix-2). 
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Figure 3.16: H441 cell migration in SAEC-H441 direct-contact co-culture wound repair. 
(A) Migration of H441 cells into the SAEC juxta-wound monolayers and wound gaps (n = 3 
independent experiments). (B, C) Laser scanning confocal microscopic images (100X) of SAEC-
H441 direct-contact co-culture at 0 (B) and 24 hours (C) respectively. DiI-labelled red cells are 
SAEC and DiO-labelled green cells are H441 cells. Vertical side bars indicate Z-slicing through the 
corresponding juxta-wound monolayers and horizontal bars indicate Z-slicing through the wound 
gap. ***p<0.001. Data presented as mean ± SD. Scale bar, 200 µm. 
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Figure 3.17: Induction of apoptosis in SAEC with soluble TRAIL. 
(A) Dose response of apoptosis induction in SAEC monoculture with different concentration of 
soluble TRAIL treatment for 24 hours (n = 3 independent experiments). (B, C, D) Laser scanning 
confocal microscopic images of TUNEL positive SAEC in negative control (cells were treated with 
serum-free basal media) (B), 1.6µg/ml of soluble TRAIL-treated sample (C) and positive control 
(cells were treated with 200 µM H2O2) for 24 hours (D). Data plots represent mean ± SD. 
**p<0.01, ***p<0.001. Scale bar, 150 µm. 
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Figure 3.18: Assessment of apoptosis in SAEC-H441 direct-contact co-culture. 
(A) Apoptosis in SAEC at juxta-wound monolayers after 24 hours in SAEC-H441 direct-contact 
co-culture wound repair (n = 3 independent experiments). For positive control, apoptosis was 
induced in SAEC monolayers by treatment of 200 µM of H2O2 for 24 hours and for negative 
control, SAEC monolayers were treated with serum-free SABM only (SAEC alone). (B, C, D) 
Laser scanning confocal microscopic images of TUNEL assay on SAEC-H441 direct-contact co-
culture (200X). Red cells are DiI-labelled SAEC and green nuclei are TUNEL positive SAEC 
nuclei. (B) Negative control, SAEC monoculture. (C) SAEC-H441 cell direct-contact co-culture 
wound repair. (D) Positive control. ***p<0.001. Data presented as mean ± SD. Scale bar, 200 µm. 
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3.3.9. TRAIL-expressing Clara cells are detected in the fibrotic alveoli of IPF lungs 
with associated AEC apoptosis  
Histologically all IPF biopsy samples showed features in keeping with Usual Intestinal 
Pneumonia (UIP); specifically a pathognomonic patchwork of normal unaffected lung 
alternating with remodelled fibrotic lung involving type I pneumocyte destruction, type II 
pneumocyte hyperplasia in the presence of fibroblastic foci and collagen type scaring. The 
fibroblastic foci are recognised to reflect sites of active ongoing fibrogenesis. 
 
Localisation of TRAIL-expressing Clara cells in the alveolar regions of control and IPF 
lung tissues was investigated by dual immunohistochemistry with CC10 (Clara cell 
marker) and TRAIL antibodies (Section- 2.12.6). Dual-labelled CC10/TRAIL Clara cells 
were not detected in the alveolar regions of control lungs (Figure 3.19A) but were 
observed in the bronchiolar walls (Figure 3.19B, arrows). However, CC10/TRAIL-positive 
Clara cells were readily detected within the hyperplasic alveolar epithelial regions (Figure 
3.19D, arrow) and in the alveolar epithelium directly overlying fibroblastic foci (Figure 
3.19E, arrow) in 18 out of 21 IPF cases. Quantitative analysis displayed an average of 15 ± 
2.66% CC10/TRAIL-positive epithelial cells within the specified areas per IPF case. 
(p=0.0004; Figure 3.19I). 
 
Dual proSP-C/TUNEL labelling was performed to identify the presence and localisation of 
apoptotic AEC in IPF lungs and control lung tissue (Figure 3.19F, 3.19G, 3.19H) (Section- 
2.10.3). Increased numbers of TUNEL-labelled proSP-C positive AEC cell were detected 
in the regions of fibroblastic foci and remodelled fibrotic areas in IPF lungs (37 ± 6.79% of 
proSP-C/TUNEL cells per IPF case vs. 11 ± 7.53% in control; p=0035) (Figure 3.19J). Ten 
out 12 control cases did not demonstrate TUNEL-labelled AEC; however, two cases 
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displayed a high number of TUNEL-positive proSP-C-labelled calls for an unknown 
reason that skewed the mean value towards 11% (Figure 3.19J). Taken together, these 
observations demonstrate evidence for a potential association of AEC apoptosis and 
TRAIL-expressing Clara cells with an involvement in the propagation of fibrogenesis in 
pulmonary fibrosis. 
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Figure 3.19: TRAIL and CC10 immunohistochemistry and TUNEL assay in normal control 
and IPF lung tissue samples. 
(A) Alveolar region of control lung dual stained with CC10/TRAIL antibodies. No CC10-labelled 
Clara cells were detected in the alveolar region. AEC were negative to TRAIL. (B) Dual 
immunostaining with CC10/TRAIL of bronchioloalveolar region of normal control lung shows 
CC10-labelled Clara cells in the bronchiolar epithelium (arrows, visualised with VIP, Very Intense 
Purple). Clusters of macrophages were positively labelled with TRAIL which was visualised with 
DAB (M). No AEC was labelled with TRAIL. (C) Clara cells were labelled with CC10 antibody 
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within epithelium of hyperplastic alveolar regions of IPF lung (visualised with DAB). (D) Dual 
labelled CC10/TRAIL Clara cells were detected in the hyperplastic alveolar region of IPF lung 
(arrows, stained with both DAB for TRAIL and VIP for CC10). Type II AEC also showed positive 
to TRAIL immunostaining but negative to CC10 (arrow heads). (E) CC10/TRAIL dual labelled 
Clara cells were detected in the epithelium overlying the fibroblastic foci (FF) and hyperplastic 
regions (arrows). AEC were TRAIL positive and CC10 negative (arrow heads). (F) proSP-
C/TUNEL dual staining of control lung. TUNEL positive green nuclei were not detected in proSP-
C positive type II AEC (red fluorophore labelled). (G) proSP-C/TUNEL
 
dual labelled cells were 
detected in the hyperplastic regions of IPF lung tissue (arrow, green apoptotic nuclei within red 
cytoplasm). A heterogeneous pattern of TUNEL positive AEC was observed. Arrow head (inset) 
indicates non-apoptotic type II AEC. Notable numbers of inflammatory cells in the interstitial 
spaces were also TUNEL positive. Magnification was 200X for all images. (H) Apoptosis was 
detected in AEC overlying the fibroblastic foci in IPF lung (arrows). (I) Quantitative analysis of 
CC10/TRAIL dual-positive cells in the alveolar region of normal and IPF lungs (21 IPF patients 
and 19 controls). (J) Quantification of proSP-C/TUNEL positive cells in the alveolar regions of 
IPF and healthy control lungs (12 IPF and same number of control). **p=0.0004, ***p=0.0035. 
Data are presented as mean ± SEM. 
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3.4. Discussion 
The precise role of Clara cells in the repair of alveolar epithelial injury in IPF remains 
unknown. A reparative role is unlikely due to failed restoration of normal architecture and 
lung function after apparent proliferation and migration into injured alveoli in IPF (Chilosi 
et al., 2002, Odajima et al., 2007). In this study, I have clarified a likely role of Clara cells 
in AEC wound repair by using an in vitro wound repair model and implicated the Clara 
cells in the pro-fibrogenic process. This first demonstration that Clara cells induce 
apoptosis in AEC through a TRAIL-dependent mechanism provides evidence of a 
previously undiscovered cell behavior with implications for lung pathophysiology. I 
further demonstrate that TRAIL-expressing Clara cells not only induced apoptosis in an 
AEC line but also in primary human small airway epithelial cells. Clara cell behavior 
towards AEC were cell-type specific as demonstrated via the contrasting behavior of 
normal lung fibroblasts on AEC. In addition, the observation that alveolar bronchiolised 
Clara cells express TRAIL and are associated with AEC apoptosis in IPF lungs suggests 
that Clara cells may drive the aberrant alveolar wound repair event cascade and propagate 
the ensuing fibrogenesis through TRAIL-mediated apoptosis induction in AEC. 
Preliminary in-house studies have demonstrated a significant up-regulation of TRAIL-R1 
and –R2 receptors in AEC of IPF lungs (data not presented in this thesis), further 
supporting a potential involvement of TRAIL-mediated apoptosis in AEC in IPF. 
 
Clara cells are non-ciliated cuboidal cells, broadly distributed throughout the bronchiolar 
epithelium which are normally quiescent in steady-state condition but become activated 
following injury and proliferate/differentiate into other bronchiolar cells, hence are termed 
as facultative progenitor cells (Stripp & Reynolds, 2008, Stripp, 2008). Not all but a 
subpopulation of Clara cells which are resistant to naphthalene-induced injury are thought 
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to be the bronchiolar progenitor cells which contribute to bronchiolar repair and 
regeneration (Chen et al., 2009). H441 cells are originated from human Clara cells and 
have widely been used for Clara cell functional study (Gazdar et al., 1990, Kulaksiz et al., 
2002, Wong et al., 2010). Due to unavailability of primary human Clara cells, the H441 
cell line was chosen for my study. 
 
Idiopathic pulmonary fibrosis is characterised as a consequence of aberrant alveolar wound 
repair potentially due to; apoptosis, dysregulated epithelial-mesenchymal homeostasis, 
basement membrane disruption, imbalanced immune response, AEC loss, and alveolar 
bronchiolisation (Selman & Pardo, 2002, Selman et al., 2001, Strieter, 2005, Uhal et al., 
1998, Kuwano et al., 1999, Barbas-Filho et al., 2001, Odajima et al., 2007, Chilosi et al., 
2002, Corrin et al., 1985). The role of alveolar bronchiolisation in aberrant wound repair 
and the precise nature of the interaction between the Clara cells and AEC are both 
relatively undefined. Bronchiolisation has been postulated as an indicator of aberrant 
alveolar wound repair in chemically-induced pulmonary fibrosis and human IPF lung 
tissue (Odajima et al., 2007, Chilosi et al., 2002, Plantier et al., 2011). 
 
During fibrogenesis in IPF, Clara and other bronchiolar cells appear in the alveolar regions 
of established fibrotic areas and directly contact with AEC. While the precise mechanism 
is unknown, animal model and ex vivo studies on IPF tissue suggest that down-regulation 
of caveolin-1 (a membrane protein that suppresses epithelial proliferation) stimulates 
bronchiolar and Clara cell proliferation (Odajima et al., 2007) and up-regulation of MMP-9 
(matrix metalloproteinase-9) facilitates their migration into the affected alveoli resulting in 
alveolar bronchiolisation (Betsuyaku et al., 2000). A recent study has suggested an 
NRG1α-dependent ectopic mucus cell differentiation involvement in the process of 
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bronchiolisation and lung remodeling in IPF lungs (Plantier et al., 2011). The migratory 
aspect of Clara cell behavior was confirmed in our model where H441 cells migrated to the 
wounded alveolar A549 cell and SAEC layers, most likely driven by a chemotactic 
mechanism as in the absence of A549 or SAEC, Clara cell migration was not observed. 
This migration was accompanied by an inhibitory effect on AEC wound repair via TRAIL-
mediated apoptosis of AEC.  
 
TRAIL (TNF-related apoptosis-inducing ligand, also known as Apo2L), a member of the 
TNF superfamily, can induce apoptosis through interaction with the TRAIL-R1 and 
TRAIL-R2 receptors (alternatively known as DR4 and DR5 respectively) (Pan et al., 1997, 
Walczak et al., 1997, Sheridan et al., 1997). TRAIL is a type 2 transmembrane protein 
which also can be released as a soluble form after being proteolytically cleaved from cell 
surface. In humans, TRAIL interacts with four membrane receptors which belong to the 
TNF receptor (TNFR) gene superfamily. TRAIL-R1 and TRAIL-R2 have conserved 
cytoplasmic death domain motifs, and can transduce apoptotic signals. Whereas, the other 
two receptors, namely DcR1 (TRAIL-R3) and DcR2 (TRAIL-R4) have truncated death 
domains and are incapable of transmitting apoptotic signal, hence are called decoy 
receptors. There is another soluble decoy receptor called osteoprotegerin (OPG) has 
relatively lower affinity of binding with TRAIL. TRAIL-mediated apoptosis occurs by 
engagement with and homotrimerisation of TRAIL-R1 or TRAIL-R2 receptor via a 
mitochondrial independent or/and dependent signaling pathways depending on cell types 
(Figure 3.20). The decoy receptors and the intracellular proteins, anti-apoptotic Bcl-2 and 
cFLIP are negative regulators of TRAIL-mediated apoptosis (reviewed in LeBlanc & 
Ashkenazi, 2003). However, the role of cFLIP in the regulation of TRAIL-mediated 
apoptosis is controversial. 
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Although expression of TRAIL and its receptors are detected in many steady-state human 
cell types (Daniels et al., 2005), their physiological function is poorly understood. 
However, TRAIL has been shown to play an important role in T-cell mediated 
immunomodulatory function and intestinal epithelium homeostasis (Falschlehner et al., 
2009, Rimondi et al., 2006). Here, the observation that Clara cells can induce apoptosis in 
alveolar A549 cells provides support for my hypothesis of the involvement of TRAIL-
expressing Clara cell in the aberrant alveolar wound repair found in IPF. 
 
Pathologically, IPF is characterised by its regional and temporal heterogeneity. Affected 
alveolar regions in proximity to the fibroblastic foci and collagen deposition displayed 
increased numbers of TRAIL expressing Clara cells (as compared to control healthy lung 
biopsies) and were associated with elevated AEC apoptosis. Furthermore in IPF lungs, 
TRAIL-positive AEC were notably present in areas of hyperplastic cuboidalised alveoli 
and in epithelia overlying fibroblastic foci. In contrast, AEC of control lungs did not 
express TRAIL. However, in contradictory with our findings, a recent non-quantitative 
immunohistochemistry study showed a relatively low TRAIL expression in IPF alveolar 
epithelial cells and high TRAIL-expression in control lung (McGrath et al., 2012). I 
however, observed TRAIL expression in bronchiolar epithelial cells of healthy control 
lung. The reason of this contradictory results is undetermined; however, the McGrath et al. 
evaluation was on 3 control and 5 IPF lung whereas, our quantitative analysis was on 19 
control and 21 IPF cases. It is possible that the TRAIL-expression in IPF AEC is 
heterogeneous within the affected population. 
 
TRAIL-mediated apoptosis has been reported in other chronic disease states. For instance 
in chronic pancreatitis the pancreatic stellate cells overexpress TRAIL and directly 
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contribute to the acinar regression through induction of apoptosis in parenchymal cells via 
TRAIL-receptor mediated apoptosis mechanism (Hasel et al., 2003). TRAIL-mediated 
apoptosis has been reported as a key mediator for progression of human diabetic 
nephropathy where TRAIL-overexpression in renal tubular epithelial cells is associated 
with severe tubular atrophy and interstitial fibrosis (Lorz et al., 2008). Other studies have 
demonstrated up-regulation of TRAIL in intestinal epithelial cells associated with 
epithelial cell destruction through TRAIL-mediated apoptosis and progression of 
inflammatory bowel disease like ulcerative colitis and Crohn‟s disease while down-
regulation is associated with the refractory stages of the disease (Begue et al., 2006, Brost 
et al., 2010). Chronic endoplasmic reticulum stress and Fas-FasL mediated apoptosis in 
alveolar epithelial cells and their association in aberrant alveolar wound repair in IPF have 
been reported previously (Kuwano et al., 1999, Korfei et al., 2008). Combining the 
literature evidence with our study findings, here I suggest that TRAIL-mediated apoptosis 
could play a crucial role in AEC apoptosis and fibrogenesis propagation in IPF; this is 
likely mediated via activated TRAIL-expressing Clara cells consequent on alveolar 
bronchiolisation (Figure 3.20). These findings unravel critical targets for further 
investigation towards development of novel therapeutic agents for IPF. 
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Figure 3.20: The graphical summary of TRAIL-expressing Clara cell induced AEC apoptosis. 
The ongoing pathognomonic events in alveolar bronchiolisation, particularly in IPF, are complex 
and largely unknow. Here is a proposed, hypothetical chain of events that takes place during 
alveolar bronchiolisation in IPF. Down-regulation of caveolin-1 in bronchiolar/Clara cells 
promotes their proliferation and up-regulation of MMP-9 facilitates their migration into the 
affected alveoli, a process called alveolar bronchiolisation. TRAIL-expressing Clara cells come in 
direct-contact with AEC within the alveoli and induce TRAIL-mediated apoptosis in AEC through 
their membranous TRAIL. TRAIL engages with TRAIL-R1/R2 receptors and makes homotrimer 
complex. This ligand-receptor complex then recruits the intracellular proteins to their death-domain 
to form DISC (death-inducing signaling complex). The TRAIL/DISC complex, which resembles to 
FADD (Fas-associated death domain), activates apoptotic inducer caspase-8. The caspase-8 then 
triggers apoptosis through proteolytic activation of caspase-3 via a mitochondrial-independent 
pathway (Cell-extrinsic pathway). Activated caspase-8 also can cleave Bid and translocate them to 
the mitochondria that augment proapototic Bax protein which stimulates release of cytochrome C 
(Cyt C). The Cyt C then activates caspase-9 and thus caspase-3 triggering apoptosis (Cell-intrinsic 
pathway) (LeBlanc & Ashkenazi, 2003). 
 
Chapter 4:             hMSC-mediated alveolar & small airway epithelial wound repair 
PhD thesis by K. M. Akram                                                                    Keele University - 160 - 
 
 
 
 
 
 
Chapter 4 
 
Mesenchymal Stem Cells promote Alveolar Epithelial 
Cell wound repair through distinct migratory and 
paracrine mechanisms 
 
Chapter 4:             hMSC-mediated alveolar & small airway epithelial wound repair 
PhD thesis by K. M. Akram                                                                    Keele University - 161 - 
4.1. Background 
Bone marrow derived mesenchymal stem cells (MSC) classically can differentiate into 
mesodermal lineages including osteoblasts, chondrocytes, adipocytes, and cardiomyocytes 
(Pittenger et al., 1999, Deb et al., 2003, Toma et al., 2002). Numerous reports also suggest 
that MSC can differentiate into other, non-mesodermal lineages including neurons 
(Dezawa et al., 2004, Zeng et al., 2011), hepatocytes (Sato et al., 2005) and lung epithelial 
cells (Liechty et al., 2000, Kotton et al., 2001, Ma et al., 2011). This evidence provides a 
strong rational for the potential application of hMSC in regenerative therapeutic 
approaches in many diseases including those of the lung where effective treatment options 
are limited, such as idiopathic pulmonary fibrosis. IPF is a chronic, progressive fibrotic 
lung disorder of unknown aetiology and the most common and lethal form of interstitial 
lung diseases with a post diagnosis median survival time of 3-5 years irrespective of its 
treatment status (Raghu et al., 2011). 
 
Hypothetically, the pathophysiology of IPF is most likely associated with multiple alveolar 
injuries, failure or delayed alveolar re-epithelialisation, abnormal immune responses and 
subsequent fibrosis (Selman et al., 2001, Strieter, 2005, Kaminski, 2003). Studies 
involving the bleomycin-induced pulmonary fibrosis mouse model, a widely used animal 
model of pulmonary fibrosis (Harrison & Lazo, 1987), demonstrated the migration and 
homing of endotracheal or systematically transplanted MSC towards the site of injury and 
attenuation of pulmonary fibrosis (Ortiz et al., 2003, Rojas et al., 2005). However, the 
magnitude of the amelioration of fibrosis appeared out of proportion to the numbers of 
engrafted MSC which had differentiated into AEC indicating the involvement of other 
mechanisms in this MSC-mediated reparative process. An emerging consensus is that 
paracrine mechanisms could be associated with MSC-mediated wound repair and tissue 
Chapter 4:             hMSC-mediated alveolar & small airway epithelial wound repair 
PhD thesis by K. M. Akram                                                                    Keele University - 162 - 
regenerative process (Weiss & Finck, 2010). However, the identity of these paracrine 
factors with a putative role in alveolar injury repair and regeneration is not clear. 
 
A wide range of different growth factors, cytokines and extracellular matrix proteins 
(ECM) have been identified as constituents of the in vitro cultured MSC secretome (Chen 
et al., 2008a, Estrada et al., 2009). Many of these secretory proteins are biologically active 
with anti-inflammatory, anti-fibrotic and immunomodulatory functions (Meirelles et al., 
2009, Nauta & Fibbe, 2007). The immunomodulatory function of MSC has been 
demonstrated through their therapeutic efficacy in alleviation of graft-versus-host disease 
(GvHD) and animal model of bronchial asthma through their putative role in modulating 
Type-1 (Th1) and Type-2 (Th2) immune responses (Nemeth et al., 2010). MSC-secreted 
factors are cytoprotective as demonstrated in a cardiac injury animal model driven by anti-
apoptotic and inotropic effects (Gnecchi et al., 2008). The MSC-mediated anti-apoptotic 
effect can be driven by up-regulation of anti-apoptotic gene, Bcl-2, which was 
demonstrated in an animal model of emphysema (Zhen et al., 2008).  
 
Animal model of myocardial infarction and pulmonary hypertension have demonstrated 
that transplanted MSC improved cardiac function and pulmonary vasculature by 
stimulating neovascularisation possibly via their secretory VEGF (vascular endothelial 
growth factor) and eNOS (endothelial nitric oxide synthase) (Burdon et al., 2011, Baber et 
al., 2007, Kanki-Horimoto et al., 2006). The anti-inflammatory function of MSC has been 
documented in many animal model studies. The mechanism is paracrine and more likely 
via blocking of anti-inflammatory cytokines such as TNF-α and IL-1 (Ortiz et al., 2007, 
Gupta et al., 2007). Previous reports have demonstrated that conditioned media obtained 
from MSC culture improved cutaneous wound healing (Chen et al., 2008a, Walter et al., 
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2010) and cardiac repair (Nguyen et al., 2010). However, data supporting the role of MSC-
secreted paracrine factors in the mediation of alveolar epithelial cell wound repair is 
absent. 
 
4.1.1. Aims and objectives of the study 
The aim of this study was to evaluate the likely role of hMSC on alveolar and small airway 
epithelial wound repair. I utilised an in vitro scratch wound repair system (Kheradmand et 
al., 1994, Atabai et al., 2002, Galiacy et al., 2003, Chen et al., 2008b, Savla & Waters, 
1998, Geiser et al., 2000, Geiser et al., 2004, Sonar et al., 2010, Curley et al., 2012) to 
evaluate the paracrine effects of hMSC on AEC and SAEC wound repair and developed a 
novel direct-contact co-culture wound repair system to investigate their migratory property 
of hMSC towards epithelial wound (Section- 2.7.2, Section- 2.7.8.2). 
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4.2. Study design 
To investigate the paracrine influence of hMSC on alveolar A549 cell and SAEC wound 
repair, SF-CM was obtained from hMSC culture and tested on A549 and SAEC wound 
repair system (Section- 2.4.2, Section- 2.7.4, Section- 2.7.5) (See Chart 4.1). The effect of 
hMSC-CM on the alveolar A549 cell wound repair was evaluated with different 
concentration of serum supplementation as well (Section- 2.7.4). The internuclear 
distances of A549 cells at wound margins were measured to evaluate cell migration 
(Section- 2.8). The MTT cell proliferation assay was performed to investigate the A549 
cell proliferation in response to hMSC-CM treatment during wound repair (Section- 2.9). 
CM obtained from human lung fibroblast cell line CCD-8Lu was also tested on A549 cell 
wound repair model to compare and contrast the observed effects by hMSC-CM (Section- 
2.4.3, Section- 2.7.4). The migratory property of hMSC was evaluated through utilisation 
of A549-MSC direct-contact in vitro wound repair model (Section- 2.7.8.2). The secretory 
proteins of hMSC-CM were identified by LC-MS/MS mass spectrometry (Section- 2.5). A 
cohort of hMSC secretory proteins were selected based on their abundance in the CM and 
biological relevance to wound repair to test on the alveolar A549 and SAEC wound repair 
model (Section- 2.7.7). A group of selected proteins were tested to investigate their 
substrate-effect on A549 cell migration by developing a novel „Collagen drop cell 
migration assay‟ (Section- 2.13). The experimental data was analysed using the Excel 
programme of Microsoft Office XP. The statistical analysis was performed using the 
GraphPad Prism version 5.00 software (Section- 2.14). A conclusion was drawn according 
to the outcome of the experimental results (See Chart 4.1). 
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Chart 4.1: Major steps of the study plan. 
Evaluation of hMSC effect on alveolar 
A549 cell and SAEC wound repair 
A549 cell wound repair and 
hMSC migration evaluation 
hMSC secretome 
analysis 
Stimulation of A549 and 
SAEC wound repair? 
Substrate effects of 
protein on A549 cell 
migration 
Result analysis and come up with a conclusion 
Evaluation of hMSC paracrine 
effect on wound repair 
Evaluation of hMSC direct-contact effect 
on A549 cell wound repair 
Collection of CM from 
cultured hMSC 
Section- 2.4.2  
Testing of MSC-CM on in 
vitro wound repair system 
Section- 2.7.4, 2.7.5 
A549-MSC direct contact 
wound repair assay 
Section- 2.7.7.2 
By cell proliferation? 
By cell migration? 
Measurement of 
internuclear distances 
Section- 2.8 
Identification and selection 
of a cohort of hMSC 
secretory protein for 
testing 
Effects of selected 
proteins on wound repair 
Section- 2.7.7 
A549 cell wound SAEC cell wound 
Collagen drop assay 
Section- 2.13 
Mass Spectrometry 
Section- 2.5 
MTT cell proliferation assay 
Section- 2.9 
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4.3. Results 
4.3.1. Assessment of hMSC phenotypic markers and their multipotency 
hMSC were isolated from bone marrow aspirates following the previously described 
methodology (D'Ippolito et al., 2004, Wimpenny et al., 2010) (Section- 2.2.3). Prior to 
experimentation, the phenotypic surface markers of hMSC were confirmed by 
immunocytochemistry (Section- 2.12.2) and their multipotency was confirmed by tri-
lineage differentiation (Section- 2.2.3.1, Section- 2.12.3). The hMSC surface markers were 
detected on passage-1 cells isolated from 3 different donors. Isolated hMSC were positive 
for surface antigens CD44, CD90, CD146, STRO-1 and negative for haematopoietic 
markers CD14 and CD19 (Figure 4.1). 
 
The isolated hMSC were also capable of differentiating into tri-lineage mesodermal 
derivatives; osteoblasts, chondrocytes and adipocytes, which were demonstrated through 
histological staining and immunocytochemistry (Figure 4.2) (Section- 2.2.3.1, Section- 
2.12.3). Calcium deposition after 3 weeks by differentiated osteoblasts was detected by 
Alizarin Red staining (Figure 4.2A) and the differentiated osteoblasts were positive for 
osteocalcin (Figure 4.2G). Fat globules produced by differentiated adipocytes were stained 
with Oil Red O (Figure 4.2B). The adipocytes were also positive for the specific marker 
FABP-4 (Figure 4.2H). GAG production by chondrogenic nodules was determined by 
Alcian Blue staining (Figure 4.2C) and aggrecan was detected by immunocytochemistry 
(Figure 4.2I). 
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Figure 4.1: Immunophenotyping of hMSC on isolated MSC. 
hMSC were positive for surface antigens CD44, STRO-1, CD146, and CD90 and negative for 
haematopoietic markers CD14 and CD19. DAPI was used for nuclear counter staining. Image 
magnification for fluorescence and phase was 200X. Scale bar, 100 µm. 
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Figure 4.2: Classical tri-lineage differentiation of hMSC. 
(A) Calcium deposition by differentiated osteoblasts was stained with Alizarin Red and (G) 
osteocalcin detected by immunofluorescence (G). D and J indicate respective control images. (B) 
Differentiated adipocytes produce triglyceride as indicated by Oil Red O stain and express FABP4 
as indicated by positive immunofluorescence (H). E and K indicate respective control images (C) 
Chondrogenic nodules stained positive with Alcian Blue and aggrecan immunofluorescence (I). F 
and L indicate respective controls. Scale bar, 150 µm (A, B, C, D, E, F); 100 µm (G, H, I, J, K, L). 
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4.3.2 hMSC secretome stimulates alveolar epithelial cell wound repair in a co-factor 
dependent manner 
To investigate the role of the hMSC secretome on AEC and SAEC wound repair, human 
MSC-derived serum-free conditioned media was tested on proSP-C expressing human type 
II AEC line A549 cells (Figure 3.2) and primary human SAEC utilising the established in 
vitro scratch wound repair model. Aberrant alveolar repair processes resulting in denuded 
alveolar walls are thought to be among the key elements required for pathogenesis of IPF. 
(Selman et al., 2001). The use of the scratch wound repair model replicates, at least in a 
part, the wounds and, through the controlled experimentation I describe, allows replication 
of the inability to repair and a platform to test novel factors in repair stimulation (Section- 
2.7, Section- 2.7.1, Section- 2.7.4). hMSC serum-free conditioned media (SF-MSC 
CM
DMEM
) did not show any stimulatory effect on alveolar A549 cell wound repair after 24 
hours (36 ± 9.84% SF-MSC CM
DMEM
 vs. 35 ± 6.57% SF-DMEM (negative control)); 
whereas, SAEC wound repair was enhanced with SF-MSC CM
SABM
 (94 ± 7.59% SF-MSC 
CM
SABM
 vs. 67 ± 6.63% SF-SABM (negative control); p<0.001) (Figure 4.3A, 4.3C) 
(Section- 2.4.2, Section- 2.7.4). 
 
Surprisingly, supplementation of SF-MSC CM
DMEM
 with trace amounts of FBS improved 
the rate of alveolar A549 cell wound repair stimulation (Figure 4.3B) (Section- 2.7.4). A 
maximal effect was observed with the addition of 0.2% FBS in SF-MSC CM
DMEM
 over its 
corresponding control (0.2% FBS supplemented DMEM) (66 ± 7.39% vs. 36 ± 9.48%; 
p<0.001) (Figures 4.3B, 4.3D). The correlation between wound repair rate and increase in 
FBS addition was poor, though consistent, when FBS concentrations of <1% were 
examined. This was noted for both SF-MSC CM
DMEM
 and DMEM (Figure 4.3B). 
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SF-MSC CM
DMEM
 without additional FBS supplementation did not increase the alveolar 
A549 cell wound repair rate. However, when exposed to SF-MSC CM
DMEM
 for 24 hours, 
isolated alveolar A549 cells migrated from their wound margins towards wound gaps with 
an accompanying migratory morphology which was not seen in the control where cells 
were treated with SF-DMEM (Figure 4.4A). Inter-nuclear distances, a measure of 
migration (Atabai et al., 2002, Geiser et al., 2000), in SF-MSC CM
DMEM
 treated alveolar 
A549 cells were significantly higher than that observed in SF-DMEM treated wounded 
A549 cells (44.57 ± 3.66 µm vs. 30.61 ± 3.02 µm; p<0.001) (Figure 4.4B) (Section- 2.8). 
 
Next, I investigated the influences of 0.2% FBS supplementation with SF-MSC CM
DMEM
 
or SF-DMEM on A549 cell proliferation during in vitro wound repair. The MTT assay, an 
established method for determination of cell proliferation (Plumb et al., 1989), 
demonstrated that supplementation of SF-MSC CM
DMEM
 or SF-DMEM with 0.2% FBS did 
not increase alveolar A549 cell proliferation after 24 hours of wound repair; whereas, 
supplementation of 10% FBS with DMEM significantly increased A549 cell proliferation 
in comparison to both SF-DMEM and SF-MSC CM
DMEM
 (p<0.001) (Figure 4.5) (Section- 
2.9). Taken together, serum-free MSC conditioned media alone can stimulate migratory 
behaviour of AEC during attempted wound repair but does not induce sufficient wound 
repair without supplementation of additional co-factor(s) at trace levels. However, SAEC 
wound repair required SF-MSC CM
SABM
 only. These findings demonstrate a phenotype-
dependant and anatomical compartment-specific diverse paracrine response to hMSC 
secretome on distal airway and AEC wound repair where, at least for the AEC, the 
reparative process was accomplished by stimulation of cell migration.  
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On the contrary, serum-free or 0.2% FBS supplemented conditioned media obtained from 
normal human lung fibroblasts CCD-8Lu (CCD-8Lu CM) neither enhanced alveolar A549 
cell wound repair (Figure 4.6A, 4.6C) nor stimulated AEC cell proliferation (Figure 4.6B) 
(Section- 2.4.3, Section- 2.7.4, Section- 2.9). This observation suggests a distinct influence 
of hMSC and normal human lung fibroblasts on alveolar epithelial wound repair in vitro. 
 
4.3.3. hMSC migrate into wounded A549 cell layers in response to injury  
hMSC migration to the site of injury is proposed as an important element of alveolar 
wound repair and regeneration in animal models of pulmonary fibrosis (Rojas et al., 2005). 
To investigate the migratory properties of hMSC, I developed a two-cell direct-contact co-
culture wound repair model (Figure 4.7A) (Section- 2.7.2, Section- 2.7.8.2). In response to 
alveolar A549 cell injury, hMSC migrated into the A549 cell wound and completely closed 
the wound gap (Figure 4.7B and 4.7C). A549 cell wound repair was significantly lower in 
both the negative and positive control than in the A549-MSC direct contact co-culture (28 
± 6.54% negative control (A549 upper PET surface mono-culture in SF-DMEM), 72 ± 
6.90% positive control (AEC upper PET surface mono-culture in 10% FBS DMEM) and 
100% A549-MSC direct-contact in SF-DMEM respectively; p<0.001 vs A549-MSC 
direct-contact) (Figure 4.7C). 
 
Cell migration assessment demonstrated a 5-fold higher hMSC migration into wound gaps 
over the juxta-wound monolayers after 24 hours of direct-contact co-culture (308 ± 13.96 
MSC/field (wound gap) vs. 66 ± 13.44 MSC/field (juxta-wound margin); p<0.001) (Figure 
4.7D) (Section- 2.7.8.2). In the absence of A549 cell, hMSC did not migrate to the contra-
lateral surface of the porous transwell membrane (Figure S4.1, Appendix-2). 
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Figure 4.3: hMSC paracrine stimulation of A549 cell and SAEC wound repair in vitro. 
(A) Alveolar A549 cell (grey bars) and SAEC (black bars) wound repair after 24 hours with SF-
MSC CM
DMEM
 and SF-MSC CM
SABM
 respectively. Negative controls indicates SF-DMEM for 
A549 cell and SF-SABM basal media for SAEC; Positive control indicates DMEM + 10% FBS for 
A549 and SAGM for SAEC. (A549, n = 8 independent experiments; SAEC, n = 6 independent 
experiments, ***p<0.001). (B) A549 cell wound repair after 24 hours with hMSC conditioned 
media and DMEM supplemented with different concentration of FBS (n = 8 independent 
experiments; ***p<0.001 vs DMEM). (C) Inverted light microscopic images of SAEC wound 
repair. (D) Inverted light microscopic images of A549 cell wound repair. Data presented as mean ± 
SD; ns = not significant. Scale bars, 200 µm. 
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Figure 4.4: Assessment of internuclear distance of alveolar A549 cell. 
(A) Representative inverted light microscopic images of alveolar A549 cell wound margins after 24 
hours in SF-DMEM (Negative control), SF-MSC CM
DMEM
 and 10% FBS supplemented DMEM 
(Positive control). Numbers of migrating AEC were observed at the wound margins of SF-MSC 
CM (arrows) and DMEM+10% FBS treated samples. (B) The internuclear distances of A549 cells 
at wound margins after 24 hours; SF-MSC CM
DMEM
 (grey bar), Positive control (DMEM+10% 
FBS) (open bar) and SF-DMEM (black bar) (n = 6 independent experiments). ***p<0.001 vs SF-
DMEM. Data presented as mean ± SD; ns = not significant. Scale bars, 100 µm. 
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Figure 4.5: MTT cell proliferation assay on alveolar A549 cell wound repair with hMSC CM. 
SF-MSC CM (black bar) or MSC CM supplemented with 0.2% FBS (grey bar) did not increase 
A549 cell proliferation comparing corresponding controls SF-DMEM (black bar) and DMEM 
supplemented with 0.2% FBS (grey bar) after 24 hours during in vitro wound repair. Positive 
control was DMEM supplemented with 10% FBS (open bar) which significantly increased A549 
cell proliferation after 24 hours comparing all other samples during wound repair in vitro (n = 4 
independent experiments). ***p<0.001, ns = not significant. 
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Figure 4.6: CCD-8Lu paracrine stimulation of alveolar A549 cell wound repair in vitro. 
(A) A549 cell wound repair after 24 hours with serum-free (SF) (black bar) and 0.2% FBS 
supplemented (grey bar) CCD-8Lu CM. Negative controls represent wound repair with SF-DMEM 
(black bar) and 0.2% FBS supplemented DMEM (grey bar). Positive control represents wound 
repair with 10% FBS supplemented DMEM (black bar = positive control for SF-media treated 
samples; grey bar = positive control for 0.2% FBS supplemented treated samples). (n = 4 
independent experiments). (B) Alveolar A549 cell proliferation (by MTT assay) after 24 hours of 
wounding treated with SF (black bars) and 0.2% FBS supplemented CCD-8Lu CM (grey bars). 
Negative controls represent A549 cell proliferation after 24 hours with SF or 0.2% FBS 
supplemented DMEM and positive control represents A549 cell proliferation with 10% FBS 
supplemented DMEM (open bar). (n = 4 independent experiments). (C) Representative inverted 
light microscopic images of A549 cell wound repair. Negative control = SF-DMEM, Positive 
control = 10% FBS supplemented DMEM. Data presented as mean ± SD. ***p<0.001. ns = not 
significant. Scale bar, 200 µm. 
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Figure 4.7: hMSC migrate to the A549 cell wound sites and close wound gaps. 
(A) Schematic diagram showing two-cell direct-contact co-culture wound repair model using 3 µm 
porous transwell system. (B) Laser scanning confocal micrographs of A549-MSC direct-contact 
co-culture wound repair model at 0 and 24 hours. Red cells are DiI-labelled A549 cells and green 
cells are DiO-labelled hMSC. Horizontal panels are the Z-slicing through the wound gaps and the 
vertical panels are Z-slicing through the corresponding juxta-wound monolayers. Appearance of 
green signals in the same plane of red signals in the in the Z-slice after 24 hours confirms hMSC 
migration to the A549 cell wound site. (C) A549-MSC direct-contact co-culture vs. negative and 
positive controls wound repair. Black and grey bars indicate A549 cell and hMSC contribution to 
repair, respectively. Negative control represents A549 cell wound repair in SF-DMEM in mono-
culture setting on upper surface of transwell PET membrane. Positive control represents A549 cell 
wound repair in 10% FBS supplemented DMEM in mono-culture setting on upper surface of 
transwell PET membrane. (n = 6 independent experiments). (D) hMSC migration in a direct-
contact co-culture wound repair system (n = 6 independent experiments). Data presented as mean ± 
SD. ***p<0.001. Scale bar, 150 µm. 
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4.3.4. Proteins detected in MSC conditioned media show differential wound repair 
potential 
hMSC conditioned media enhanced alveolar A549 cell migration and wound repair (with 
trace FBS supplementation). I hypothesised that candidate molecules within the hMSC 
secretome could enhance alveolar epithelial cell wound repair. To test this hypothesis, I 
first evaluated the composition of the SF-MSC CM
DMEM
 secretome from hMSC isolated 
from three donor independent marrow samples using LC-MS/MS mass spectrometry 
(Table 4.1) (Section- 2.5). The composition of CCD-8Lu CM was also evaluated to 
compare with that of SF-MSC CM
DMEM
 (Table S4.1, Appendix-2). Based on biological 
relevance to epithelial wound repair Fibronectin, Lumican, Periostin, IGFBP-7 and MMP-
2 candidate proteins were chosen from the list of the whole MSC secretome (Table 4.1) to 
evaluate their reparative effects on in vitro AEC wound. My primary target cell type was 
alveolar A549 cell; however, I replicated equivalent experiments on SAEC to compare and 
contrast the wound repair responses to the paracrine stimuli of above mentioned commonly 
identified hMSC-secreted candidate proteins (Table 2.3, 4.1) (Section- 2.7.7). 
 
Fibronectin displayed no effect on alveolar A549 cell wound repair rate when added to 
serum-free medium; however, when supplemented with 0.2% FBS, it significantly 
increased A549 cell wound repair (Figure 4.8A and 4.8C). Fibronectin-induced wound 
repair was maximal at a concentration of 100 ng/ml when compared to the corresponding 
control medium (NC) (51 ± 6.73% vs. 34 ± 6.26% NC (0.2% FBS supplemented DMEM); 
p<0.001) (Figure 4.8A). On the other hand, Fibronectin significantly increased SAEC 
wound repair without an additional serum supplementation requirement (Figure 4.8B and 
4.8D). Fibronectin displayed a maximal wound repair effect on SAEC with a 100 ng/ml 
concentration (73 ± 12.90% vs. 49 ± 8.54% NC (SABM); p<0.05) (Figure 4.8B).  
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Lumican also displayed no effect on A549 cell wound repair in serum-free medium; 
however, when supplemented with 0.2% FBS they significantly increased A549 cell 
wound repair after 24 hours (Figure 4.9A and 4.9C). Lumican displayed maximal A549 
cell wound repair effect at 1 ng/ml concentration (59 ± 9.09% vs. 30 ± 3.55% NC (0.2% 
FBS supplemented DMEM); p<0.001) (Figure 4.9A). Like Fibronectin, Lumican 
significantly increased SAEC wound repair without an additional serum supplementation 
requirement (Figure 4.9B, 4.9D) where it displayed significant wound repair effect at a 
concentration of 100 ng/ml (92 ± 6.55% vs. 54 ± 12.39% NC (SABM); p<0.001) (Figure 
4.9B, 4.9D). However, a significant SAEC wound repair response was observed at a 
minimum concentration of 1ng/ml Lumican (73 ± 11.83% vs. 54 ± 12.39% NC (SABM); 
p<0.01) (Figure 4.9B). 
 
Unlike Fibronectin and Lumican, Periostin significantly enhanced alveolar A549 cell 
wound repair without any additional supplementation where a maximal effect was 
observed with a 100 ng/ml concentration in serum-free medium (50 ± 4.50% vs. 29 ± 
2.43% NC (SF-DMEM); p<0.01) (Figure 4.10A, 4.10C). Periostin also enhanced alveolar 
A549 cell wound repair when supplemented with 0.2% FBS, where a minimum 
concentration of Periostin at 10 ng/ml elicited significant wound repair response (53 ± 
6.48% vs. 32 ± 2.06% NC (0.2% FBS supplemented DMEM); p<0.01) (Figure 4.10A, 
4.10C). A maximum wound repair response, however, observed at a concentration of 1 
µg/ml Periostin when supplemented with 0.2% FBS (61 ± 11.00% vs. 32 ± 2.06% NC 
(0.2% FBS supplemented DMEM); p<0.001) (Figure 4.10A, 4.10C). Periostin also 
enhanced SAEC wound repair in serum-free basal medium (90 ± 5.20% vs. 62 ± 15.97% 
NC (SABM); p<0.05) (Figure 4.10B). 
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On the other hand, IGFBP-7 (Insulin-like growth factor binding protein-7) showed no 
significant effect on A549 cell wound repair (Figure 4.11A); whereas, SAEC wound repair 
was significantly stimulated by all tested concentrations of IGFBP-7 in serum-free basal 
media where a maximum effect was observed with 100 ng/ml concentration (95 ± 3.51% 
vs. 53 ± 13.38% (SABM); p<0.001) (Figure 4.11B, 4.11C). A significant SAEC wound 
repair effect was observed at a minimum concentration of 1 ng/ml IGFBP-7 comparing 
control (85 ± 6.30% vs. 53 ± 13.38% NC (SABM); p<0.01) (Figure 4.11B, 4.11C). 
Gelatinase A (MMP2) had no discernable effect on A549 cell wound repair irrespective of 
the presence of 0.2% FBS in the media (Figure 4.12). 
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Table 4.1: Protein components of SF-MSC CM detected by LC-MS/MS mass spectrometry. 
SF-MSC CM preparation was as described in Section- 2.4.2, 2.5. Proteins selected for 
investigations in wound repair and migration are indicated in bold. Accession numbers are derived 
from MS/MS data searches against non-redundant Human NCBI Protein Database. Average 
peptide count from 3 biologically independent replicates of hMSC secretome profiles. 
 
Protein name Accession number Peptide count 
Fibronectin 1, isoform CRA gi|119590945 39.0 
Collagen alpha-2(I) chain gi|124056488 30.0 
Collagen alpha 1 chain precursor variant gi|62088774 23.5 
Pro alpha 1(I) collagen gi|186893270 23.5 
Alpha 1 (I) chain propeptide gi|180392 21.3 
Collagen, type VI, alpha 1 precursor gi|87196339 11.0 
Precursor polypeptide (AA -31 to 1139) gi|37465 7.5 
Actin, gamma 1 propeptide gi|4501887 7.0 
Gelatinase A  gi|5822007 6.7 
Keratin 1 gi|7331218 6.5 
Tumor necrosis factor gi|339992 6.3 
Osteoblast specific factor 2 (Periostin) gi|393319 6.0 
Chain A, Crystal Structure Of The Thrombospondin-1  gi|88191917 5.5 
Biglycan gi|179433 4.7 
Lumican gi|642534 4.7 
Collagen alpha 1(V) chain precursor gi|219510 4.5 
Insulin-like growth factor binding protein 7 gi|119625925 4.5 
CALU gi|49456627 4.0 
Thrombospondin 2 precursor gi|40317628 4.0 
Fructose-bisphosphate aldolase A gi|4557305 3.5 
Heparan sulfate proteoglycan gi|184427 3.5 
Pigment epithelium-derived factor gi|1144299 3.5 
Profilin Binds Proline gi|5822002 3.0 
Protein disulfide isomerase gi|860986 3.0 
Versican isoform 3 precursor gi|255918077 3.0 
Decorin gi|181519 2.7 
The Antigenic Identity Of Peptide(Slash)mhc Complexes gi|442989 2.5 
COL1A1 and PDGFB fusion transcript gi|3288487 2.5 
Peptidylprolyl isomerase A gi|10863927 2.5 
Fibrillin gi|306746 2.0 
Similar to cardiac leiomodin gi|51095092 2.0 
Solution Structure Of Calcium-Calmodulin N-Terminal 
Domain 
gi|16974825 1.7 
Myosin, light chain 6, alkali, smooth muscle and non-
muscle isoform 1 
gi|17986258 1.5 
Protein disulfide-isomerase A3 gi|729433 1.5 
Insulin-like growth factor binding protein 6 gi|183894 1.0 
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Figure 4.8: Alveolar A549 cell and SAEC wound repair assay with Fibronectin. 
(A) Alveolar A549 cell wound repair after 24 hours with recombinant human plasma Fibronectin in 
serum-free condition (open bars) and with 0.2% FBS supplementation (black bars) (n = 6 
independent experiments). Negative control (NC) and Positive control (PC) indicate wound repair 
with SF-DMEM and DMEM + 10% FBS respectively. (B) SAEC wound repair after 24 hours with 
recombinant human plasma Fibronectin in SF-SABM (grey bar). Negative control (NC) (black bar) 
and Positive control (PC) (open bar) indicate wound repair with SF-SABM and SAGM 
respectively. (n = 6 independent experiments). (C) Inverted light microscopic images of alveolar 
A549 cell wound repair with 100 ng/ml Fibronectin (FN) in 0.2% FBS supplemented media. (D) 
Inverted light microscopic images of SAEC wound repair with 100 ng/ml Fibronectin (FN) in 
serum-free SABM. Data presented as mean ± SD. *p<0.05, **p<0.01, ***p<0.001. ns = not 
significant. Scale bar, 200 µm. 
Chapter 4:             hMSC-mediated alveolar & small airway epithelial wound repair 
PhD thesis by K. M. Akram                                                                    Keele University - 182 - 
 
 
Figure 4.9: Alveolar A549 cell and SAEC wound repair assay with Lumican. 
(A) Alveolar A549 cell wound repair after 24 hours with recombinant human Lumican in serum-
free condition (open bars) and with 0.2% FBS supplementation (black bars). Negative control (NC) 
and Positive control (PC) indicate wound repair with SF-DMEM and DMEM + 10% FBS 
respectively. (n = 3 independent experiments, 3 replicates per n). (B) SAEC wound repair after 24 
hours with recombinant human Lumican. Negative control (NC) (black bar) and Positive control 
(PC) (open bar) indicate wound repair with SF-SABM and SAGM respectively. (n = 3 independent 
experiments, duplicate per n). (C) Inverted light microscopic images of alveolar A549 cell wound 
repair with 1 ng/ml Lumican (Lum) in 0.2% FBS supplemented media. (D) Inverted light 
microscopic images of SAEC wound repair with 100 ng/ml Lumican (Lum) in serum-free SABM. 
Data presented as mean ± SD. **p<0.01, ***p<0.001. ns = not significant. Scale bar, 200 µm. 
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Figure 4.10: Alveolar A549 cell and SAEC wound repair assay with Periostin. 
(A) Alveolar A549 cell wound repair after 24 hours with recombinant human Periostin in serum-
free condition (open bars) and with 0.2% FBS supplementation (black bars). Negative control (NC) 
and Positive control (PC) indicate wound repair with SF-DMEM and DMEM + 10% FBS 
respectively. (n = 4, ≥2 replicates per n, $p<0.001 vs corresponding serum-free NC). (B) SAEC 
wound repair after 24 hours with recombinant human Periostin in SF-SABM. Negative control 
(NC) (black bar) and Positive control (PC) (open bar) indicate wound repair with SF-SABM and 
SAGM respectively. (n = 6 independent experiments). (C) Inverted light microscopic images of 
alveolar A549 cell wound repair with 100 ng/ml Periostin in serum-free and 0.2% FBS 
supplemented media. Data presented as mean ± SD. *p<0.05, **p<0.01, ***p<0.001. ns = not 
significant. Scale bar, 200 µm. 
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Figure 4.11: Alveolar A549 cell and SAEC wound repair assay with IGFBP-7. 
(A) Alveolar A549 cell wound repair after 24 hours with recombinant human IGFBP-7 in serum-
free (open bars) and with 0.2% FBS supplementation (black bars). Negative control (NC) and 
Positive control (PC) indicate wound repair with SF-DMEM and DMEM + 10% FBS respectively. 
(n = 3 independent experiments, 3 replicates per n; *p<0.001 vs 0.2% FBS supplemented NC, 
$
p<0.001 vs serum-free NC). (B) SAEC wound repair after 24 hours with recombinant human 
IGFBP-7 in SF-SABM. Negative control (NC) (black bar) and Positive control (PC) (open bar) 
indicate wound repair with SF-SABM and SAGM respectively. (n = 6 independent experiments; 
**p<0.01, ***p<0.001). (C) Inverted light microscopic images of SAEC wound repair with 100 
ng/ml IGFBP-7 in serum-free SABM. Data presented as mean ± SD. ns = not significant. Scale bar, 
200 µm. 
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Figure 4.12: Alveolar A549 cell wound repair assay with Gelatinase A. 
Alveolar A549 cell wound repair after 24 hours with recombinant human Gelatinase A (MMP-2) in 
serum-free (open bars) and with 0.2% FBS supplementation (black bars). Negative control (NC) 
and Positive control (PC) indicate wound repair with SF-DMEM and DMEM + 10% FBS 
respectively. (n = 3 independent experiments). Data presented as mean ± SD. *p<0.001 vs 0.2% 
FBS supplemented NC, $p<0.001 vs serum-free NC. 
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4.3.5. Fibronectin, Lumican and Periostin-mediated alveolar A549 cell wound repair 
occurs through cell migration 
Earlier, I demonstrated that Fibronectin and Lumican required 0.2% FBS to stimulate 
A549 cell wound repair; whereas, Periostin enhanced wound repair in serum-free 
condition. Here, by performing the MTT assay, I investigated whether this observed 
wound repair was driven by cell proliferation or migration (Section 2.9). The MTT data 
showed that none of the tested candidate proteins (Fibronectin, 100 ng/ml; Lumican, 1 
ng/ml; Periostin, 100 ng/ml; IGFBP-7, 100 ng/ml) increased A549 cell proliferation after 
24 hours during wound repair (Figure 4.13). In addition, supplementation of 0.2% FBS 
with the candidate proteins also did not show any significant effect on cell proliferation 
(Figure 4.13). However, the A549 cell proliferation was significantly higher in positive 
control (PC) when compared with negative control and all other groups (p<0.05 vs. all 
other groups) (Figure 4.13). In this assessment, the tested dose of individual protein was 
the effective wound repair dose that was determined in previous separate experiment 
(Section 4.3.4). Taken together, it concludes that Fibronectin, Lumican and Periostin 
stimulate alveolar epithelial wound repair through cell migration but not by cell 
proliferation. 
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Figure 4.13: MTT cell proliferation assay on A549 cell wound repair with candidate proteins. 
Recombinant human proteins Fibronectin, Lumican, Periostin and IGFBP-7 did not stimulate A549 
cell proliferation in serum free (black bars) or in 0.2% FBS supplemented media (grey bars) after 
24 hours of wound repair. NC (Negative control) represents serum-free (black bar) or 0.2% FBS 
supplemented (grey bar) DMEM treated sample. PC (Positive control) was DMEM supplemented 
with 10% FBS (open bar) treated sample that significantly increased A549 cell proliferation after 
24 hours of wounding comparing all other samples (n = 3 independent experiments). Data 
presented as mean ± SD. *p<0.05 vs all other groups, ns=not significant. 
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4.3.6. Periostin and Lumican display a significant correlation in alveolar epithelial 
cell and SAEC wound repair response 
The correlation between concentrations of the above tested proteins and their wound repair 
responses were evaluated by non-parametric Spearman correlation coefficient assessment 
(Moine et al., 1997, Park et al., 2011) (Section- 2.14). Periostin enhanced alveolar A549 
cell wound repair in both serum-free and 0.2% FBS supplemented media; however, a 
strong correlation between the concentrations and wound repair rate was observed when 
this protein was applied in 0.2% FBS supplemented media (Spearman correlation 
coefficient, r = 1.000; p=0.016) (Figure 4.14A; Table 4.2). Periostin also showed a strong 
correlation with SAEC wound repair in serum-free basal medium (Spearman r = 0.9747; 
p=0.0176) (Figure 4.14B; Table 4.2). 
 
A strong correlation between Lumican and its wound repair effect on SAEC was noted 
(Spearman r = 0.9747; p=0.0167) (Figure 4.14C; Table 4.2). However, although 
Fibronectin and Lumican displayed a critical optimal concentration for maximal A549 cell 
wound repair response, no significant concentration-response correlation was established; 
similarly, Fibronectin failed to show the significant correlation on SAEC wound repair 
(Table 4.2). IGFBP-7 displayed significant SAEC wound repair across all tested 
concentrations (1 ng/ml to 1µg/ml) (Figure 4.11B) without any demonstrable correlation 
(Table 4.2). 
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Figure 4.14: Correlation effects of proteins on wound repair rate. 
(A) Correlation between Periostin concentrations and A549 cell wound repair responses in 0.2% 
FBS supplemented DMEM. Spearman correlation coefficient, r = 1.000; p=0.016. (B) Correlation 
between Periostin concentrations and SAEC wound repair responses. Spearman r = 0.9747; 
p=0.0176. (C) Correlation between Lumican concentrations and SAEC wound repair responses. 
Spearman r = 0.9747; p=0.0167. Data are plotted on logarithmic-logarithmic scale to allow better 
representation. 
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Table 4.2: Determination of correlation coefficient between recombinant human protein 
treatment and in vitro wound repair responses of alveolar A549 and SAEC wounds. 
A549 SAEC wound repair were performed in 0.2% FBS supplemented DMEM and serum-free 
SABM. Correlation coefficient was determined by non-parametric Spearman analysis. 
 
Protein Cell type Spearman ‘r’ P value Is correlation significant 
Fibronectin 
A549 0.2000 0.7139 No 
SAEC -0.4000 0.5167 No 
Lumican 
A549 0.0000 1.0500 No 
SAEC 0.9747 0.0167 Yes 
Periostin 
A549 1.0000 0.0167 Yes 
SAEC 0.9747 0.0167 Yes 
IGFBP-7 
A549 N/A N/A N/A 
SAEC 0.8000 0.1333 No 
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4.3.7. Fibronectin and Lumican but not Periostin stimulate alveolar A549 cell 
migration as substrate components 
Fibronectin, Lumican and Periostin induced alveolar A549 cell wound repair when 
delivered as a culture medium supplement. As these proteins are abundant within the 
ECM, I hypothesised that these proteins could influence A549 cell migration as substrate 
components. Immediate relevance to fibrotic lung disease is evidenced by the abrogation 
of effective AEC migration over denuded alveolar epithelium. To test this hypothesis, I 
developed a „collagen drop‟ cell migration assay, where an aggregated population of 
alveolar A549 cells were resuspended in a drop of collagen which was „dropped‟ onto a 
culture surface coated with Fibronectin, Lumican, or Periostin (Section- 2.13) (Figure 
2.13). To provide an additional „positive‟ bias to A549 cell migration, the collagen drop 
contained 0.2% FBS whereas the external serum concentration was 20% (Figure 2.13). 
 
Optimal cell migration was observed on either Fibronectin or Lumican coated surfaces at a 
concentration of 10 ng/ml (Fibronectin 28 ± 11.10 cells/mm vs. 7 ± 1.52 cells/mm 
(uncoated surface), p<0.001; Lumican 31 ± 6.85 cells/mm vs. 6 ± 1.38 cells/mm (uncoated 
surface), p<0.001) (Figure 4.15A, 4.15B, 4.15C, 4.15F). On the other hand, Periostin did 
not stimulate A549 cell migration (Figure 4.15A, 4.15D). Taken together, this data 
indicates that Fibronectin and Lumican stimulate alveolar A549 cell wound repair as both 
soluble factors and as a substrate component; whereas, Periostin stimulates A549 cell 
wound repair as a soluble factor only. 
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Figure 4.15: Collagen drop alveolar A549 cell migration assay 
(A) Fibronectin and Lumican coating at various concentration stimulate alveolar A549 cell migration 
(Fibronectin, n = 3 independent experiments; Lumican, n = 6 independent experiments). Periostin 
coating did not stimulate A549 cell migration (n = 6 independent experiments). (B, C, D) Inverted light 
microscopic images of A549 cell migration across the collagen-drop barrier on protein coated surfaces. 
(E, F) Enlarged images of cell migration on Fibronectin coated surface at 0 hr and 24 hrs respectively 
showing impression of cells in collagen (arrows). Data presented as mean ± SD. ***p<0.001. Scale bar, 
250 µm. 
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4.4. Discussion 
Human mesenchymal stem cells are in current clinical trials for diseases including 
osteogenesis imperfecta, graft-versus-host disease, chronic ischemic heart disease, and 
chronic obstructive pulmonary disease (www.clinicaltrials.gov) and are the focus of many 
other clinical applications. Studies on animal pulmonary fibrosis models demonstrate that 
intravenous and endotracheal administration of MSC attenuate lung injury and fibrosis 
suggesting a potential clinical application of MSC for the treatment of IPF (Rojas et al., 
2005, Ortiz et al., 2003, Moodley et al., 2009). However, the mechanism of MSC-mediated 
amelioration of pulmonary fibrosis is not clear and an active participation of MSC through 
differentiation into AEC and lung regeneration is under debate (Ortiz et al., 2003, 
Neuringer & Randell, 2006). Bleomycin-induced mouse lung fibrosis models have 
demonstrated an MSC-stimulated reduction in pulmonary fibrosis via inhibition of pro-
fibrotic cytokines TNF-α and IL-1 through a paracrine mechanism (Ortiz et al., 2007). 
Furthermore, rat models of pulmonary emphysema demonstrated that MSC reduce AEC 
apoptosis through paracrine mechanism via up-regulation of anti-apoptotic Bcl-2 gene 
(Zhen et al., 2008). Here, I demonstrate that in response to injury hMSC display site-
specific migration into alveolar epithelial wounds and that in response to SF-MSC CM 
migration and wound repair (A549 cell and SAEC) occur with distinct trace serum 
augmentation requirements. I also provide evidence supporting specific hMSC-secreted 
paracrine components for effective alveolar and small airway epithelial wound repair. 
 
hMSC secrete a myriad of proteins that include growth factors, cytokines and ECM 
proteins (Chen et al., 2008a, Estrada et al., 2009). Many of these secretory proteins are 
biologically active with anti-inflammatory, anti-fibrotic and immunomodulatory functions 
(Meirelles et al., 2009, Nauta & Fibbe, 2007). Previous and current studies are mostly 
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focused on evaluation of MSC-secreted growth factors and their effects on tissue repair. 
Here, in line with others, my mass spectrometry-mediated hMSC secretome analyses 
indicate the presence of a high abundance of ECM/matricellular protein components with 
diverse biological activities on wound healing and tissue repair (Estrada et al., 2009, 
Walter et al., 2010). Fibronectin (a multifunctional glycoprotein), Lumican (collagen-
binding keratin sulfate proteoglycan), Periostin (matricellular N-glycoprotein), and IGFBP-
7 (IGF-I, -II low affinity binding protein) were identified as major components of SF-MSC 
CM through high peptide counts and ion score confidence intervals (Table 4.1). Data 
supportive of a role for these factors in alveolar wound repair is relatively scarce though 
implied in previous studies. Fibronectin up-regulation is implicated in abdominal wall, 
corneal, and skin in vivo and ex vivo wound repair and migration where values ranging 
from 100 ng/ml to 60µg/ml of Fibronectin have been evaluated (Fujikawa et al., 1981, 
Grinnell et al., 1981, Nishida et al., 1983, Cheng et al., 1988, Kwon et al., 2007). In vitro 
models including corneal epithelial cells, corneal fibroblasts, keratinocyte, dermal 
fibroblast, nasal airway epithelial cells, gingival fibroblast, and SAEC have further 
demonstrated that fibronectin stimulated wound repair and cell migration as either soluble 
factor or substrate component frequently through integrin signaling activation (Dean & 
Blankenship, 1997, Herard et al., 1996, Hocking & Chang, 2003, Nishida et al., 1992, 
Schmidinger et al., 2003, Yamada, 2000). 
 
Lumican, a small leucine-rich proteoglycan (SLRP) family member, is a major component 
of the proteoglycan-based ECM. Lumican displays a heterogeneous, diffuse, staining 
profile in the alveolar walls and peripheral regions of adult human lung and its sub-
epithelial deposition is implicated in airway remodeling and counteracting the severity of 
asthma (Dolhnikoff et al., 1998, Pini et al., 2007). In vivo and ex vivo studies indicate that 
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Lumican is essential for corneal epithelial cell, skin, and oral mucosa wound repair and 
promotion of chemotactic migration (Honardoust et al., 2008, Lee et al., 2009b, Saika et 
al., 2000, Yeh et al., 2010). In vitro migration and wound healing of corneal epithelial cells 
was also induced by Lumican (Seomun & Joo, 2008, Yeh et al., 2005). Circulating plasma 
and cellular Fibronectin concentrations (300 µg/ml and 2.46 µg/ml, respectively) are 
substantially in excess of those required to induce wound repair and migration in my, and 
previously described (see above), in vitro models; whereas, physiological levels of 
Lumican are yet to be defined (Ylatupa et al., 1995). In support and extension of these 
previous reports, I have now demonstrated that both Fibronectin and Lumican facilitated 
alveolar A549 cell and SAEC wound repair as soluble factors (with trace serum 
supplementation for A549 cell only) and migration of A549 cells as a substrate component. 
 
Periostin (or OSF-2, Osteoblast Specific Factor-2) is a matricellular protein with a poorly 
defined role in wound repair and a physiological serum level of approximately 39 ng/ml 
(Hamilton, 2008, Okamoto et al., 2011). In vivo studies revealed an association of Periostin 
with fracture healing, wound-derived blood vessels, acute myocardial infarction response, 
skin wounds, and ligament repair (Chamberlain et al., 2011, Jackson-Boeters et al., 2009, 
Nakazawa et al., 2004, Nishiyama et al., 2011, Shimazaki et al., 2008, Zhou et al., 2010). 
In addition to those above, low levels of Periostin expression are common in normal lung 
while high levels of Periostin are detected in IPF lungs and patient serum, although the role 
of this protein in the pathogenesis of lung fibrosis has not been clarified (Okamoto et al., 
2011). A relationship between Periostin and wound repair across multiple tissues is 
immediately apparent though little is known, at this time, of mechanism of action. A 
solitary report describes exogenous overexpression of Periostin in A549 cells, as used in 
our study, which enhanced both proliferation and migration in routine culture (Hong et al., 
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2010). I have, herein, reported that Periostin has a role in alveolar A549 cell and SAEC 
wound repair and migration as a soluble factor and identified a putative hMSC source of 
wound associated Periostin. 
 
IGFBP-7 (also known as IGFBP-rP1) is an IGFBP-related protein (IGFBP-rPs) 
superfamily member. IGFBP-rPs have less binding affinity to IGF (insulin growth factor) 
and are involved in diverse biological activities in an IGF-independent manner (Hwa et al., 
1999). IGFBP-rP2 (CTGF, connective tissue growth factor), another IGFBP-rP family 
member, plays a critical role during fibrogenesis in IPF (Allen et al., 1999, Pan et al., 
2001). However, the role of IGFBP-7, which has a normal serum concentration of 33 
ng/ml (Kutsukake et al., 2008), in pulmonary fibrosis is unknown. IGFBP-7 is up-regulated 
in the fibrotic regions of IPF lung tissue as well as in isolated IPF fibroblasts though absent 
from controls (Hsu et al., 2011). Here, I have demonstrated that recombinant human 
IGFBP-7 significantly increased human primary SAEC wound repair when applied in 
serum-free basal media; whereas, alveolar A549 cells were non-responsive to this protein. 
The mechanism behind these divergent responses remains to be clarified. The development 
of transferable and accessible primary human AEC cultures (which replicate in vivo 
characteristics; i.e. monolayer formation) will be necessary before clarification can be 
achieved. However, at this time I cannot preclude the possibility that the distinct response 
is due tissue source or phenotypic background of the AEC and SAEC used in this study. 
However, this distinction in response provides strong support for broad therapeutic 
applicability across multiple clinical applications for the hMSC secretome. 
Characterization of these cell-specific responses will underpin the continuing development 
of the stem cell-driven regenerative medicine industry. 
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The protein composition of ECM is variable, tissue specific, and provides essential 
scaffold and biochemical signals required for cell growth, tissue homeostasis, development 
and wound repair (Hamilton, 2008, Frantz et al., 2010). My in vitro alveolar A549 cell 
wound repair data encouraged us to investigate the substrate roles of Fibronectin, Lumican 
and Periostin on A549 cell migration. The in vitro scratch wound repair system is not 
suitable to test the effectiveness of individual substrate components as the wounding 
process would disrupt the protein coating. Therefore, I developed a novel „collagen drop‟ 
cell migration assay to evaluate individual substrate component capacity to support or 
inhibit migration (Section- 2.13). Normal basement membrane architecture provides a 
favourable substrate for AEC migration; whereas, disrupted alveolar basement membrane 
and aberrant ECM remodeling play a crucial role in the abrogation of alveolar re-
epithelialisation in pulmonary fibrosis (Selman et al., 2001). Data from my „collagen drop‟ 
cell migration assay has identified that both Fibronectin and Lumican are supportive of cell 
migration as substrate component. This has potential implications in strategy development 
to address repair of the disrupted alveolar basement membrane in pulmonary fibrosis. 
 
These data provide insight into potential hMSC paracrine influences on epithelial wound 
repair during alveolar injury repair. Aberrant alveolar re-epithelialisation is believed to be 
one of the major contributing factors for uncontrolled fibrogenesis in IPF (Selman et al., 
2001). Therefore, stimulation of re-epithelialisation within the alveolar regions could be a 
potential active vector for alleviation of the pro-fibrogenic processes as a curative 
therapeutic measure for IPF. Previous animal model-based studies demonstrated that MSC-
paracrine factors attenuate pulmonary fibrosis through modulation of inflammation, 
suppression of fibrogenesis and stimulation of angiogenesis (Ortiz et al., 2007, Chen et al., 
2008a, Estrada et al., 2009, Moodley et al., 2009). Here, I have demonstrated the 
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efficacious influence of the hMSC secretome in the modulation of alveolar and small 
airway epithelial cell dynamics resulting in stimulation of wound repair. In-depth 
understanding of the humoral mechanisms of hMSC in epithelial wound repair and 
regeneration will provide extended therapeutic options for clinical application of hMSC or 
their secretory products for fibrotic lung diseases, such as IPF. 
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Chapter 5 
 
Activin-directed differentiation of hESC enhances 
alveolar epithelial wound repair via distinct paracrine 
mechanisms in vitro 
Chapter 5:                                         hESC-mediated alveolar epithelial wound repair 
PhD thesis by K. M. Akram                                                                    Keele University - 200 - 
5.1. Background 
Embryonic stem cells (ESC) are self-renewing pluripotent stem cells derived from the 
inner cell mass of a 5-6 day-old blastocyst of an early mammalian embryo and are capable 
of unlimited, undifferentiated proliferation in vitro. Unlike adult stem cells, ESC are 
capable of differentiating into tissues of all three germ layers (Evans & Kaufman, 1981, 
Kaufman et al., 1983) (Martin, 1981). Pluripotent hESC lines express a set of antigens 
including SSEA-3, SSEA-4, TRA-1-60, TRA-1-81, the enzyme alkaline phosphatase 
(ALP), transcription factors Oct-4 and Nanog, and display high levels of telomerase 
activity (Thomson et al., 1998, Reubinoff et al., 2000, Henderson et al., 2002, Laslett et al., 
2003).  
 
hESC lines maintain a pluripotent differentiation potential enabling formation of cell types 
representative of all three embryonic germ layers. The pluripotency of hESC is 
demonstrated in vivo through teratoma development after injection into the SCID (severe 
combined immunodeficient) mice (Thomson et al., 1998). Teratoma is a germ layer benign 
tumour comprised of endodermal derivatives, such as gut epithelium; mesodermal 
derivatives, such as bone, cartilage, smooth muscle, striated muscle and ectodermal 
derivatives such as neural epithelium, embryonic ganglia, and stratified squamous 
epithelium (Thomson et al., 1998). Embryonic stem cells also can differentiate into 
derivatives of all three germ layers when allowed to undergo spontaneous differentiation in 
in vitro culture, either as adherent monolayer or EB suspension culture (Itskovitz-Eldor et 
al., 2000, Heo et al., 2005). However, differentiation of ESC into definitive ectodermal, 
mesodermal and endodermal lineages is difficult. Successful derivation of cardiomyocytes 
or neuronal cells from ESC has already been described (Mummery et al., 2002, Mummery 
et al., 2003, Ying et al., 2003, Shin et al., 2005, Abranches et al., 2009). Meanwhile, 
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definitive endodermal lineage differentiation has appeared to be more challenging and the 
protocols are currently evolving. The definitive endoderm forms during gastrulation, in 
which pluripotent epiblast cells are localised to the three principle embryonic germ layers- 
ectoderm, mesoderm and definitive endoderm. The definitive endoderm gives rise to the 
epithelium of lung, intestine, liver, pancreas, thyroid glands and thymus (D'Amour et al., 
2005) (Figure 5.1). 
 
 
 
 
Figure 5.1: ESC differentiation into ectodermal, mesodermal and endodermal derivatives. 
Wnt, BMP and Activin inhibit ectodermal differentiation from primitive ectoderm. High 
concentrations of Activin or Nodal directs definitive endodermal differentiation; whereas, low 
concentrations of Activin directs mesodermal differentiation from brachyury-expressing cells of 
primitive streak. BMP4 is shown can induce posterior mesoderm and skin. FGF is involved in 
neural induction (Modified from Keller, 2005). 
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Serum plays a critical role in endodermal differentiation of ESC during in vitro culture. 
Restricted exposure of EBs to serum followed by serum-free culture enhances endodermal 
differentiation and suppresses development of mesodermal derivatives within the EBs 
(Kubo et al., 2004). Work performed on mouse ESC demonstrated that stimulation of EBs 
with serum for 2.5 days followed by a serum-free culture for further 3.5 days increased 
expression of endodermal genes, Foxa2 and Sox17 and simultaneously decreased 
expression of mesodermal gene, Gata1 and brachyury; whereas, continuous exposure of 
EBs to serum reduced endodermal gene expression (Kubo et al., 2004). Activin A has also 
been suggested to have a strong role in directing differentiation of hESC into definitive 
endoderm (D'Amour et al., 2005, Kubo et al., 2004, McLean et al., 2007). 
 
Activin A, a member of the TGF-β super-family, has a dual role in ESC differentiation. 
Different concentrations of Activin A induce different developmental programs in EB. 
High concentrations stimulate an endodermal differentiation programme and low 
concentration stimulate mesodermal differentiation (Kubo et al., 2004) (Figure 5.1). 
Differentiation of mouse ESC in EB culture with Activin A at a concentration of 100 ng/ml 
in a serum-free condition significantly increased expression of definitive endodermal 
genes, Foxa2 and Sox17 where more than 50% of differentiated EB cell population 
expressed the Foxa2 protein. On the other hand, when EBs were differentiated with 1-3 
ng/ml concentration of Activin A, expression of mesodermal gene brachyury was high and 
Foxa2 and Sox17 were undetectable (Kubo et al., 2004). In addition, high concentrations of 
Activin completely suppressed expression of neuroectoderm-specific gene Pax6 (Kubo et 
al., 2004). The generation of endodermal derivatives from ESC has been demonstrated 
through differentiation of pancreatic islets (Colman, 2004, Stoffel et al., 2004), hepatocytes 
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(Hamazaki et al., 2001, Jones et al., 2002, Yamada et al., 2002a), intestinal cells (Yamada 
et al., 2002b) and lung epithelial cells (Ali et al., 2002, Rippon et al., 2006). 
 
ESCs have been suggested as a suitable tool for application in regenerative cell therapy for 
lung repair and regeneration due to their differentiation potential into lung epithelial cells 
(Weiss & Finck, 2010). For IPF, ESC could be utilised to replace damaged AEC to 
facilitate alveolar wound repair. Type II AEC have been successfully differentiated from 
human (Wang et al., 2007) and mouse (Ali et al., 2002, Rippon et al., 2006, Roszell et al., 
2009) ESC. More recently, Wang and colleagues have demonstrated that intratracheal 
administration of ESC-derived type II AEC improved survival and ameliorated pulmonary 
inflammation and fibrosis in a bleomycin-induced experimental lung injury model (Wang 
et al., 2010). In this study, structural engraftment of transplanted ESC-derived type II AEC 
and their differentiation into type I AEC were also noted (Wang et al., 2010). However, 
attenuation of bleomycin-induced fibrotic responses occurred as early as 24 to 48 hours 
post ESC-derived type II AEC administration which indicated a putative paracrine 
mechanism involved in the amelioration of pulmonary fibrosis. The notion of a paracrine 
influence of stem cells in the repair of lung injury has been widely demonstrated utilising 
adult stem cells such as MSC and HSC, as discussed in chapter 4. However, data 
supportive of an ESC-paracrine influence in lung injury repair is limited. The current 
hypothesis suggests that failure or delay of alveolar re-epithelialisation following injury 
plays a major role in propagation of fibrogenesis in IPF (Selman et al., 2001). Thereby, 
stimulation of an alveolar re-epithelialisation process by stem cells or their secretory 
product(s) could have potential clinical benefits in the development of novel regenerative 
therapies for IPF where efficacious treatment is currently absent. 
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5.1.1. Aim of this study 
The primary objective of this study was to explore the paracrine effects of hESC on 
alveolar epithelial cell wound repair. 
 
5.2. Study design 
The in vitro scratch wound repair system was implemented to test the paracrine influences 
of undifferentiated and differentiated hESC on alveolar A549 cell wound repair as 
described in Section- 2.7.6 (See Chart 5.1). Conditioned media (CM) was obtained from 
the undifferentiated adherent culture of hESC cell line SHEF-2 (Section- 2.4.4.1). To 
collect CM from differentiated hESC, SHEF-2 cells were differentiated with Activin A 
(Section- 2.4.4.2). CM was collected during various time points (stages) of differentiation. 
Collected CM from undifferentiated and differentiated hESC were tested on A549 cell 
wound repair (Section- 2.7.6). To determine whether the A549 cell wound repair occurred 
due to the stimulation of cell proliferation or migration or both, the internuclear distances 
between A549 cells at wound margin was measured (Section- 2.8), and MTT cell 
proliferation assay was performed (Section- 2.9). hESC differentiation was confirmed by 
the evaluation of lineage-specific gene expression by RT-PCR (Section- 2.11) and 
pluripotent marker protein expression by immunocytochemistry (Section- 2.12.5). LC-
MS/MS mass spectrometry analysis was performed to identify the secretory proteins of 
differentiated hESC (Section- 2.5). The experimental data was analysed using the Excel 
programme of Microsoft Office XP. The statistical analysis was performed using the 
software GraphPad Prism v5.00 (Section- 2.14). A conclusion was drawn according to the 
outcome of the experimental results (See Chart 5.1). 
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Chart 5.1: Experimental plan flowchart. 
Evaluation of paracrine influence of hESC 
on alveolar A549 cell wound repair 
CM collection from undifferentiated 
hESC adherent culture 
Section- 2.4.4.1 
Testing of CM on in vitro 
wound repair system 
Section- 2.7.6 
hESC differentiation with 
Activin A through EB culture 
Section- 2.4.4.2 
Collection of CM at different time-
points during hESC differentiation 
Section- 2.4.4.2 
Testing of CM on in vitro 
wound repair system 
Section- 2.7.6 
Processing of CM for 
secretome analysis 
Section- 2.5 
Wound repair by 
cell migration? 
Wound repair by 
cell proliferation? 
Secretome analysis 
by LC-MS/MS 
Section- 2.5 
Measurement of 
internuclear distances  
Section- 2.8 
MTT cell 
proliferation assay  
Section- 2.9 
Result analysis and conclusion generation 
Undifferentiated 
hESC 
Differentiated 
hESC 
Chapter 5:                                         hESC-mediated alveolar epithelial wound repair 
PhD thesis by K. M. Akram                                                                    Keele University - 206 - 
5.3. Results 
5.3.1. SHEF-2 cell line retains the hESC criteria 
hESC cell line SHEF-2 was utilised for my experiments and cultured in a feeder-free, 
culture condition using MEFs-CM media following the established protocol described in 
the Section- 2.2.4 (Xu et al., 2001). SHEF-2 cells readily formed distinct colonies in 
adherent culture and were capable of forming EBs in suspension culture, which are 
described as the specific morphological criteria of human embryonic stem cells (Thomson 
et al., 1998) (Figure 5.2A, 5.2C). SHEF-2 cells had a high nucleus to cytoplasm ratio and 
prominent nucleoli (Figure 5.2B). Throughout the culture period, SHEF-2 cells grew in a 
steady manner and did not show any apparent sign of senescence. SHEF-2 cells displayed 
high levels of hTERT gene expression as detected by RT-PCR (Figure 5.2D) (Section- 
2.11), a common criterion for hESC (Thomson et al., 1998). Cells were also positive for 
pluripotent nuclear markers Octamer-binding protein-4 (Oct-4) (also know as POU 
domain, class 5, transcription factor 1, POU5F1) and Nanog (also know as Homeobox 
protein NANOG) again detected by RT-PCR (Figure 5.2D) and immunocytochemistry 
(Figure 5.3) (Section- 2.12.4) (Reubinoff et al., 2000, Chambers et al., 2003, Mitsui et al., 
2003). SHEF-2 cells were highly positive for alkaline phosphatase (ALP) and stage-
specific embryonic antigen-4 (SSEA-4) markers and negative for SSEA-1 (Thomson et al., 
1998, Reubinoff et al., 2000).  
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Figure 5.2: Pluripotent ESC criteria of SHEF-2 cell line. 
Inverted light microscopic images show (A) SHEF-2 colonies on matrigel coated culture surfaces 
in adherent culture (100X magnification), (B) High ratio of nucleus to cytoplasm with prominent 
nucleoli (400X magnification) and (C) Formation of EB in suspension culture (400X 
magnification). (D) mRNA expression for Oct-4, Nanog and hTERT was detected in hESC cell 
line, SHEF-2 by RT-PCR. β-actin was run as a house-keeping gene. Scale bar, 100 µm.  
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Figure 5.3: hESC Pluripotent markers profile in SHEF-2 detected by immunocytochemistry. 
SHEF-2 cells were positive for ALP, Oct-4, Nanog and SSEA-4 and negative for SSEA-1. Nuclear 
counter staining with DAPI. Scale bar, 100 µm. 
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5.3.2. Undifferentiated hESC secretome inhibits alveolar A549 cell wound repair 
To investigate the effect of secretory factors of undifferentiated hESC on A549 cell wound 
repair, I prepared conditioned media (CM) from adherent cultures of undifferentiated 
SHEF-2 cells (Section- 2.4.4.1) and tested these with the in vitro wound repair system 
(Section- 2.7.6). Three sets of CM were prepared with KO-DMEM based on presence of 
KO-SR and bFGF in the media composition as tabulated below (Table 5.1). Each type of 
CM was paired with its own control where composition was identical to that of the CM 
excepting that it was not conditioned (Un-CM). 
+SR+bFGF
CM from undifferentiated SHEF-2 
significantly inhibited alveolar A549 cell wound repair after 24 hours in comparison to its 
control 
+SR+bFGF
Un-CM (83 ± 6.56% vs 99 ± 2.38% control; p<0.01) (Figure 5.4A, 5.4B). 
A similar effect was observed in 
+SR-bFGF
CM treated samples when compared to control 
+SR-
bFGF
Un-CM (82 ± 5.12% vs 99 ± 0.5% control; p<0.001) (Figure 5.4A, 5.4B). Whereas, no 
significant difference was observed in wound repair rate between 
-SR-bFGF
CM and 
-SR-
bFGF
Un-CM treated samples (35 ± 4.79% vs 42 ± 8.29% control) (Figure 5.4A). This data 
indicates that presence or absence of bFGF (4 ng/ml) in the media did not influence A549 
cell wound repair; however, absence of KO-SR in the media significantly inhibited wound 
repair after 24 hours when compared to KO-SR containing CM or Un-CM treated samples 
(p<0.001; Figure 5.4A). Taken together, the secretome of undifferentiated hESC is 
inhibitory to the A549 cell wounds in vitro. 
Table 5.1: Composition of culture media for CM preparation from undifferentiated hESC 
Media name Composition 
+SR +bFGF
CM KO-DMEM supplemented with 20% KO-SR, 4 ng/ml bFGF 
+SR -bFGF
CM KO-DMEM supplemented with 20% KO-SR 
-SR -bFGF
CM KO-DMEM 
All above mentioned media were supplemented with 1% L-glutamine, 1% NEAA and 0.1 
mM β-mercaptoethanol.  
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Figure 5.4: Alveolar A549 cell wound repair with CM obtained from undifferentiated hESC. 
(A) A549 cell wound repair with 3 different sets of conditioned (CM) and un-conditioned (Un-CM) 
media after 24 hours. (B) Inverted light microscopy representative images of A549 cell wound 
repair with conditioned and un-conditioned media obtained from undifferentiated hESC. Data 
presented as mean ± SD. n = 4 independent experiments. **p<0.01. ns = not significant. Scale bar, 
200 µm. 
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5.3.3. Differentiated hESC secretome displays differential alveolar epithelial cell 
wound repair effects in vitro 
To evaluate the role of secretory factors of differentiated hESC on alveolar A549 cell 
wound repair, SHEF-2 cells were differentiated towards endodermal lineages by Activin A 
(100 ng/ml) (Rippon et al., 2006, Kubo et al., 2004) through an EB suspension culture 
method (Section- 2.4.4.2). During differentiation, CM was collected at different time-
points from a continuous EB-suspension culture (Figure 5.5). The composition of media 
for conditioning/culture is tabulated below (Table 5.2). Collected CM was tested on A549 
cell wound repair system (Section- 2.7.6). CM collected on day 8 (3.5-8 day-CM) 
significantly inhibited A549 cell wound repair after 24 hours when compared to its 
corresponding control (positive control) (62 ± 15.17% vs 90 ± 14.66% positive control; 
p<0.05) (Figure 5.6A, 5.6B). 11-16 day-CM and 16-22 day-CM also inhibited A549 cell 
wound repair compared to the positive control (63 ± 6.95%, 11-16 day-CM and 52 ± 
6.24%, 16-22 day-CM vs 90 ± 14.66%, positive control; p<0.05 for 11-16 day-CM and 
p<0.01 for 16-22 day-CM) (Figure 5.6A, 5.6B). In contrast, 8-11 day-CM did not inhibit 
alveolar A549 cell wound repair after 24 hours in comparison to the positive control (86 ± 
10.07% vs 90 ± 14.66% positive control) (Figure 5.6A, 5.6B). Although the starting media 
composition of 8-11 day-CM, 11-16 day-CM and 16-22 day-CM were identical the wound 
repair rate was significantly higher in 8-11 day-CM treated sample compared to 11-16 day-
CM (p<0.01) and 16-22-day CM (p<0.01) (Figure 5.6A, 5.6B). The wound repair rate was 
significantly higher in 8-11 day-CM treated sample compared to 3.5-8 day-CM as well 
(p<0.05; Figure 5.6A, 5.6B).  
 
Next, I performed a separate set of similar wound repair experiment with CM collected 
from non-Activin-directed differentiating hESC (Section- 2.4.4.2). To compare and 
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contrast, wound repair with CM collected from Activin-directed differentiation protocol 
was performed in parallel. The overall observation was that A549 cell wound repair with 
CM collected from different stages of Activin-directed or non-Activin directed 
differentiating EBs were not significantly different (Figure 5.7). However, a contrasting 
effect was observed when comparing wound repair rate induction with 16-22 day-CM from 
either Activin-treated or un-treated EBs. 16-22 day-CM collected from non-Activin treated 
differentiating EBs did not show any significant inhibitory effect on A549 cell wound 
repair comparing 8-11 day-CM of un-treated group (70 ± 14.9%, 16-22 day-CM vs 71 ± 
14.64%, 8-11 day-CM) (Figure 5.7); whereas, 16-22 day-CM of Activin-treated 
differentiating EBs significantly suppressed A549 cell wound repair (Figure 5.6, 5.7). 
Activin A (100 ng/ml) itself, when present in 3.5-8 day-CM, did not influence A549 
wound repair (Figure 5.7). Taken together, it can be concluded that during Activin-directed 
hESC differentiation, differentiated ESC secrete factors on day 8-11 which stimulate 
alveolar epithelial cell wound repair; whereas, secreted factors earlier or later than 8-11 
days of differentiation are wound repair-inhibitory in nature. 
Table 5.2: Composition of culture media for CM preparation from differentiating hESC 
through EB suspension culture. 
Media name Composition 
3.5-8 day-CM KO-DMEM supplemented with 10% KO-SR, Activin A (100 ng/ml) 
8-11 day-CM KO-DMEM supplemented with 10% KO-SR 
11-16 day-CM KO-DMEM supplemented with 10% KO-SR 
16-22 day-CM KO-DMEM supplemented with 10% KO-SR 
Positive control KO-DMEM supplemented with 10% KO-SR (Un-conditioned) 
Negative control KO-DMEM (Un-conditioned) 
All above mentioned media were additionally supplemented with 1% L-glutamine, 1% 
NEAA and 0.1 mM β-mercaptoethanol. Positive and Negative controls were not 
conditioned but all others were conditioned in EB culture. 
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Figure 5.5: CM preparation and collection from different stages of hESC differentiation with 
Activin A through EB suspension culture. CM were collected on 1
st
, 3.5
th
, 8
th
, 11
th
, 16
th
 and 22
nd
 
day of differentiation. Colour images were captured on an inverted light microscope with attached 
CCD camera. Scale bar, 50 µm.  
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Figure 5.6: Alveolar A549 cell wound repair with CM collected from different stages of hESC 
differentiation in Activin A-directed differentiation protocol. (A) A549 cell wound repair after 
24 hours with CM obtained from differentiating hESC through EB culture. 3.5-8 day-CM contains 
100 ng/ml concentration of Activin A. Other CM from day 8 to day 22 were Activin A free (post-
treatment stages) and the media composition was identical. Positive and negative controls represent 
A549 cell wound repair with 10% KO-SR supplemented KO-DMEM and KO-SR-free KO-DMEM 
respectively; both of these control media were un-conditioned. (B) Inverted light microscopic 
representative images of A549 cell wound repair with CM obtained from different stages of hESC 
differentiation. Data presented as mean ± SD. (n = 4 independent experiments, triplicate per n). 
*p<0.05, **p<0.01, ***p<0.001. ns = not significant (Newman-Keuls Multiple Comparison 
Posthoc Analysis). Scale bar, 200 µm.  
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Figure 5.7: Alveolar A549 cell wound repair with CM collected from different stages of hESC 
differentiation. A549 cell wound repair with CM collected from different stages of Activin A 
directed (green bars) or Activin-free (open green bars) hESC differentiation through EB suspension 
culture after 24 hours. Positive and negative control represent A549 cell wound repair with 10% 
KO-SR supplemented KO-DMEM or KO-SR free KO-DMEM respectively. Both positive and 
negative controls were un-conditioned. Data presented as mean ± SD. n = 4 independent 
experiments. *p<0.05, ***p<0.001. ns = not significant. 
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5.3.4. Day 8-11 CM of hESC differentiation promotes alveolar A549 cell wound 
repair via cell migration and proliferation when compared with other CM groups 
A successful epithelial wound repair is reported as requiring cell spreading, migration and 
proliferation (Zahm et al., 1991, Puchelle et al., 2006). As seen above, in general, CM 
obtained from differentiated hESC was inhibitory to A549 cell wound repair except 8-11 
day-CM which was comparatively stimulatory (Figure 5.6). Here, I first evaluated the 
influence of CM collected from different time-points of Activin A-directed differentiated 
hESC on A549 cell migration during wound repair by measuring internuclear distance, an 
established method for assessment of cell migration (Geiser et al., 2000, Atabai et al., 
2002) (Section- 2.8). The internuclear distances between A549 cells at the wound margins 
of 8-11 day-CM treated samples were significantly higher than that of 3.5-8 day-CM and 
16-22 day-CM treated samples after 24 hours of wounding (57.26 ± 5.87 µm, 8-11 day-
CM vs  47.41 ± 2.84 µm, 3.5-8 day-CM; p<0.05 and 45.80 ± 2.80 µm, 16-22 day-CM; 
p<0.01) (Figure 5.8A, 5.8B). The internuclear distances between A549 cells at the wound 
margins of 8-11 day-CM treated samples were significantly higher than that of positive 
control as well (57.26 ± 5.87 µm, 8-11 day-CM vs 49.01 ± 4.52 µm; p<0.05) (Figure 5.8A, 
5.8B). The mean internuclear distances in positive control was significantly higher than 
that of negative control (49.01 ± 4.52 µm vs 31.68 ± 2.95 µm, p<0.001) (Figure 5.8A, 
5.8B). However, no statistical significance was determined between internuclear distances 
of positive control and other CM-treated wound repair groups (day 3.5-8 CM and day 16-
22 CM) (Figure 5.8A). 
 
Next, I evaluated the influences of above mentioned CM on A549 cell proliferation during 
wound repair by conducting an MTT cell proliferation assay (Section- 2.9). 8-11 day-CM 
significantly stimulated A549 cell proliferation during wound repair when compared to 
other CM-treated wound repair groups, 3.5-8 day-CM and 16-22 day-CM treated samples 
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(104 ± 27.95%, 8-11 day-CM vs 51 ± 23.97%, 3.5-8 day-CM and 45 ± 3.87%, 16-22 day-
CM; p<0.05) (Figure 5.9). A549 cell proliferation was significantly higher in day 8-11 
CM-treated samples when compared with positive control (104 ± 27.95%, 8-11 day-CM vs 
69 ± 6.21%, positive control) (Figure 5.9). A significant inhibition of A549 cell 
proliferation was also noted in 16-22 day-CM treated wound repair samples when 
compared with positive control (16-22 day CM vs positive control, p<0.05) (Figure 5.9). 
Taken together, conditioned media obtained from day 8-11 of differentiated hESC 
enhances alveolar epithelial cell wound repair through stimulation of both cell migration 
and proliferation. 
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Figure 5.8: Internuclear distances of A549 cells at wound margins after 24 hours of 
wounding. (A) Internuclear distance of A549 cells at the wound margins after 24 hours of wound 
repair with different CM obtained from different stages of Actin-directed differentiated hESC 
through EB culture. Positive and negative controls represent A549 cell wound repair with 10% 
KO-SR supplemented KO-DMEM and KO-SR-free KO-DMEM respectively; both control media 
were un-conditioned. (B) Representative inverted light microscopy images of A549 cell wound 
margins after 24 hours of treatment with CM and control media. Data presented as mean ± SD. (n = 
4 independent experiments, a minimum of 40 measurements were recorded for each sample each 
time). *p<0.05, **p<0.01, ***p<0,001. ns = not significant (Newman-Keuls Multiple Comparison 
Posthoc Analysis). Scale bar, 200 µm. 
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Figure 5.9: MTT cell proliferation assay on A549 cell wound repair. 
A549 cell proliferation was determined by the colorimetric MTT assay on different conditioned 
media obtained from Activin A directed hESC differentiation treated wound repair samples after 24 
hours. Positive and negative controls represent A549 cell wound repair with 10% KO-SR 
supplemented KO-DMEM and KO-SR-free KO-DMEM respectively; both these control media 
were un-conditioned. Data presented as mean ± SD. (n = 3 independent experiments). *p<0.05, 
**p<0.01. ns = not significant (Newman-Keuls Multiple Comparison Posthoc Analysis).  
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5.3.5. Day 8-11 CM was collected from a mixed population of endodermal and 
mesodermal differentiated hESC 
High concentration of Activin directs ESC differentiation into endodermal and mesodermal 
derivatives and suppresses ectodermal differentiation (Kubo et al., 2004, Rippon et al., 
2006). Earlier, I have shown that CM obtained form 8-11 day of Activin-directed hESC 
differentiation enhanced alveolar epithelial cell wound repair (Figure 5.6). Here, I sought 
to investigate whether the CM of this stage of differentiation was from differentiated 
hESC. I performed semi-quantitative RT-PCR (Section- 2.11) and immunocytochemistry 
(Section- 2.12.5) to determine the differentiation status of the Activin-treated hESC. RT-
PCR analysis showed that the differentiated cell population within the EBs of day-11 
expressed endodermal lineage-specific gene, AFP (α-Fetoprotein) (Abe et al., 1996) 
(Figure 5.10, lane-3). AFP expression was also noted in EBs of day-22 of differentiation 
(Lane-4). However, undifferentiated hESC from adherent cultures and spontaneously 
differentiated hESC did not express AFP (Figure 5.10; lane-1, 5 respectively). hESC were 
spontaneously differentiated in adherent culture with 10% FBS in KO-DMEM for 20 days. 
ACTC1 (actin, alpha, cardiac muscle 1), a gene specific to mesodermal lineage (Bruce et 
al., 2007), was expressed in both Activin-directed and spontaneously differentiated hESC 
(Figure 5.10). Unexpectedly, slight expression of ACTC1 was noted in undifferentiated 
hESC. On the other hand, neuro-ectodermal lineage-specific gene, SOX1 (sex determining 
region Y-box 1) (Pevny et al., 1998) expression was not detected any of the differentiated 
samples (Figure 5.10). Previous studies also showed that differentiation of ESC with high 
concentration of Activin A (100 ng/ml) completely suppressed neuro-ectodermal gene 
expression (Kubo et al., 2004). 
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Next, I performed immunocytochemistry on differentiated EBs to evaluate their pluripotent 
marker expression (Section- 2.12.5). EBs from day 1 of differentiation was strongly 
positive for ALP, Oct-4, Nanog and SSEA-4; and weakly positive for SSEA-1 (Figure 
5.11). On the other hand, the expression of above marker proteins was very low (or 
negative) in the day 11 EBs (Figure 5.12). Taken together, I conclude that 8-11 day-CM 
EBs contain endodermal and mesodermal cell population and therefore, 8-11 day-CM 
contains secretory products of a mixed population of endodermal and mesodermal 
differentiated derivatives. 
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Figure 5.10: Semi-quantitative RT-PCR on differentiated hESC. 
Endodermal lineage-specific gene, AFP expression was detected on day-11 differentiated EBs 
(lane-3). AFP expression was not detected in undifferentiated hESC (lane-1) or spontaneously 
differentiated hESC (lane-5). Differentiated hESC on day-11 (lane-3) and day-22 (lane-4) 
expressed mesodermal specific gene, ACTC1. SOX1, an ectodermal specific gene, expression was 
not detected in our tested samples. β-actin was used as a house-keeping gene. 
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Figure 5.11: Evaluation of hESC pluripotent markers on day 1 EBs. 
IgG is for secondary antibody control. DAPI used for nuclear counterstaining. Scale bar, 50 µm. 
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Figure 5.12: Evaluation of hESC pluripotent markers on day 11 EBs. 
IgG is for secondary antibody control. DAPI used for nuclear counterstaining. Scale bar, 50 µm. 
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5.3.6: Secretome analysis CM obtained from differentiated hESC 
As 8-11 day-CM and 16-22 day-CM have shown contrasting alveolar epithelial wound 
repair effects; I hypothesised that the secretome composition of these two CM would 
differ. To test this hypothesis and to identify the proteins responsible for the differential 
wound repair, LC-MS/MS mass spectrometry was performed on CM (Section- 2.5). 
Immediately, I experienced difficulties of determining proteins in the above mentioned 
conditioned media, possibly due to presence of high KO-SR content (10%) in the CM. 
Two approaches were taken to identify secretory human proteins in the CM by this 
method. It detected comparatively high abundance of human proteins in 8-11 day-CM; 
whereas, only one human protein was so far significantly detected in 16-22 day-CM (Table 
5.3). A large numbers of mammalian proteins were although detected in the 10% KO-SR 
supplemented KO-DMEM. The source of these mammalian proteins was mostly bovine in 
origin (Table S4.2, Appendix 2). 10% KO-SR supplemented KO-DMEM was used for 
preparation of CM from differentiating hESC from Day 3.5 to 22. 
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Table 5.3: Activin-directed differentiated hESC secretome detected in 8-11 day-CM and 16-
22 day-CM by LC-MS/MS MALDI TOF/TOF mass spectrometry. 
Detected proteins Accession No Peptide count 
8-11 day-CM 
Actin, gamma 1 propeptide  gi|4501887 3 
Actin-like protein gi|62421069 2 
Alpha 2 globin gi|4504345 4 
Albumin preproprotein gi|4502027 3 
Actin, beta-like 2 gi|63055057 3 
Apolipoprotein C-III precursor gi|4557323 1 
Chain A, Apolipoprotein E3 22kd Fragment 
Lys146glu Mutant 
gi|15826264 1 
Chain B, Nmr Structure Of Human Insulin Mutant 
His-B10-Asp, Val-B12- Aba, Pro-B28-Lys, Lys-B29-
Pro 
gi|159163040 2 
Chain D, Human Insulin Hexamers With Chain B His 
Mutated To Tyr Complexed With Phenol 
gi|5542375 1 
Kininogen L, high MW gi|225724 2 
Heterogeneous nuclear ribonucleoprotein A2/B1 
isoform B1 
gi|14043072 1 
16-22 day-CM 
Chain A, Apolipoprotein E3 22kd Fragment 
Lys146glu Mutant 
gi|15826264 1 
 
Human proteins were tabulated with total Ion score C.I. 100% to >95% in a descending 
manner. Accession numbers are of NCBI protein database. 
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5.4. Discussion 
Regenerative cell therapy for incurable lung diseases continues to evolve at a rapid pace. 
Preliminary studies suggested that adult stem cells, such as bone marrow-derived MSC 
might engraft to the injured lung, replace damaged epithelium and potentiate lung repair in 
animal models of COPD/emphysema, cystic fibrosis and IPF. However, it is now 
recognised that structural engraftment of MSC in lung is generally a rare occurrence with 
an uncertain fate of differentiation into alveolar epithelial cells (Weiss & Finck, 2010). A 
growing body of evidence suggests that the MSC-mediated lung repair effect largely 
occurs through paracrine mechanisms (Ortiz et al., 2007, Zhen et al., 2008, Burdon et al., 
2011, Baber et al., 2007, Nemeth et al., 2010). Unlike adult stem cells, ESC have 
enormous potential to differentiate into wide variety of cell types. Therefore, ESC have 
been suggested as a suitable source of lung epithelial/progenitor cells for cell-based 
regenerative therapy for lung diseases. Numerous approaches have been taken to 
differentiate human and mouse ESC into lung epithelial cells (Wang et al., 2007, Ali et al., 
2002, Rippon et al., 2006, Roszell et al., 2009). More recently, it has been reported that 
intratracheal administration of ESC-derived type II AEC ameliorated pulmonary 
inflammation and fibrosis in a bleomycin-induced experimental lung injury model; where, 
minimally, the early reparative response was mediated by a paracrine mechanism, although 
this paracrine effect has yet to be confirmed (Wang et al., 2010, Banerjee et al., 2012). 
Here, I demonstrate that secretome of differentiated hESC (8-11 day CM) promotes 
alveolar epithelial cell wound repair via stimulation of cell migration and proliferation. 
This paracrine effect of cell-secretory products is specific to a particular stage of ESC 
differentiation, where the secretome of 8-11 day of differentiation is only found to be 
effective in the repair of alveolar epithelial wound in vitro. 
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Data supportive of ESC-mediated paracrine influence in lung injury repair is lacking. 
However, a rat model of cardiac ischemia demonstrated that infusion of mouse-ESC or 
ESC-conditioned media attenuated myocardial ischemia and improved cardiac function 
through a paracrine mechanism by ESC-secretory anti-inflammatory and cytoprotective 
cytokines, IL-10 and VEGF. In addition, transplantation of ESC suppressed pro-
inflammatory cytokines TNF-α, IL-1 and IL-6 production by the injured cardiomyocytes 
(Crisostomo et al., 2008). Moreover, Crisostomo and colleagues demonstrated that the 
ESC paracrine protective mechanism in cardiac ischemia was superior to those of adult 
stem cells (Crisostomo et al., 2008). An in vitro study demonstrated that conditioned media 
obtained from undifferentiated pluripotent human ESC stimulated neonatal cardiomyocyte 
proliferation through secretory growth factors (LaFramboise et al., 2010). ESC paracrine-
mediated anti-apoptotic effects have also been demonstrated in cardiomyocytes and 
corneal endothelial cells in the in vitro culture system (Singla & McDonald, 2007, Singla 
et al., 2008, Lu et al., 2010). Conditioned media obtained from undifferentiated mouse 
ESC was shown to be capable of inhibiting H2O2-induced apoptosis in rat cardiomyocyte 
cell line H9c2 through ESC-secretory anti-apoptotic proteins cystatin c, osteopontin, 
clusterin and tissue inhibitor of metalloproteinase-1 (TIMP-1) via activation of PI3K/Akt 
signalling pathway (Singla & McDonald, 2007, Singla et al., 2008).  
 
To date, ESC-paracrine effects were evaluated mostly by using undifferentiated ESC. In 
my study, approaches were taken to evaluate the paracrine effects of both undifferentiated 
and differentiated hESC on alveolar A549 cell wound repair. My data demonstrates that 
the conditioned media obtained from undifferentiated hESC inhibits alveolar cell wound 
repair. Indirectly, it can be speculated that cell proliferation is not likely to be stimulated 
when an in vitro wound repair is inhibited. In support of this, I observed that conditioned 
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media obtained from day 16-22 of hESC differentiation significantly inhibited alveolar 
epithelial cell wound repair which was also associated with suppression of cell 
proliferation. Considering the LaFramboise et al. 2010 finding coupled to my observation, 
it suggests that secretome of undifferentiated hESC may have a phenotype-specific effect, 
particularly on cell proliferation. 
 
Here, I have demonstrated that after 8-11 days of Activin-directed hESC differentiation, 
the differentiated cell population secrete factors which can stimulate alveolar A549 cell 
wound repair. This wound repair effect was accompanied by cell proliferation and 
migration stimulation. I investigated the effects of stage-specific secretome of 
differentiating hESC separately in the in vitro wound repair system. The comparative data 
analysis reveals an interesting observation that the paracrine effects of differentiating 
hESC on alveolar wound repair is heterogeneous. Unlike day 8-11, the secretome of day 
3.5-8 and 16-22 stage of hESC differentiation appeared to be inhibitory to cell proliferation 
and migration resulting in an inhibition of alveolar epithelial cell wound repair. 
 
Delay or failure of alveolar re-epithelialisation is thought to play a major role in aberrant 
alveolar wound healing and fibrogenesis in IPF (Selman et al., 2001). Type II AEC are the 
progenitors for type I AEC. Type II AEC participate in the injury repair by proliferation 
and differentiation into type I AEC promoting re-epithelialisation of denuded alveolar wall 
and restore the alveolar function (Uhal, 1997, Fehrenbach, 2001). Histopathological 
findings show features of type II AEC hyperplasia, which are presumably due to reparative 
response. A recent study showed that targeted injury of type II AEC induced pulmonary 
fibrosis (Sisson et al., 2010). Therapeutic intervention to facilitate type II AEC migration, 
proliferation and differentiation, therefore could augment the reparative process of injured 
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alveoli. More recently, it has been demonstrated that the milieu of damaged type II alveolar 
epithelial cells stimulates alveolar wound repair by autocrine and paracrine mechanism 
(Buckley et al., 2011). Herein, I report that ex vivo manipulation of hESC towards 
differentiation into endodermal and mesodermal derivatives provides a biological cue 
supportive of alveolar epithelial wound repair. 
 
In this study, hESC were differentiated by restricted exposure of serum (FBS) followed by 
treatment with high concentration of recombinant human Activin A which, according to 
previous published data, generates prominently cells of endodermal origin (Kubo et al., 
2004, Rippon et al., 2006). However, in my protocol, differentiated cells within the EBs, 
particularly on day 11 and 22, expressed both endodermal and mesodermal specific genes. 
The similarity of this gene expression profile in differentiating EBs is also supported by the 
work of Rippon and colleagues (Rippon et al., 2006). Using a similar differentiation 
protocol but on mouse-ESC, Rippon et al. demonstrated that endodermal lineage-specific 
genes Foxa2 and Sox17 appeared to be highly expressed between 10 and 15 days of 
differentiation, whereas, distal lung progenitor marker TTF-1 and type II AEC-specific 
marker SPC gene expression appeared after 15 days of EB differentiation (Rippon et al., 
2006). The mesodermal gene expression spiked on and afterwards the 7
th
 day of 
differentiation. The Rippon et al findings combined with my data, suggest that the 
secretome of day 8-11 hESC differentiation is originated from a mixed population of 
endodermal and mesodermal derivatives. 
 
Identification of ESC-secretory proteins and understanding their biological function in 
alveolar wound repair and regeneration is important for ex vivo optimal differentiation of 
ESC towards regenerative therapeutic application. I explored LC-MS/MS mass 
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spectrometry to identify secretory proteins in 8-11 day-CM of differentiated hESC. 
However, I was not successful in detection of well-documented wound repair-associated 
secretory proteins of H. sapiens origin by this method. Mass spectrometry is a high 
throughput technique and, a wide range of proteins from cell lysates of undifferentiated 
and differentiated ESC have been identified by this method before (Van Hoof et al., 2006). 
Difficulties are apparent in identification of secretory proteins in high serum-containing 
cell culture conditioned media via a LC-MS/MS approach without any immediately 
identified reason (Thorsell et al., 2008). Thereby, a complete secretory profile of the day 8-
11 differentiated hESC remains unknow. By using multiple antibody/ELISA techniques 
myriads of secretory proteins were identified in undifferentiated hESC, among them some 
have proven cell proliferation and differentiation effects (LaFramboise et al., 2010). 
Adaptation of suitable technique(s) will reveal the secretome profile of our specified stage 
of ESC differentiation which preliminarily has shown potential for alveolar epithelial 
repair. 
 
Idiopathic pulmonary fibrosis is a terminal lung disease with poor prognosis. Alveolar 
epithelial cell damage (apoptosis) and failure of re-epithelialisation underpin the 
pathogenesis. ESC has been shown to have anti-apoptotic and anti-fibrotic effects, and here 
I demonstrate their re-epithelialisation stimulatory effect. Due to enormous differentiation 
potential, ESC has been proposed for clinical application of incurable lungs disease (Weiss 
& Finck, 2010). However, potential risk of teratoma formation and graft rejection in post 
transplantation period are the major obstacles in the ESC-mediated cell therapy. Herein, 
alternatively, I propose an acellular ESC-mediated intervention where secretory products 
from an optimised ex vivo-differentiated hESC could be utilised for regenerative therapy 
for IPF or other lung diseases avoiding direct cellular application. Development of a xeno-
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free ESC differentiation culture condition and the identification of their secretome are the 
next steps towards achieving the goal. 
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6.1. General discussion 
The aim of this thesis was to explore two aspects of idiopathic pulmonary fibrosis; one was 
related to the pathogenesis of this disease and another was associated with its regenerative 
therapeutics. Despite intense research, the pathophysiological process of IPF remains 
largely unknown. Although many aspects of this disease have been studied, many aspects 
remain widely unexplored. One of the relatively unexplored pathognomic entities is the 
alveolar bronchiolisation and its effect on fibrogenesis. Using in vitro models and ex vivo 
studies, efforts have been made to understand the role of bronchiolar Clara cells on 
alveolar epithelial wound repair in the context of alveolar bronchiolisation (Chilosi et al., 
2002, Odajima et al., 2007, Plantier et al., 2011). 
 
Currently, there is no effective/curative treatment for IPF other than lung transplantation. 
Due to insufficient donor lungs and post-transplantation complication/failure, a new and 
effective curative therapy needs to be developed. It is now recognised that anti-
inflammatory agents and steroids are ineffective to halt this disease progression. Recent 
unsatisfactory outcomes from newly developed anti-fibrotic drugs warrant an alternative 
stem cell-mediated regenerative approach for the treatment of IPF. In this thesis, 
experiments have been conducted to explore, particularly, the paracrine aspects of hMSC 
and hESC in alveolar epithelial wound repair. IPF is a disease of aberrant alveolar 
epithelial wound repair where inflammation is not the pivotal pathological player (Selman 
et al., 2001). Therefore, a therapeutic measure to facilitate alveolar epithelial restitution is 
likely to be an effective approach. My studies have demonstrated that hMSC and hESC 
stimulate alveolar epithelial wound repair via a paracrine mechanism. Of itself, this 
preliminary finding is important to support future development of stem cell-mediated 
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regenerative therapy for IPF, and highlights why this approach may work. In the following 
sections the major findings of this thesis have been discussed in general. 
 
6.1.1. Clara cells inhibit alveolar epithelial wound repair via TRAIL-depended 
apoptosis mechanism, a new hypothesis has been proposed for the pathogenesis of 
IPF. 
Currently the understanding of IPF pathogenesis is based on several hypotheses as 
discussed in the Chapter 1. While the inflammatory hypothesis is no longer valid, the 
evolving hypothesis implies that IPF develops due to multiple alveolar epithelial injuries, 
failure of alveolar epithelial restitution and abnormal epithelial-mesenchymal cross-talk. 
Type II AEC hyperplasia and fibroblastic foci within the active lesions are consistent 
pathognomic features of IPF. Numerous studies have been performed to explore the 
mechanism of fibroblastic foci formation and the source of myofibroblasts. Besides, the 
feature of alveolar epithelial cell hyperplasia has been explained as an overt-reparative 
response (Panos et al., 1990). Hyperplasia causes remodelling of the alveoli with 
cuboidalised epithelium leading to impaired gaseous exchange, which is the major function 
of the lung. The alveolar cuboidalisation seen in human IPF lungs and animal lung fibrosis 
models is contributed by both alveolar and bronchiolar epithelial cells (Odajima et al., 
2007, Chilosi et al., 2002, Betsuyaku et al., 2000); this alveolar remodelling process is 
called alveolar bronchiolisation. However, the extent of bronchiolar epithelial cell 
contribution in alveolar bronchiolisation in IPF lung was hitherto unknown. Through this 
current study, we now know that 15% of cuboidalised epithelial cells within the alveolar 
bronchiolised area are phenotypically Clara cells, as shown in the Chapter 3 of this thesis. 
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Alveolar bronchiolisation is a part of the pathological process of IPF (Odajima et al., 2007, 
Chilosi et al., 2002, Betsuyaku et al., 2000). However, the effect of Clara cells on alveolar 
epithelial wound repair remains unknown. In this thesis, experiments were undertaken to 
investigate the consequence of Clara-AEC cross-talk during alveolar wound repair in IPF. 
The first challenge was to develop a suitable in vitro model which could be utilised to 
investigate the direct-contact effects of Clara cells on AEC wound repair, as no such model 
existed. A transwell system was utilised. Transwell provides an infrastructure of two 
compartments which are separated by a porous PET membrane. Alveolar epithelial cells 
were grown in monolayer on the upper surface of the PET membrane to make an alveolar 
compartment. Whereas, H441 Clara cells were grown in monolayer on the opposite surface 
to provide a bronchiolar compartment, where the porous PET membrane allowed cell 
migration from one compartment to another. Mechanical injury was made on alveolar 
A549 cells and responses of Clara and A549 cells were monitored. This model was 
replicable and transferable to other cell types as demonstrated through successful 
implementation in SAEC-H441, A549-CCD8Lu and A549-hMSC direct-contact co-culture 
wound repair settings, as shown in the Chapter 3 and Chapter 4. Therefore, this model 
offers a valuable tool for the investigation of interactive cell behaviour of one cell type 
onto another. 
 
The mechanism of Clara cell migration into the affected alveoli is not clearly understood. 
Study on the animal model of lung fibrosis suggests that up-regulation of MMP-9 
facilitates bronchiolar/Clara cell migration to the affected alveoli (Betsuyaku et al., 2000). 
Our in vitro model has demonstrated a distinct type of Clara cell migration, where the 
majority of cells localise to the alveolar epithelial wound margins but not within the wound 
gaps. This migration apparently occurred through a chemotactic-dependent mechanism, as 
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in the absence of AEC, Clara cells were unable to migrate. However, due to time and 
resource limitations, the chemokine(s) responsible for this phenomenon has (have) not 
been identified and remains as an important subject for future study.  
 
According to the current hypothesis, multiple injuries take place in the alveolar epithelial 
cells but does not indicate if there is any direct injury-stimulation to the bronchiolar 
epithelium (Selman et al., 2001, Kaminski et al., 2003). Following alveolar injury, 
fibroblastic response is a part of the normal healing process; however, the 
bronchiolar/Clara cell response in IPF remains hitherto unexplained. Down-regulation of 
caveolin-1 in bronchiolar cells which causes hyperproliferation of Clara cells 
(bronchiolisation) has been reported in IPF (Odajima et al., 2007). Ectopic mucous cell 
differentiation has also been reported, which is involved in the process of bronchiolisation 
in IPF (Plantier et al., 2011). The ectopic differentiation takes place in a NRG1-α 
dependent manner where AEC do not contribute to this differentiation (Plantier et al., 
2011). The evidence above is suggestive of an active involvement of Clara or other 
bronchiolar cells in the pathogenesis of IPF.  
 
Clara cells are the progenitors of bronchiolar epithelium but do not take part in alveolar 
wound repair (Evans et al., 1976, Rawlins et al., 2009, Reynolds & Malkinson, 2010). The 
in vitro data shown in the Chapter 3 of this thesis suggests an inhibitory influence of Clara 
cells on AEC wound repair that is driven via a TRAIL-mediated apoptosis pathway. The ex 
vivo findings on IPF lung tissues also supports the in vitro observation by showing the 
evidence of TRAIL-expressing Clara cells within the bronchiolised alveoli with an 
association of AEC apoptosis, as shown in the Chapter 3. This first report suggests a 
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putative involvement of TRAIL-expressing Clara cells in the pathogenesis of IPF, which 
occurs more likely through the induction of AEC apoptosis.  
 
This study has also demonstrated an anatomical compartment-specific distribution of 
epithelial TRAIL expression profile in the normal healthy lung. TRAIL expression has 
been observed in bronchiolar/Clara cells but not in the alveolar epithelium in health. A 
similar TRAIL expression pattern has been observed in cultured Clara cell line H441 cells 
and type II AEC line A549 cells, where H441 cells were strongly positive to TRAIL but 
A549 cells were negative. The reason for this compartment-specific differential TRAIL 
expression in normal lung epithelium is not clear; however, it is possible that bronchiolar 
cells require TRAIL for normal tissue homeostasis whereas AEC follow a different 
pathway. However, in disease states, this phenotype-specific TRAIL expression alters, 
where AEC express TRAIL along with bronchiolar cells as shown in the Chapter 3. A 
recent study however showed contrasting findings, demonstrating high levels of TRAIL 
expression in AEC of normal healthy lung compared to IPF counterparts (McGrath et al., 
2012). The reason for these opposing findings is as yet unclear. But this reason can be 
methodological. McGrath et al. utilised resected lung tissues from primary lung cancer as 
control subjects where their smoking status was undisclosed. There is a possibility that 
existing disease condition or cigarette smoking can alter TRAIL expression in healthy 
lung. Moreover, they presented non-quantitative data from three control cases, which is, I 
think, inadequate number of control subjects to make a concrete conclusion in this regard. 
 
It has been reported that administration of bleomycin in the lung of TRAIL-knock out mice 
decreases apoptosis in inflammatory cells that exacerbate inflammation and collagen 
deposition (McGrath et al., 2012). Another report however has shown that, application of 
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recombinant TRAIL stimulates collagen secretion by the lung fibroblasts (Yurovsky, 
2003). TRAIL involvement in the pathogenesis of bronchial asthma has also been reported 
(Weckmann et al., 2007). Administration of recombinant TRAIL induces asthma-like 
pathological features in animal models. High levels of TRAIL have also been detected in 
the sputum of asthmatic patients (Weckmann et al., 2007). In addition, both soluble TRAIL 
and TRAIL-expressing Clara cells are capable of inducing apoptosis in alveolar and small 
airway epithelial cells and, application of TRAIL-receptor blocker mAbs reverses Clara 
cell direct-contact induced inhibition of AEC wound repair in vitro, as shown in the 
Chapter 3 of this thesis. 
 
In this thesis, a set of experimental protocols has been designed to clarify the role of Clara 
cells on AEC wound repair. The generated data provide a novel concept for IPF 
pathogenesis. Considering the in vitro and ex vivo findings, I propose that the extensive 
pro-fibrotic remodelling observed in IPF lungs is, at least in part, driven by the TRAIL-
expressing Clara cells through induction of alveolar epithelial cell apoptosis via a TRAIL-
dependent mechanism. However, further experimentation is required to consolidate this 
hypothesis; possible future studies are suggested below (Section 6.2). 
 
6.1.2. hMSC enhance lung epithelial wound repair through paracrine mechanisms 
Due to the lack of effective anti-IPF treatment to date, an MSC-mediated strategy has been 
suggested. Pre-clinical studies on animal models of acute lung injury (ALI) and pulmonary 
fibrosis have shown some promise for clinical application of hMSC in idiopathic 
pulmonary fibrosis. The MSC-mediated regenerative therapy for IPF is still in its infancy. 
However, a recent small scale Phase I clinical trials of adipose-derived MSC on 12 IPF 
patients has shown promising safety profile (Tzouvelekis et al., 2011), which is 
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encouraging for future broader multicenter clinical trials. The reparative mechanism of 
MSC is largely mediated by paracrine mechanisms in injured lung (Weiss & Finck, 2010). 
More recently, this notion has been further supported by the work of Curley et al., where 
they demonstrate that MSC themselves and the conditioned media obtained from MSC 
exert similar wound repair effects on a ventilator induced murine model of ALI and 
alveolar A549 cell wound repair (Curley et al., 2012). 
 
Anti-inflammatory effects of MSC have been demonstrated through murine models of ALI 
and pulmonary fibrosis (Ortiz et al., 2007, Gupta et al., 2007, Curley et al., 2012). 
However, the effect of MSC or their secretory product on injured AEC remains widely 
unexplored. The animal model is not suitable for monitoring the AEC migration. An in 
vitro wound repair model can be a suitable alternative for this purpose, where the epithelial 
cell migration and proliferation in response to given stimuli can be monitored. Using this 
method, a recent study has demonstrated that serum-free MSC conditioned media enhances 
alveolar A549 cell wound repair (Curley et al., 2012). Following a similar model, the 
experiments in this thesis show that the serum-free MSC conditioned alone is unable to 
enhance A549 cell wound repair but requires trace serum supplementation (0.2% FBS). 
The reason for this different pattern of A549 cell response to hMSC CM is not clear, but it 
is possible that this happens due to the donor variation of hMSC secretome profile. 
Another possible cause can be the source of the A549 cell lines. Curley et al. obtained 
A549 cell line from Porton Down, UK; whereas, our study used ATCC, USA originated 
A549 cell line which expressed type II AEC marker, proSP-C. However, in this study, 
serum-free MSC CM alone was capable of SAEC wound repair, as shown in the Chapter 4. 
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Understanding the function of the hMSC secretome on AEC wound repair is important, as 
delayed or failure of AEC restitution is the likely cause of uncontrolled fibrosis in IPF. 
Hyperplasia of type II AEC within the IPF lung, as seen in histopathological tissue 
samples, indicates a presence of sufficient cells for repair. Therefore, modulation of type II 
AEC migration and/or differentiation can be an effective measure for appropriate wound 
repair. This study demonstrates the paracrine stimulatory effects of hMSC secretome on 
pulmonary epithelial wound repair. 
 
Identification and characterisation of the individual component of hMSC secretome were 
the next steps of my investigation protocol. Myriads of secretory proteins have been 
identified in the hMSC conditioned media in previous studies. However, published hMSC 
secretome profiles largely vary depending on the detection techniques (Chen et al., 2008a, 
Estrada et al., 2009, Walter et al., 2010). The antibody based techniques have identified 
mostly growth factors and cytokine (Parekkadan et al., 2007, Chen et al., 2008a); on the 
other hand, the mass spectrometry based technique identified proteins which are mostly 
ECM proteins (Estrada et al., 2009, Walter et al., 2010, Scheibe et al., 2012). The reason 
for this difference is not clear, possibly, secretory growth factors and cytokines present in 
the conditioned media at a very low concentration which is beyond the lowest detection 
limit of LC-MS/MS mass spectrometry. Moreover, it is recognised that the adoption of 
ELISA-based approaches carries with it an inherent bias towards identification only of 
those constituents that one may wish to detect. I therefore, specifically elected to adopt an 
approach that would minimise such a potential bias, which admittedly in turn generates a 
methodological bias away from proteins present at lower abundance levels. However, 
considering my findings and those of others, it can be concluded that hMSC effectively 
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secrete a wide and varied spectrum of growth factors, cytokines and ECM/matricellular 
proteins with diverse biological and functional properties.  
 
Using antibody depletion technique, a recent study has shown that hMSC-CM enhances 
alveolar A549 cell wound repair through secreted KGF (Curley et al., 2012). In line with 
other studies, KGF was not detected in hMSC-CM or lung fibroblast-CM in our study 
(Parekkadan et al., 2007, Estrada et al., 2009, Walter et al., 2010, Scheibe et al., 2012). 
However, we have consistently detected Fibronectin, Lumican, and Periostin in the hMSC-
CM which appear to be capable of stimulating alveolar and small airway epithelial cells 
wound repair with or without supplementation of trace serum. The alveolar epithelial cell 
wound repair occurs through stimulation of cell migration but not by cell proliferation with 
hMSC-CM or secretory individual protein components, as shown in the Chapter 4. Growth 
factors such as KGF, HGF have an established role in epithelial restitution during injury 
repair. It is now recognised that ECM proteins not only provide the structural support of 
the tissue but also provide biological cues for cell growth, proliferation, migration and 
differentiation (Frantz et al., 2010). Previous studies have demonstrated that Fibronectin, 
Lumican and Periostin are crucial for epithelial wound repair. This study has not confirmed 
that hMSC conditioned media enhances alveolar or small airway epithelial wound repair 
through their secretory Fibronectin or Lumican or Periostin, but demonstrated an abundant 
presence in hMSC secretome which are capable of pulmonary epithelial wound repair. 
Therefore, it is not unlikely that these secretory proteins contribute, at least in a part, to the 
hMSC-mediated pulmonary epithelial cell wound repair.  
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6.1.3. Differentiated hESC displays both positive and negative regulatory effects of 
alveolar epithelial wound repair depending on their stage of differentiation through 
paracrine mechanisms 
hESC are pluripotent stem cells with the capacity to differentiate into derivatives of all 
three germ layers including alveolar epithelial cells. Due to this enormous differential 
potential, hESC have been suggested for the regenerative therapy for lung injury and 
pulmonary fibrosis. Numerous protocols have been developed for the differentiation of 
type II AEC from human and mouse ESC (Ali et al., 2002, Rippon et al., 2006, Wang et 
al., 2007, Roszell et al., 2009). However, data supportive of ESC-mediated healing effect 
in pulmonary fibrosis is limited. 
 
Intratracheal administration of ESC-derived type II AEC has shown amelioration of 
pulmonary inflammation and fibrosis in a bleomycin-induced experimental lung injury 
model, where, the early reparative response was thought to be mediated via paracrine 
mechanisms (Wang et al., 2010, Banerjee et al., 2012). The paracrine effect of 
differentiated hESC on alveolar epithelial cell wound repair is, to date, unexplored. 
Through this study the paracrine role of undifferentiated and differentiated hESC have 
been investigated on in vitro alveolar epithelial wound repair system. The data that 
generated through this study is an important addition to our understanding of the paracrine 
role of hESC on alveolar wound repair.  
 
The secretome of undifferentiated pluripotent hESC inhibits alveolar epithelial wound 
repair, as shown in the Chapter 5; whereas, the secretome of Activin-directed differentiated 
hESC has shown differential alveolar epithelial cell wound repair effects. Overall, the 
conditioned media obtained from differentiated hESC appeared to be inhibitory to alveolar 
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epithelial wound repair comparing control except the Day 8-11 CM. Conditioned media 
obtained from day 8-11 of differentiation significantly stimulated wound repair comparing 
that were observed with CM collected from before and after the specific differentiation 
window of 8-11 days. Subsequent studies clarify that the alveolar epithelial wound repair 
inhibition by CM obtained from 3.5-8 and 16-22 days differentiated hESC occurs through 
inhibition of cell migration and proliferation. 
 
The anti-inflammatory and cytoprotective functions of ESC or ESC-conditioned media 
have already been demonstrated in animal models of cardiac ischemia and pulmonary 
fibrosis (Wang et al., 2010, Crisostomo et al., 2008). My study data demonstrated human 
ESC-paracrine mediated pulmonary epithelial wound repair stimulation which is albeit a 
differentiation-stage specific. The next step was to identify the hESC secretory molecules 
that were responsible for this observed effect. After successful detection of the hMSC 
secretory proteins, as shown in the Chapter 4, LC-MS/MS mass spectrometry was 
attempted. However, despite the repetitive efforts, the mass spectrometry technique was 
unable to identify any well-known biologically relevant secretory proteins in differentiated 
hESC conditioned media. Mass spectrometry is a high throughput technique and a wide 
range of proteins from cell lysates of undifferentiated and differentiated ESC have been 
identified previously by this method (Van Hoof et al., 2006). Due to consecutive failures, I 
concluded that the LC-MS/MS mass spectrometry approach may not be suitable for 
identification of secretory proteins from a high serum-containing culture media. An 
antibody-based growth factor/cytokine array kit can be used instead. 
 
Although this study and previous reports provide supportive evidence for the clinical 
application of ESC, there are certain concerns including potential risk of teratoma 
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formation and graft-rejection during post transplantation period. As ESC have potential 
paracrine-mediated healing effects, through this study I propose an acellular ESC-mediated 
intervention, where secretory products from an optimised in vitro-differentiated hESC 
could be utilised for regenerative therapy in various lung diseases including IPF to avoid 
direct application of cellular components. However, there is still a long way to go and 
many other issues need to be explored before development of such acellular regenerative 
modalities for the treatment of IPF. 
 
6.2. Recommendations for future studies 
1. Due to the unavailability of primary and IPF Clara cells, human Clara cell line, H441 
cells have been utilised in this study to evaluate the role of Clara cells on AEC wound 
repair. Similar experiments can be replicated using primary alveolar epithelial cells and 
Clara cells isolated from IPF and healthy control lungs. Anatomically, Clara cells and AEC 
are situated in close proximity; therefore, it is difficult to isolate a homogeneously pure 
population of type II AEC and Clara cells. These two cell populations can be separated 
from each other and from lung fibroblasts by using antibody coated magnetic micro-bids, 
such as MACS
®
 Cell Separation Technology. Magnetic micro-bids will be conjugated with 
antibody proSP-C specific for type II AEC and antibody CC10 specific for Clara cell 
isolation. The next challenge is the optimisation of appropriate culture conditions for AEC 
and Clara cells. As primary human small airway epithelial cells (SAEC) grew well in 
SAGM (Small airway growth media, Lonza). SAGM can be used for AEC and Clara cell 
culture initially and subsequently media could be optimised by adding suitable growth 
factors if required. 
 
Chapter 6:                                                               General discussion and conclusion 
PhD thesis by K. M. Akram                                                                    Keele University - 246 - 
2. My thesis has explored the TRAIL expression profile in IPF and normal healthy lung 
tissues. TRAIL has an equal binding affinity to its four cell membrane receptors TRAIL-
R1, TRAIL-R2, TRAIL-R3 (DcR1) and TRAIL-R4 (DcR2). Up-regulation of TRAIL-R1 
and TRAIL-R2 sensitises cells to undergo TRAIL-mediated apoptosis; conversely, up-
regulation of decoy receptors TRAIL-R3 and TRAIL-R4 makes cells resistant to TRAIL-
induced apoptosis. Therefore, a complete expression profile of these four receptors in IPF 
and normal healthy lung tissue samples needs to be evaluated. Evidence of TRAIL-R1 and 
TRAIL-R2 up-regulation along with TRAIL-R3 and TRAIL-R4 down-regulation in AEC 
of IPF lungs will further support the hypothesis proposed here.  
 
3. In this thesis, the paracrine influences of hMSC on alveolar A549 cell and primary small 
airway epithelial cell wound repair have been investigated. It would be interesting to 
replicate similar sets of experiments on alveolar epithelial cells isolated from IPF lung to 
see if hMSC elicit the same response. 
 
4. My studies have not confirmed that hMSC CM stimulates pulmonary epithelial cell 
wound repair through secretory Fibronectin, Lumican or Periostin. This study suggests a 
possibility of hMSC CM-mediated wound repair effects may be driven by the above 
secretory protein(s). Further studies can be done to confirm if this is the case. A depletion 
method could be adopted using neutralising antibodies specific to Fibronectin, Lumican 
and Periostin in hMSC conditioned media in similar or adapted wound repair systems. 
 
5. In my study, 10% KO-SR has been used for the hESC differentiation protocol and 
hESC-CM preparation as an initial step. Adaptation of a similar xeno-free ESC 
differentiation culture protocol by withdrawal of serum and addition of recombinant 
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growth factor(s) is the next step towards development of hESC-mediated acellular 
regenerative therapeutic modalities. The identification of hESC secretory proteins in the 
CM of different stages of differentiation remains elusive. A suitable technique, such as, 
protein array method can be approached for precise profiling of the hESC secretome. 
 
6. I have proposed a possible TRAIL-mediated apoptosis mechanism for the alveolar 
epithelial cell apoptosis during the pathogenesis of IPF. As anti-apoptotic paracrine effects 
of MSC and ESC have been shown (Zhen et al., 2008, Singla & McDonald, 2007), it 
would be important to dissect this further through further exploration to seek whether the 
hMSC CM or hESC CM could abrogate the TRAIL-mediate AEC apoptosis. 
 
6.3. CONCLUSION  
In the UK, 4000 new IPF cases are being diagnosed each year and amongst them more 
than two-third die within 3-5 years of diagnosis. Therefore, a better understanding and 
clarification of critical pathogenic events in IPF and exploration of novel therapeutic 
approaches are timely. Through this thesis, I have suggested a new aspect of pathogenesis 
which implies that the TRAIL-expressing Clara cells are likely to be involved in the 
aberrant alveolar wound repair and subsequent fibrogenesis in IPF, which occurs possibly 
through induction of alveolar epithelial cell apoptosis via a TRAIL-medicated mechanism. 
This finding unravels critical targets for further investigative dissection towards 
development of novel therapeutic agents for IPF. The study of this thesis has also 
demonstrated the paracrine role of hMSC and hESC in the alveolar epithelial wound repair. 
hMSC conditioned media and a cohort of secretory proteins, namely, Fibronectin, Lumican 
and Periostin have shown some promise in pulmonary epithelial wound repair. As a 
preliminary step, I have also demonstrated the paracrine healing capacity of differentiated 
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hESC which has opened a new horizon for future study. Further identification and 
characterisation of hESC and hMSC secretome on alveolar wound repair are the next steps 
towards development of novel acellular stem cell-mediated regenerative therapeutic 
intervention for IPF and other incurable lung diseases. 
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Appendix 1: 
Table S1: Media and other supplements for cell culture. 
Name Description Cat No Company 
DMEM 
Dulbeco‟s Modified Eagle 
Medium 
21969 
Gibco, Invitrogen, 
Paisley, UK 
KO-DMEM Knock Out DMEM 10829 
Gibco, Invitrogen, 
Paisley, UK 
FBS Fetal Bovine Serum DE14-870F Lonza, Belgium 
KO-SR Knock Out Serum Replacement 10828 
Gibco, Invitrogen, 
Paisley, UK 
PBS Phosphate Buffered Saline BE17-516F Lonza, Belgium 
SABM Small Airway Basal Medium CC-3119 Lonza, USA 
Trypsin/EDTA Trypsin 10X with Versene BE02-007E Lonza, Belgium 
DMSO Dimethyl Sulphoxide  D2650 Sigma-Aldrich, UK 
L-glutamine L-Glutamine BE17-605E Lonza, Belgium 
NEAA Non Essential Amino Acid BE13-114 Lonza, Belgium 
Matrigel BD Matrigel Matrix 354234 
BD, Bedford, MA, 
USA 
Collagen I Rat tail Collagen Type I 354249 
BD Bioscience, 
Bedford, MA, USA 
bFGF Human FGF-basic 100-18B PeproTech, London 
PSA 
Penicillin-Streptomycin-
Amphotericin B 
17-745E Lonza, MD, USA 
β-mercaptoethanol  2-Mercaptoethanol 31350-010 
Gibco, Invitrogen, 
Auckland, NZ 
Activin A Human Activin-A 120-14 
PeproTech, Inc., 
Rocky Hill, NJ, USA 
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Table S2: Panel of primary antibodies used for immunocytochemistry and 
immunohistochemistry.  
Antibody Description Dilution Company 
proSP-C 
Anti-ProSurfactant Protein C 
antibody. Rabbit polyclonal  (IgG) 
1:250 cell 
1:1500 tissue 
Abcam 
Cat No- ab40879 
CC10 
Anti-Uteroglobin antibody 
Rabbit polyclonal (IgG) 
1:200 
Abcam 
Cat No- ab40873 
TRAIL 
Anti-TRAIL antibody 
Rabbit polyclonal (IgG) 
1:100, cell 
1:80, tissue 
Abcam 
Cat No- ab2435 
TRAIL-R1 
Recombinant anti-TRAIL-R1 
antibody. Mouse monoclonal (IgG1) 
10µg/ml 
Enzo Life Science 
Cat No- ALX-804-297A-
C100  
TRAIL-R2 
Recombinant anti-TRAIL-R2 
antibody. Mouse monoclonal (IgG1) 
10µg/ml 
Enzo Life Science 
Cat No- ALX-804-298A-
C100 
CD44 
Anti-H-CAM antibody 
Mouse monoclonal (IgG2a) 
1:500 
Millipore, USA 
Cat No- CBL154-20UL, 
Component of Cat No- 
SCR067 
CD90 
Anti-THY-1 antibody 
Mouse monoclonal (IgG1) 
1:500 
Millipore, USA 
Cat No- CBL415-20UL, 
Component of Cat No- 
SCR067 
CD146 
Anti-MCAM antibody 
Mouse monoclonal (IgG1) 
1:500 
Millipore, USA 
Cat No- MAB16985-20UL, 
Component of Cat No- 
SCR067 
CD14 
Anti-CD14 antibody 
Mouse monoclonal (IgG1) 
1:500 
Millipore, USA 
Cat No- MAB1219-20UL, 
Component of Cat No- 
SCR067 
CD19 
Anti-CD19 antibody 
Mouse monoclonal (IgG1) 
1:500 
Millipore, USA 
Cat No- MAB1794-20UL, 
Component of Cat No- 
SCR067 
STRO-1 
Anti-STRO-1 antibody 
Mouse monoclonal (IgM) 
1:500 
Millipore, USA 
Cat No- MAB4315-20UL, 
Component of Cat No- 
SCR067 
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Continued 
Osteocalcin 
Anti-Osteocalcin antibody 
Mouse monoclonal  
1 µg/100µl 
R & D System 
Part No- 962645, 
Component of Cat No- 
SC006 
Aggrecan 
Anti-Aggrecan antibody 
Goat polyclonal  
1 µg/100µl 
R & D System 
Part No- 962644, 
Component of Cat No- 
SC006 
FABP-4 
Anti-FABP-4 antibody 
Goat polyclonal 
1 µg/100µl 
R & D System 
Part No- 962643, 
Component of Cat No- 
SC006 
ALP 
Anti-Alkaline phosphatase antibody. 
Mouse monoclonal (IgG1) 
1 µg/100µl 
R & D System 
Part No- 962647, 
Component of Cat No- 
SC008 
Oct-4 
Anti-Oct-3/4 antibody 
Goat polyclonal 
1 µg/100µl 
R & D System 
Part No- 962649, 
Component of Cat No- 
SC008 
Nanog 
Anti-Nanog antibody 
Goat polyclonal 
1 µg/100µl 
R & D System 
Part No- 963488, 
Component of Cat No- 
SC008 
SSEA-1 
Anti-SSEA-1 antibody 
Mouse monoclonal (IgM) 
1 µg/100µl 
R & D System 
Part No- 963489, 
Component of Cat No- 
SC008 
SSEA-4 
Anti-SSEA-4 antibody 
Mouse monoclonal (IgG3) 
1 µg/100µl 
R & D System 
Part No- 962648, 
Component of Cat No- 
SC008 
 
All primary antibodies are anti-human except FABP-4 which is anti-mouse. 
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Appendix 2 
 
 
Figure S3.1: Assessment of apoptosis in migrated H441 cells in A549-H441 direct contact co-
culture wound repair. 
(A) Apoptosis in migrated H441 cells at juxta-wound monolayers after 24 hours of direct contact 
co-culture (n = 3 independent experiments). Negative control: apoptosis in A549 wounded 
monolayers cultured in SF-DMEM and positive control: apoptosis in A549 wounded monolayers 
cultured in 200 µM H2O2 for 24 hours. (B) Confocal laser Z-scanning shows juxta-position of 
cluster of TUNEL-positive nuclei of un-labelled A549 cells (Green nuclei) and TUNEL-negative 
migrated DiI-labelled H441 cells (Red) (image magnification, 700x). (C) Laser scanning confocal 
microscopic image show TUNEL positive un-labelled A549 cells in negative control. (D) Red cells 
are DiI-labelled migrated H441 cells and green nuclei are TUNEL positive nuclei in A549-H441 
direct contact co-culture wound repair system after 24 hours. (E) Positive control. Scale bar, 100 
µm (C, D, E). 
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Figure S3.2: TUNEL assay on A549-CCD 8Lu direct-contact co-culture wound repair system. 
TUNEL positive cells were not observed in A549 cell population (Red) in the A549-CCD 8Lu 
direct-contact co-culture wound repair system and A549 monoculture (negative control). In 
positive control, apoptosis was induced in A549 cell monoculture with 200 µM H2O2 for 24 hours. 
A549 cells were labelled with DiI and green signal indicate TUNEL positive apoptotic nuclei. 
Scale bar, 200 µm.  
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Figure S3.3: SAEC apoptosis in SAEC-H441 direct contact co-culture wound repair model. 
Laser scanning confocal Z-slicing demonstrates that TUNEL positive nuclei were confined within 
the DiI-labelled cells and hence confirms the apoptotic cells are SAECs. Image magnification 
1000x.  
Appendices  
PhD thesis by K. M. Akram                                                                    Keele University - 284 - 
 
Figure S4.1: Migration of MSC towards contra-lateral surface of transwell PET membrane 
after 24 hours of culture in absence of A549 cells. 
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Table S4.1: Protein components of serum-free CCD-8Lu CM detected by LC-MS/MS 
mass spectrometry. 
CCD-8Lu CM preparation was as described in the Section- 2.4.3, 2.5. Accession numbers 
are derived from MS/MS data searches against the non-redundant Human NCBI Protein 
Database.  
 
Protein Name 
Accession 
Number 
Peptide 
Count 
Ion Score 
C.I. % 
Keratin, type II cytoskeletal 1 gi|1346343 4 99.99374889 
Albumin preproprotein [Homo sapiens] gi|4502027 5 99.99759033 
Unnamed protein product [Homo sapiens] gi|28317 5 99.76069218 
Keratin 2 [Homo sapiens] gi|47132620 3 99.99695241 
Keratin 6B, isoform CRA_a [Homo sapiens] gi|119617032 2 99.98225986 
Alpha2-HS glycoprotein [Homo sapiens] gi|2521981 2 99.96394569 
Fibronectin precursor [Homo sapiens] gi|31397 2 99.89359627 
Keratin type II gi|908801 2 98.12086939 
Chain A, Structure Of Human Apolactoferrin gi|4699853 1 99.5147597 
Nebulin gi|19856971 1 96.50089446 
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Table S4.2: Protein components detected in 10% KO-SR supplemented KO-DMEM 
by LC-MS/MS MALDI TOF/TOF mass spectrometry. 
Detected proteins Accession No Peptide count 
10% KO-SR in KO-DMEM (Un-conditioned media) 
Apolipoprotein A-I, apoA-1 gi|245563 11 
Serum albumin gi|1351907 7 
Apolipoprotein C-III precursor [Bos Taurus] gi|47564119 4 
Chain A, Crystal Structure Of The First Active 
Autolysate Form Of The Porcine Alpha Trypsin 
gi|1942351 3 
Haemoglobin subunit alpha [Bos Taurus] gi|116812902 3 
Chain A, The Crystal Structure Of Modified Bovine 
Fibrinogen 
gi|6980814 2 
Complement C4 gi|31563307 2 
Alpha-2-HS-glycoprotein precursor [Bos Taurus] gi|27806751 1 
Albumin [Felis catus] gi|30962111 3 
Haemoglobin subunit alpha [Homo sapiens] gi|4504345 3 
Haemoglobin subunit alpha-3 gi|122299 3 
Haemoglobin alpha gi|122413 2 
Serotransferrin gi|2501351 2 
Chain D, Human Insulin Hexamers With Chain B His 
Mutated To Tyr Complexed With Phenol 
gi|5542375 2 
Kininogen L, high MW gi|225724 3 
Complement component 3 [Bos taurus] gi|4093220 1 
Haemoglobin subunit alpha-1/2 gi|122449 1 
Hepatocyte growth factor activator preproprotein 
[Homo sapiens] 
gi|4504383 1 
Complement C3 gi|116597 1 
Chain B, Structural Properties Of The B25tyr-Nme-
B26phe Insulin Mutant. 
gi|61680182 2 
Haemoglobin subunit alpha gi|122500 2 
Alpha-1-globin [Mus musculus] gi|553919 2 
Angiotensinogen gi|113876 1 
Serum amyloid A2 [Pongo abelii] gi|197101992 2 
Serum amyloid A protein [Canis lupus familiaris] gi|164060 2 
Insulin precursor [Felis catus] gi|57163807 2 
Serpin A3-1 precursor [Bos taurus] gi|31340900 3 
 
Proteins were tabulated with total Ion score C.I. 100% to >95% in a descending manner. 
Accession numbers are of NCBI protein database.  
